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1. Introduction. General Overview of Cyanating Reagents 
in Organic Synthesis. 
 
1.1. Cyanides.  
 
The cyanide moiety is a functional group consisting of a carbon atom triple-bonded to a 
nitrogen, which contains an additional lone pair of electrons. In this situation two of the 
bonds are described as π-bonds and the remaining one as a σ-bond (Figure 1). Cyanide 
salts are available as free anions, which can serve as ligands in cyanide complexes, or as 
nitrile synthons after reaction with alkyl halides in the well-known Kolbe synthesis.[1] The 
preparation and properties of cyano-containing compounds are further detailed below in 
the next Chapters.[2]  
 
 
            Figure 1. C–N bonds in a cyano group. 
 
1.1.1. Alkali metal cyanides. 
 
The common method for the synthesis of alkali cyanides consists of a neutralization 
process of an alkali hydroxide in aqueous solution with either gaseous or aqueous solution 
of hydrogen cyanide (Scheme 1).[3] The latter is currently produced in great quantities by 
several industrial processes from methane and ammonia. 
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Scheme 1. Alkali cyanides synthesis. 
 
Following this methodology, the two most commonly used alkali metal cyanides — NaCN 
3a and KCN 3b — can be prepared. Both are white crystalline solids of high toxicity. 
 
These two salts have been used worldwide in gold mining.[4] Gold is a noble chemically 
inert metal that cannot easily be converted into water-soluble derivatives. Such 
transformation requires a strong oxidant in the presence of a complexing agent. The 
classical example is the use of aqua regia — 1/3 mixtures of HNO3(conc.)/HCl(conc.) — where 
nitricic acid is the oxidant and the complexing agent is a chloride generated by HCl(aq.). As 
cyanides are even stronger coordinating agents, they can be used for the same purpose 
using oxygen as oxidant (Scheme 2).[4] 
 
 
Scheme 2. Gold extraction with cyanides. 
 
In organic synthesis their most common uses are in nucleophilic addition (for example, 
formation of cyanhydrines, Scheme 3a) or in nucleophilic substitution (cyanation of acyl 
chlorides or of (pseudo)halogen-substituted alkanes, Scheme 3b,c) reactions.[5]  
 
 
Scheme 3. Common reactivity of alkali cyanides. 
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1.1.2. Transition metal complexes with cyanides. 
 
When the lone electron pair localized on a carbon atom in the cyanide ion is employed for 
coordination to a metal, a very stable M–CN σ-bond is formed.[3] In such a case, a cyanide 
acts either as a σ-donating ligand, thus stabilizing high oxidation states of transition 
metals, or as a π-acid ligand, which accepts electron density in one of its empty π∗-
antibonding orbitals from transition metals in low oxidation states (Figure 2). Different 
binding models, in which the nitrogen coordinates to the metal (isocyanide) or the cyanide 
acts as a bidentate or π-donor ligand are also possible.[6]   
 
C NM
empty *-orbitalfilled d orbital
C NM
-donationempty d orbital
 
Figure 2. Cyanide anion as a ligand. 
 
General procedures for their synthesis include ligand exchange with excess of a cyanide 
source or oxidative addition of cyanogens to metal centers in low oxidation states.  
 
Hexacyanometallates of Fe(III) or Co(III) — K3[Fe(CN)6] (5) and  K3[Co(CN)6] (6) — and 
tetracyanometallates of Pd(II) and Pt(II) — K2[Pd(CN)4] (7) and  K2[Pt(CN)4] (8) — can be 
highlighted as representative examples of these complexes. 
 
1.2. Nitriles. 
 
A nitrile, which can also be more specifically designated as organonitrile, is every organic 
molecule containing a cyano group directly bonded to a C-atom.[7] In contrast to inorganic 
cyanides, the lone electron pair of a cyano moiety located on the carbon atom is used to 
form a covalent bond with an organic framework, thus modifying the polarity of the 
structure. The partial positive charge in nitriles is located on the carbon atom, whereas the 
partial negative charge – on the more electronegative nitrogen atom (Figure 3). Since the 
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carbon center has sp hybridization, the geometry of a molecule is expected to be linear. 
 
Figure 3. Polarity and molecular geometry in nitriles. 
 
Organonitriles are undoubtedly very useful molecules playing an important role in 
everyday life of humans.[8] As representative examples, worth mentioning cyanoacrylate, 
which is used as an adhesive,[9a] — so-called nitrile rubber — acrylonitrile polymer 
derivatives employed as a resistant material for gloves or seals[9b] and a myriad of drugs 
featuring nitrile groups in their structures (Scheme 4).[10] 
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Scheme 4. Practically useful synthetic products possessing nitrile functionalities. 
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Regarding synthetic aspects, nitriles are extremely versatile groups in organic chemistry 
as they can easily be converted into different functional groups. Thus, they can be 
reduced to primary amines, aldehydes or ketones, hydrolyzed to carboxylic acids or 
amides, transformed into tetrazoles by “click chemistry” or be transformed into 
esters.[1][5][11] The most representative procedures to achieve these transformations 
through classical organic and organometallic chemistry are summarized in Scheme 5 
below.  
 
 
Scheme 5. Chemical transformation of nitriles. 
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1.2.1. Synthesis of nitriles. 
 
Alkyl nitriles are generally synthesized by nucleophilic substitution at alkyl halides using 
inorganic cyanide salts. Hence, the most classical approach to afford nitriles is the 
modified Kolbe synthesis,[12] where alkyl halides are converted into alkyl nitriles by 
treatment with sodium (3a) or potassium (3b) cyanides in DMSO (Scheme 6a). 
Alternatively, secondary nitriles can be accessed from ketones by reacting with 
sulfonylmethyl isocyanides according to Van Leusen protocol, which is also valid for the 
synthesis of arylnitriles (Scheme 6b).[13] 
 
 
Scheme 6. Synthesis of alkyl nitriles. 
 
Aryl nitriles represent important intermediates in organic synthesis and, as a 
consequence, a plethora of methodologies for their preparation have been established 
along the years.[14] As their synthesis is a main target of my dissertation, a detailed study 
of their formation will be discussed in the next sections.  
 
Basically, there are two pathways to construct these frameworks: (1) by an indirect way 
performing a functional group derivatization or (2) by direct implantation of the cyano 
moiety into the molecule using a cyanating reagent. 
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1.2.1.1. Functional group derivatization. 
 
These methodologies are based on chemical transformations of functional groups and 
afford the nitrile group by forming the C≡N bonds via oxidation, reduction or elimination 
which take place on other functional groups. For example, aryl nitriles can be obtained 
upon refluxing primary amides with excess of POCl3[15a] or SOCl2[15b] (Scheme 7).[15] 
 
 
Scheme 7. Traditional approach to access aryl nitriles. 
 
Other more modern methods for their synthesis have been developed; some of them are 
summarized in Scheme 8.[14] In these preparations, aryl-substituted oxiranes ([a]),[16] 
benzaldehydes ([b]),[17] alkenes ([c]),[18] alkynes ([d])[19] and benzyl halides[20] were suitable 
starting materials when combined with different nitrogen sources to afford the formation of 
the corresponding aryl nitriles. Oxidation of benzylamines ([f])[21] as well as catalytic 
dehydration of aldoximes ([g])[22] and benzamides ([h])[23] also appeared to be suitable 
protocols for their synthesis.  
Ar
Ar
Ar
Ar
O
Ar
NH2
Ar
Ar
N
X
X = H, Ph
N3
OH
X
Ar C N
O
O
Ar
NH2
X = H, Br, alkyl, aryl
[a]
[b]
[c]
[d]
[e]
[f]
[g]
[h]
 
Scheme 8. Modern strategies for the synthesis of aryl nitriles. [a] DMP (2.0 equiv.), NH3, 70 °C, 4 h. [b] NaN3 
(1.5 equiv.), TfOH (3.0 equiv.), MeCN, rt, 2 min. [c] PhI(OAc)2 (5.5 equiv.), NH4HCO3 (6.0 equiv.), MeOH/H2O, 
36 °C, 12 h. [d] TMSN3 (2.4 equiv.), NIS (2.4 equiv.), 1,2-DCE/MeCN, rt to 70 °C, 1–4 h. [e] TBAB (5.0 mol%), 
DDQ (1.3 equiv.), 1,2-DCE, rt to reflux, 24 h. [f] 4-(acetylamino)-2,2,6,6-tetramethyl-1-oxopiperidinium (4.0 
equiv.), pyridine (4.0 equiv.), DCM, rt, 12–36 h. [g] CuCl2 (5.0 mol%), MeCN, rt, ultrasound, 1 h. [h] TBAF (5.0 
mol%), PhSiH3 (1.0 equiv.) toluene, 100 °C, 30 min.     
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Most of these examples are based on the a) formation of a C≡N bond by utilizing different 
nitrogen sources (such as azides, ammonia or ammonium salts), b) an oxidation of a pre-
installed C–N bond or c) by a dehydrative transformation. As a rule, an elimination step at 
some point is involved in all mechanistic rationalizations of these transformations. Even if 
the processes are simple and fast, they rely on the employment of excesses of oxidants, 
additives and may require a metal-based catalyst. 
 
1.2.1.2. Cyanations. 
 
In this group of reactions, the cyano functionality is inserted into the selected substrate in 
one step by employment of a cyanating reagent. Mechanistically this step can be 
accomplished via an addition or substitution stage, in the last case also as a transition 
metal-catalyzed process (Scheme 9). 
 
 
Scheme 9. Cyanation strategies. 
 
The most representative and generally accepted cyanating reagents that have been used 
through the history of chemistry will be discussed in this Section, starting with the classical 
nucleophilic substitutions or additions and up to new environmentally friendly 
methodologies developed in the last decades. 
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1.2.1.2.1. Cyanide-based reagents. 
 
Main commercially available inorganic cyanide sources are hydrogen cyanide (HCN, 1), 
and its metal salts — NaCN (3a), KCN (3b), CuCN (9) or K4[Fe(CN)6]— (10). 
 
Hydrogen cyanide (1) is a highly toxic low-boiling point liquid which is produced industrially 
by the so-called Andrussow process from methane and ammonia through oxidation with 
oxygen in the presence of platinum catalyst (Scheme 10a).[24] Due to its extreme toxicity, 
HCN in the laboratory is normally generated in situ from concentrated sulfuric acid and 
sodium cyanide (Scheme 10b).[25] As for applications, compound 1 is generally used for 
the addition onto alkenes, alkynes and carbonyl compounds to access alkyl nitriles 
(hydrocyanation), acrylonitriles or cyanohydrins, respectively (Scheme 10c).[26] 
 
 
Scheme 10. Synthesis of hydrogen cyanide (1) and its general reactivity. 
 
The synthesis of α-hydroxynitriles (Scheme 10c, top), most known as cyanohydrins, is the 
most important application of this reagent, as cyanohydrins are widely employed in 
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industry as precursors of carboxylic and amino acids.[27] The first example of the synthesis 
of these compounds was published by Winkler in 1832, consisting on the simple addition 
of hydrogen cyanide (1) to aldehydes 11 (Scheme 11a).[28] The reaction was then 
optimized in 1903 by Lapworth, who used catalytic amounts of cyanide (Scheme 11b).[29] 
Thus, hydrogen cyanide has been replaced by cyanating reagents 3a and 3b or TMSCN 
(14) (Scheme 11c).[30] 
 
Scheme 11. Development of synthetic procedures towards cyanohydrines. 
 
One widely employed application of HCN is in the hydrocyanation of alkenes, which can 
be selectively performed by using a Lewis acid-assisted [nickel(0)-triarylphosphite]-
catalyzed process.[31] The proposed mechanism of the transformation is shown in Scheme 
12. Initially the nickel complex NiL4 (S12-I) dissociates into NiL3 (S12-II). Oxidative 
addition of hydrogen cyanide to S12-II forms intermediate S12-III which dissociates again 
affording complex S12-IV. After this, the alkene S12-1 is coordinated to the vacant 
coordination site of the metal center in S12-IV thus generating intermediate S12-V which, 
after migratory insertion and reductive elimination in S12-VI, furnishes the corresponding 
hydrocyanation product S12-2.  
 
 
 11 
 
 
Scheme 12. Mechanism of nickel(0)-catalyzed hydrocyanation of alkenes. 
 
Alkali metal cyanides have been extensively used for nucleophilic substitution reactions of 
alkyl halides.[12] Their main drawback arises from their high basicity that makes them 
prone to initiate side reactions like dehydrohalogenation or solvolysis.[1] These problems 
were overcome by replacing alkali metal cyanides with transition metal-based cyanides, 
more specifically copper(I) cyanide (9). CuCN was initially used in stoichiometric amounts 
for classical transformations like the Sandmeyer[32] or the Rosenmund-von Braun 
reaction.[33] Specifically, in the Sandmeyer reaction, an aryl diazonium salt is generated in 
situ and, after stoichiometric addition of copper(I) cyanide, the corresponding products are 
formed by a single electron transfer (SET)[33c] pathway (Scheme 13).  
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Scheme 13. Sandmeyer cyanation. 
 
Another classical transformation performed with the salt 9 is the Rosenmund-von Braun 
reaction, where aryl halides undergo oxidative addition with the copper salt forming a 
copper(III) intermediates S14-I, which afford the corresponding aryl nitriles after reductive 
elimination (Scheme 14). 
 
 
Scheme 14. Rosenmund-von Braun reaction. 
 
Interestingly, in 2003 Buchwald and co-workers reported that these reactions could be 
performed by in situ generation of 9 from NaCN (3a) using catalytic amounts of copper 
halides (Scheme 15a).[34] This paved the way for the development of a wide scope of 
copper-catalyzed cyanations proceeding via catalytic formation of CuCN from different 
inorganic cyanide sources such as NaCN (3a), AgCN (15), Zn(CN)2 (16) or K4[Fe(CN)6] 
(10). Two years later, Beller and co-workers reported cyanoferrate 10 to be an efficient 
cyanating source for the copper-catalyzed cyanation of aryl bromides (Scheme 15b).[35] 
After this, in 2011 Cheng and co-workers established a copper-catalyzed cyanation of aryl 
boronic acids using different types of cyanating sources: TMSCN (14), AgCN (15) and 
Zn(CN)2 (16) (Scheme 15c).[36] 
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Scheme 15. Cyanations via in situ generation of 9.  
However, despite all these achievements, all the reagents discussed above are far from 
ideal because of their toxicity. Indeed, generally the salts containing a cyanide anion 
represent a serious health risk, as they are capable to generate highly toxic hydrogen 
cyanide (1) in aqueous acidic media. Therefore, new methodologies to obtain organonitrile 
compounds without the employment of cyanides have become a stronger research field in 
the last decades. 
 
1.2.1.2.2. Recent developments. 
 
All new procedures target the elaboration of efficient and non-toxic cyanation protocols as 
final goal. At the moment, two general strategies are employed: one of them based upon 
in situ formation of cyanides from non-cyanide sources, and the second one consists of 
using nitriles as cyano sources. The latter has an additional advantage of providing 
asymmetric variants when the selected nitrile is properly designed and conveniently 
activated, either by transition metals or Lewis acids.  
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1.2.1.2.2.1. In situ functionalization and derivatization. 
 
In this cyanation procedure, the starting material can be in situ transformed into an 
activated species, which serves as aryl nitrile precursor and undergoes cyanation upon 
reacting with components of the reaction mixture. These procedures are formally 
cyanations performed without participation of any cyanating reagent.  
 
The first example of this type was published in 2006 by Yu and co-workers.[37] In this study 
2-phenylpyridine (17a) was cyanated using nitromethane (18) as a cyanating solvent 
employing stoichiometric amounts of copper(II) acetate in the presence of oxygen. The 
proposed mechanism depicts the generation of copper(II) intermediate S16-I —whose CN 
moiety is speculated to be formed by a still unknown pathway from nitromethane— which 
leads to the generation of cation-radical intermediate S16-II via a SET process, 
intramolecular anion transfer (S16-III) and a following SET step that provides 19a 
(Scheme 16). 
 
 
                  Scheme 16. Nitromethane (18) as a cyanating reagent. 
 
This concept was further developed by Tsuchimoto and co-workers, who reported in 2014 
a zinc-catalyzed direct cyanation of indoles and pyrroles accelerated by Ph2SiH2 acting as 
Lewis acid (Scheme 17).[38] In the proposed mechanism, nitromethane (18) is initially 
activated by a zinc(II) center forming intermediate S17-I. The latter is attacked by electron-
rich heteroarene substrate affording intermediate S17-II, zinc(II)-catalyzed 
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dehydrogenative silylation of which with Ph2SiH2 then furnishes intermediate S17-III. The 
corresponding aryl nitrile S17-1 is generated from S17-III after two consecutive 
eliminations of Ph2HSiOH moieties. 
 
  
Scheme 17. Cyanation of indole derivatives20 with nitromethane (18). 
 
Alternative breakthrough was made in 2011 by Jiao and co-workers, who reported the 
cyanation of indoles and benzofuranes in an unprecedented manner using DMF (23) as a 
cyanating precursor.[39] Along the same year, the substrate scope was extended by 
Bhanage and co-workers, who reported the procedure to perform the cyanation of aryl 
halides using again DMF as a precursor in the presence of catalytic amounts of 
palladium(II) species.[40] Optimization of this reaction employing catalytic amounts of 
cuprous iodide was published in 2014 by the same research group.[41] Mechanistic details 
of this transformation are shown in Scheme 18. The process starts with an oxidative 
addition forming intermediate S18-II, which reacts with the in situ generated Vilsmeier-type 
reagent S18-3 producing intermediate S18-III. After β-hydride elimination, the resulting 
iminium cation S18-4 is further hydrolyzed (18-5), and oxidized with POCl3 to the 
corresponding aryl nitrile S18-2 (Scheme 18, bottom). The catalytic cycle continues with 
a reductive elimination step that regenerates initial copper(I) salt S18-I. 
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Scheme 18. Cyanations with dimethylformamide (23). 
 
 
Further studies on this topic, this time using tetramethylethylenediamine (TMEDA, 24) 
instead of DMF as a carbon source, and (NH4)2CO3  as a nitrogen source, were published 
by Cheng and co-workers in 2014.[42] The proposed mechanism is presented in Scheme 
19. According to this, TMEDA (24) is oxidized to imine S19-I which, after nucleophilic 
attack of the substrate, oxidation of intermediate S19-II into S19-III, ammonolysis (S19-IV 
to VI) and dehydration of amide S19-VII, generates the corresponding aryl nitrile S19-1. 
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Scheme 19. Cyanations with TMEDA (23). 
 
All these new methodologies represent efficient, atom-economy and safe ways to produce 
aryl nitriles from cheap and readily available reagents, the research of which is ongoing 
nowadays. 
 
1.2.1.2.2.2. In situ generation of cyanides. 
 
The in situ generation of cyanide ions in the reaction mixture allows the possibility of 
performing chemical transformations in a safer fashion regarding laboratory handling. 
Following this idea, in 2010 Chang and co-workers designed a novel strategy to cyanate 
2-arylpyridines by an in situ cyanide formation directly from NH3 and DMF.[43] Experiments 
with isotopically labeled compounds demonstrated that the nitrogen atom came from the 
ammonia and the carbon atom from a methyl moiety in DMF. Once the cyanide is 
generated, the desired product is obtained by a C–H activation process[43b–e] promoted by 
the palladium catalyst (Scheme 20). 
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Scheme 20. Cyanation with a combination of NH3 and DMF. 
 
The proposed mechanism for the cyanide formation is detailed in Scheme 21. 
Presumably, imine specie S21-1 is formed initially by a SET pathway[32c] initiated by 
CuBr2. After this, ammonia attacks S21-1 forming an amidine that coordinates to the 
copper center generating intermediate S21-2; aerobic conditions promote a C–N bond 
cleavage in S21-2 affording cyanide anion S21-3.  
 
 
Scheme 21. In situ generation of cyanides from DMF. 
 
A similar approach was reported in 2011 by Cheng and co-workers.[44] In this case indoles 
20 were cyanated with a cyanide anion formed from a combination of the nitrogen atom 
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contained in NH4HCO3 salt and the carbon from the DMSO used as the solvent. The 
process was likewise catalyzed by a palladium(II) complex using stoichiometric amounts 
of a copper(II) salt (Scheme 22).  
 
 
Scheme 22. Cyanation of indoles with DMSO and NH4HCO3. 
Later reports are based on similar ideas using copper- or palladium-based catalysts 
combined with suitable oxidants.[45]  
Another strategy to perform effective cyanations considers in situ breaking the carbon-
carbon bond between a cyano group and an organic framework, thus generating in the 
reaction mixture a cyanide species that is ready to react with the selected substrate. As 
example of these procedures, I would like to mention the one that uses acetone 
cyanohydrine, to liberate hydrogen cyanide in solution, which can be directly used as a 
cyanide source.[46] Nonetheless even if hydrogen cyanide is liberated in situ, such a 
reaction is still a risky process that needed to be avoided.  
 
1.2.1.2.2.3. Organonitriles as cyanating reagents. 
 
In the recent years, several synthetic methodologies, in which the cyanating reagent is in 
fact a constituent of another nitrile molecule have been studied. All these new techniques 
are based on initial activation of the CN group by transition metals or Lewis acids, forming 
a so-called transfer reagent, followed by CN-transfer to the substrate molecule. (Scheme 
23). 
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Scheme 23. Organonitriles as cyanating reagents. 
 
All these novel protocols can be divided into three general groups based on the 
mechanism pathway that rules the reaction and the nature of the substrate, namely a) 
nucleophilic cyanations, b) electrophilic cyanations and c) radical cyanations. 
 
1.2.1.2.2.3.1. Nucleophilic cyanations. 
 
Different protocols to achieve nucleophilic cyanations without the need of a cyanide 
source are discussed in this section. All the procedures require the activation of 
organonitrile molecules with transition metals, palladium and copper complexes in most of 
the cases. In 2012 Zhou and co-workers reported the copper-catalyzed cyanation of aryl 
iodides using malononitrile (24) as a nitrile source. Mechanistic studies of this 
transformation elucidated that the reaction was performed via in situ formation of a copper 
cyanide complex 25 which was the actual cyanating reagent (Scheme 24).[47] 
 
 
Scheme 24. Cyanations with malononitrile (24). 
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One of the first examples in this field was reported by Cheng et al. in 1998. In this study, 
aryl halides S25-1 were transformed into aryl nitriles S25-2 in a metallic zinc-mediated 
Pd(0)-catalyzed cyanation using acetonitrile (MeCN), EtCN (26), PrCN (27) or BnCN (28) 
as cyanating reagents.[48] The catalytic cycle is shown in Scheme 25.  
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Scheme 25. Nitrile solvents MeCN, EtCN, PrCN and BnCN used as cyanating reagents. 
 
In the proposed mechanism Pd halide S25-I is initially generated by employment of a Zn 
specie. Then the oxidative addition of aryl halides S25-1 that generates palladium(II) 
complex S25-II occurs. In the next step the zinc halide salt extracts a halogen atom from 
the complex S25-II generating a coordination vacancy for the further coordination of the 
nitrile solvent. Afterwards the aryl group in S25-III is transferred to the carbon atom of a 
cyano group, thus generating imine intermediate specie S25-IV. Transmetallation with zinc 
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followed by a carbon-carbon bond cleavage in S25-3 generates the corresponding aryl 
nitrile S25-2 and an organozinc by-product S25-4. 
 
Shen and co-workers reported later a palladium-catalyzed cyanation of aryl halides using 
ethyl cyanoacetate (29) as a cyanide source.[49] Similar to the mechanism presented in 
Scheme 25, the actual cyanating reagent was in fact a cyanide palladium complex S26-II, 
formation of which is detailed in Scheme 26. Thus, cyanating proreagent 29 coordinates 
to the palladium(II) center forming complex S26-I, which generates after hydrolysis the 
actual cyanating complex S26-II. Addition of aryl halide S26-1 forms intermediate S26-III, 
and subsequent reductive elimination in S26-III releases the desired organonitrile S26-2 
and restartes the catalytic cycle.  
 
 
Scheme 26. Cyanations with ethyl cyanoacetate (30). 
 
The following reports were published in 2012 and 2013 by J. Cheng and co-workers, 
including a new procedure in which aryl boronic acids and aryl halides were converted into 
aryl nitriles in the copper(I)-catalyzed process employing stoichiometric amounts of silver 
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salt as the oxidizing agent and 2,3-dichloro-5,6-dicyano-1,2-benzoquinone (DDQ, 30) as a 
cyanide source (Scheme 27).[50] The mechanism of this transformation still remains 
unclear. 
 
 
Scheme 27. Cyanations with 30. 
 
An indirectly but closely related protocol describing a novel hydrogen cyanide-free 
hydrocyanation with isovaleronitrile (31) consisting of a thermodynamically controlled 
reversible hydrofunctionalization of alkenes was recently published in 2016 by Morandi 
and co-workers. In this procedure, different alkenes are treated with alkyl nitriles as 
suitable hydrocyanating reagents using catalytic amounts of nickel(0) and an aluminum-
based Lewis acid. The mechanism of this transformation is detailed in Scheme 28. The 
initial activation of the nitrile 31 with the aluminum-based Lewis acid promotes the 
oxidative addition of 31 to the Ni(0) catalyst S28-I forming complex S28-II. Subsequent β-
hydride elimination and ligand exchange in the complex S28-III generates intermediate 
S28-IV with isobutene evolution. After migratory insertion  and reductive elimination in 
S28-V, product 33 is generated.[51] 
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Scheme 28. Hydrogen cyanide-free hydrocyanations. 
Isocyanides, more specifically defined as organo(iso)nitriles, are by definition isomers of 
cyanides featuring a zwitterionic species with two possible resonance structures. As the 
terminal carbon possesses high nucleophilicity, in theory isocyanides can be used for 
cyanations as well.  
 
In 1982 Saegusa and co-workers reported a novel hydrocyanation of α,β-unsaturated 
carbonyl compounds using tert-butyl isocyanide (36) in combination with titanium 
tetrachloride. The mechanism, detailed in Scheme 29, is rationalized through an initial 
TiCl4-promoted carbonyl activation which generates a carbocation in the γ-position of 
substrate 35. The carbocationic center in S29-I then reacts with the isocyanide 36 
furnishing intermediate S29-II which, after a β-elimination step followed by protolysis, 
forms the corresponding hydrocyanated product 37.[52]  
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Scheme 29. Ti-promoted cyanations with tert-butyl isocyanide (36). 
 
Recently the research groups of Xu[53a] and and Zhu[53b] reported a novel palladium-
catalyzed, copper-assisted regioselective cyanation of different heteroarenes using tert-
butyl isocyanide as a cyanating reagent. As detailed in Scheme 30,[53] this transformation 
proceeds through a C–H activation in the electrophilic position of the heteroarene (indole 
in Scheme 30) employing Pd(II) species (S30-I). Simultaneously, isocyanide 36 replaces 
one trifluoroacetate moiety in Cu(TFA)2. Thus, activated isocyanide molecule is 
subsequently transferred to the palladium center forming the corresponding palladium 
complex S30-II and Cu(I) trifluoroacetate. The catalytic cycle continues with a migratory 
insertion of the isocyanide ligand generating intermediate S30-III. Finally, a β-tert-butyl 
elimination forms the cyanated product 21, isobutene (34) as a gas waste and Pd(0) 
specie S30-IV. The latter is transformed to S30-I by copper-moderated oxidation using 
atmospheric oxygen. Xu and co-workers optimized further the reaction in 2014 using 
Rh(III) as a catalyst.[54] 
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Scheme 30. Pd-catalyzed cyanations with tert-butyl isocyanide (36). 
 
 
1.2.1.2.2.3.2. Electrophilic cyanations. 
 
All the cyanations discussed above rely on the nucleophilic character of the cyano group. 
This implies that the substrates employed for these reactions are required to possess a 
certain electrophilic character, such as alkyl and aryl halides. Such a limitation of the the 
scope of cyanations can be overcome by development of electrophilic sources of the 
cyano group, which in principle can promote the electrophilic cyanation of any desired 
nucleophile. To achieve an electrophilic cyanation, two different approaches can be 
followed, consisting either in the in situ generation of [+CN] species under oxidative 
conditions, or by the reversal of polarity in a molecule (Umpolung) via a proper design of 
the architecture of the cyanating reagent (Scheme 31). This last procedure requires a pre-
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oxidation step to generate the corresponding cyanating reagent which can be either 
isolated and characterized or applied in situ. The major advantage of such cyanating 
reagents is that can be used for metal-free cyanations as a last step of a synthesis 
sequence, and furthermore, they open the route to asymmetric cyanations.  
 
 
Scheme 31. Electrophilic cyanation strategies. 
 
The first registered electrophilic cyanations were based on the employment of cyanogens 
such as cyanogen [(CN)2, 38], cyanogen chloride (ClCN, 39), cyanogen bromide (BrCN, 
40) and cyanogen iodide (ICN, 41). Compound 38 can be prepared from hydrogen 
cyanide (1) using chlorine as an oxidant,[55] and cyanogens 39–41 by oxidizing a metal 
cyanide salt with the corresponding halide.[56] One of the first examples of cyanations was 
the synthesis of diethyl cyanomalonate (43) using ClCN (39) (Scheme 32a),[57] which was 
promoted by cyanogens and employed enolates as a nucleophiles. Later, in 1959 the 
synthesis of β-ketonitriles by electrophilic cyanation of enamines was reported as well 
(Scheme 32b).[58]  
 
 
Scheme 32. Cyanations with cyanogen chloride (39). 
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Cyanogen bromide (40) is a white solid at ambient temperature and therefore more 
convenient for laboratory preparations than ClCN. This compound has been also applied 
for the cyanation of amines,[59] alkynes,[60] esters[61] or alcohols[62] (Scheme 33). These 
reagents have the major disadvantage of possessing a high volatility, toxicity as well as 
high vapor pressure which becomes them in non-enviromentally friendly reagents. 
 
 
Scheme 33. Cyanations with cyanogen bromide (40). 
 
Further examples of cyanations with cyanogens were reported in 1967 by Dell and Boltze, 
who used thiocyanogen (SCN)2 (54) for the electrophilic cyanation of aryl lithium 
derivatives. The limitation of this approach was the formation of undesired thiocyanated 
products.[63] 
 
On the pursuit of finding a less toxic alternative for cyanogens, the idea of in situ 
generating “[+CN]” species using cyanide anions under oxidative conditions arose. The 
first example, consisting in the cyanation or electron-rich aromatic rings through the 
electrolysis of sodium cyanide, was described in 1965.[64] Unfortunately, the reaction 
resulted in a formation of a complex mixture of cyanated products. However, half a 
century later, in 2014, Chen and co-workers published a cyanation protocol for secondary 
amines based on this idea. Thus, by in situ oxidation of TMSCN to ClCN a wide variety of 
N-cyanated tertiary amines were prepared (Scheme 34).[65] 
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Scheme 34. In situ generation of cyanogen chloride (39) for the cyanation of secondary amines. 
 
The most common result of these initial studies in the field of electrophilic cyanation was 
the formation of complex mixtures due to the high reactivity of the corresponding XCN 
reagents, whereas the target products were obtained in poor yields.  
 
A new reagent was introduced in 1967 by Grigat and Pütter, who reported on electrophilic 
cyanations of different nucleophiles employing phenyl cyanate (53). Deprotonated 
alcohols, thiols or amines were also suitable substrates for these transformations 
(Scheme 35a).[66] Additionally, in the subsequent publications by Sato this reagent was 
applied for the cyanation of carbanionic organolithiums and organomagnesiums (Scheme 
35b).[67]  
 
Scheme 35. Cyanations with phenyl cyanate (53). 
 
Starting with the pioneering report by Leusen and Jagt in 1970 on application of tosyl 
cyanide (55) for electrophilic cyanation,[68] this reagent (or its derivatives) was successfully 
applied on the cyanation of enolate-type substrates such as malonates or boron enolates, 
as indicated in recent publications (Scheme 36).[69]  
 30 
 
 
Scheme 36. Cyanations with tosyl cyanide (55). 
Moreover, several syntheses of TsCN avoid the inconveniency of using toxic reagents or 
harsh conditions (Scheme 37).[70] 
 
 
Scheme 37. Syntheses of tosyl cyanide (55).  
The electrophilic cyanation of aryllithium-compounds using pentachlorobenzonitrile (64) 
via a Li/CN exchange process, although with low yields and formation of undesired by-
products, was reported in 1972 (Scheme 38).[71]  
 
 
Scheme 38. Cyanations with pentachlorobenzonitrile (64). 
 
Studies in the field were further extended in 1996 and 1998 after invention of 1-
cyanobenzotriazole (BtCN, 67), which was synthesized in two simple steps (Scheme 38). 
Its potential as a cyano-transfer reagent was probed using organolithium- and malonate-
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based substrates (Scheme 39).[72] 
 
Scheme 39. Synthesis of 1-cyanobenzotriazole (67) and examples of cyanations with 67. 
 
Following similar strategy, a variety of N-CN reagents were developed in the following 
years such as N-cyano imidazole (ImCN, 72), N-cyano benzimidazole (BiCN, 73) or 3-
cyano-2-(N-cyanoimino)thiazolidine (3-cyano-NCT, 74) (Figure 4). These reagents could 
be prepared avoiding a direct use of cyanides and represent an alternative for 67, 
targeting a similar substrate scope.[73] 
 
 
Figure 4. Structures of N-CN reagents 72, 73 and 74. 
 
On the other hand, employment of all the reagents discussed above is in most cases 
limited to cyanation of strong nucleophiles of anionic character. This limitation was 
overcome with the design of novel N-cyano-tosylsulfonamide (NCTS, 76) that constitutes 
nowadays one of the most employed electrophilic cyanating reagent in organic chemistry. 
Its synthesis by adding BrCN (40) to the corresponding sodium tosylanilide 75 was first 
described in 1949 by Kurzer (Scheme 40a),[74] but it was not until 2011 when this was 
prepared by the reaction of phenylurea with p‐toluenesulfonyl chloride in pyridine by Beller 
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and co-workers (Scheme 40b), who tested reactivity of 76 as a cyanating reagent.[75] 
 
Scheme 40. Syntheses of NCTS (76). 
 
As a proof of concept, they were able to carry out the cyanation of aryl Grignards 
(Scheme 41a), which were generated in situ. Most impressively, they performed the first 
rhodium-catalyzed cyanation of aryl boronic acids. (Scheme 41b).[76] Its noteworthy to 
mention that aryl boronic acids represent the first type of mild air- and moisture-stable 
nucleophiles in such transformations. 
 
Scheme 41. Cyanations with NCTS (76). 
 
Another prominent example of electrophilic cyanations with 76 was published in the same 
year by Wang and co-workers. In this case, a selected set of indole derivatives 20 was 
successfully cyanated via a metal-free protocol using BF3.Et2O as Lewis acid catalyst 
(Scheme 42).[77]  
 
Scheme 42. Lewis acid-promoted cyanation with NCTS (76). 
 
In the recent years, a number of research groups have been focused on exploring further 
applications of 76 in metal-catalyzed cyanations, in most of the cases through a C–H 
activation, using cobalt,[78] copper,[79] manganese,[80] palladium[81] or ruthenium and 
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rhodium[82] complexes. Some recent examples are depicted in Scheme 43. 
Scheme 43. Transition metal catalyzed cyanations with NCTS (76). 
 
 
1.2.1.2.2.3.3. Radical cyanations. 
 
An alternative strategy for cyanations can be based upon the in situ formation of cyano 
radicals. Han and co-workers reported in 2013 the first example on generating of this 
radical 85 initiated with decomposition of commercially available azabisisobutyronitrile 
(AIBN, 84).[83] In this report, classical substrates 2-phenylpyridines 17 could be cyanated 
via C–H activation using a copper(I)-based catalyst. This novel procedure for the 
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generation of a cyano radical 85, as well as the proposed mechanism are detailed in 
Scheme 44. Unfortunately, to the best of our knowledge, the transformations of this type 
were not further investigated. 
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Scheme 44. Radical cyanations initiated with AIBN (84). 
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2. Hypervalent Compounds: Design and Electrophilic 
Cyanation. 
 
2.1. Introduction. 
 
Hypervalency model was first introduced by Musher in 1969[84] and defined as molecules 
formed from atoms of Groups V–VIII of the periodic table in their higher valences, bearing 
more than 8 electrons in their valence shell and not obeying the general tendency of the 
octet rule. The excess of electrons is rationalized by the formation of a hypervalent bond 
between three atoms with participation of four electrons (three-center four-electron bond, 
or 3c-4e–, proposed by Pimentel in 1951)[84b]. These bonds resemble to those formed 
between ligands and metals and can be refered to as weak covalent bonds and with 
longer interatomic distances. In the 3c-4e– model, three atomic orbitals are combined into 
three molecular orbitals: bonding, non-bonding and antibonding, where four electrons 
occupy the bonding and non-bonding orbitals. As can be seen, the HOMO orbital features 
a node in the central atom (A), so the entire electron density is localized in the ligands (L) 
(Figure 5).[85] 
 
 
Figure 5. Three-center four-electrons model orbitals. 
 
Regarding electrophilic cyanations, an elegant alternative metal-free approach to 
accomplish the Umpolung (change of polarity) of the cyano group has been successfully 
demonstrated by employing hypervalent iodine reagents. Most organic molecules with 
iodine, such as alkyl or aryl iodides, are monovalent iodine compounds with an oxidation 
state of 1. However, due to the large size of the iodine atom and its high polarizability 
 36 
 
because of strategic position in the periodic table, the bonding in iodine compounds is 
different from that of the lighter main-group elements. Iodine in higher oxidation states is 
capable to form oligocoordinated structures; these molecules are also known under the 
common name of "hypervalent iodine (III) compounds".[86] As a consequence of the high 
electronegativity of the iodine atom, when a cyano group is directly connected to the 
iodine center, the electrophilicity of the nitrile moiety becomes higher, and can be 
transferred to a selected nucleophile. 
It should be noticed, however, that the iodine atom is only slightly more electronegative 
than the carbon one and, therefore, the polarization is not pronounced.[87] Nevertheless, 
as iodine is one of the biggest and highly polarizable atoms, the electron density can be 
distributed in an easier manner by the formation of hypervalent bonds, thus affording 
hypervalent iodine(III) species. 
In the specific case of compounds of hypervalent iodine (III), iodine atom contains 10 
electrons in its valence shell, adopting the trigonal bipyramid geometry, where the most 
electronegative groups L occupy the axial (a) positions. Conversely, the less 
electronegative substituent R is linked in a covalent fashion to iodine, occupying an 
equatorial (e) position together with the two equatorial lone pairs of electrons in the same 
plane. Because of this, iodine(III) compounds adopt T-shaped structure (Figure 6).[88] 
            
Figure 6. T-shape of hypervalent iodine(III) species. 
 
When these compounds react with a given nucleophile three possible scenarios can 
explain the mechanism of the transformation; first situation involves a nucleophile attack 
directly on the cyanide moiety, which will generate the desired product and will release an 
iodane by-product (Scheme 45a). A second possible pathway regards the generation of a 
three-membered-ring  intermediate described by the carbon atom of the cyano group, the 
iodine atom and the nucleophile (S45-I),[86] due to the high electrophilicity of the iodine 
center, the latter constitutes an excellent leaving group, thus transferring the cyano group 
to the nucleophile and affording the subsequent nitrile (Scheme 45b). The third possible 
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mechanism depicts a nucleophilic attack in the iodine center (S45-II), which will lead to the 
formation of the product by a reductive elimination step (Scheme 45c).  
 Scheme 45. Reactivity of hypervalent iodine(III). 
2.2. Synthesis of hypervalent iodine reagents. 
Different hypervalent iodine compounds containing a CN group were synthesized in the 
early 90s, such as 87, 87, 90, 92 and 94 (Scheme 46)[89], which could have potential as 
cyanating reagents. 
 
Scheme 46. Synthesis of hypervalent iodine(III) species 87, 88, 90, 92 and 94. 
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Reagent 92 was proved to be suitable to cyanate N-alkyl groups of N,N-dialkylanilines 95; 
however, in this case the transformation was proposed to proceed rather through a radical 
than electrophilic pathway (Scheme 47).[90d]   
 
 
Scheme 47. Cyanation with 92. 
Very recently the latter transformation was extended to alkanes and ethers employing 
modified reaction conditions.[90e] 
It should be mentioned that these iodanes are very unstable with respect to moisture and 
exhibit decomposition or violent explosions at elevated temperatures. This considerably 
limits their applicability.  
The first example of electrophilic cyanation through a metal-free process using 
hypervalent iodine species and electron-rich heteroaromatics was reported in 2007 by Kita 
and co-workers.[90] Phenyliodine(III) dicyanide was generated in situ from phenyliodine(III) 
bis(trifluoroacetate) (PIFA) and TMSCN. Once generated, BF3.Et2O coordinates to the 
nitrile group enhancing electrophilicity in the intermediate S48-I and subsequently 
facilitating the nucleophilic attack. The reaction conditions and scope are detailed in 
Scheme 48. 
 
Scheme 48. Cyanation with phenyliodine(II) dicyanide-BF3.Et2O complex (S47-I). 
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The high potential of these reagents was realized only after 2015, when Chen and co-
workers reported on cyanation of various cyclic β-dicarbonyl compounds 100 using 
hypervalent iodine reagent 92 (Scheme 49).[91] 
 
 
Scheme 49. Cyanation with hypervalent iodine reagent 92. 
 
In the same year, Waser and co-workers described the cyanation of deprotonated aryl and 
alkyl thioles with hypervalent iodine reagents 92 and 94. The mechanism was rationalized 
as occurring via a concerted pathway through the formation of intermediate S50-I 
(Scheme 50).[92] 
 
Scheme 50. Cyanations with hypervalent iodine reagents 92 and 94. 
 
The next breakthrough in this area was the development of a method allowing asymmetric 
cyanations. Hence, experimental protocols applying compound 92a were tested in the 
same year by Waser and co-workers[93] and then improved by Zheng and co-workers by 
using the iodine reagent 92b, which is essentially a tBu-substituted analogue of 92a. In 
combination with a cinchona-based chiral catalyst ee’s of up to 93% were obtained 
(Scheme 51).[94] 
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Scheme 51. Asymmetric cyanations with modified iodine reagent 92b. 
 
The most recent advances in this field were published in 2016 by Studer and Wang, who 
reported the first example of iron(II)-catalyzed electrophilic cyanation of intenal alkynes 
102. In this case, iodane 101 afforded the corresponding substituted 2-cyanopropenyl 
trifluormethylsulfonates 103 as final products (Scheme 52).[95]  
 
Scheme 52. Cyanation with iodane 101. 
 
 
 
2.3. New cyanating reagents developed in our group. 
 
The general trend used in literature for designing new cyanating reagents is based on the 
use of heteroatoms with high electronegativity directly attached to the cyano group. This 
decreases the electron density on the carbon atom in the nitrile group, thereby creating a 
certain electrophilic environment. To further enhance the electrophilicity of this center, a 
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proper selection of the substituents which will be liked to this heteroatom is crucial 
(generally electron-withdrawing groups) (Figure 7). 
 
 
Figure 7. Design of electrophilic cyanating reagents. 
 
As previously mentioned, hypervalent iodine (III) compounds can react violently when 
exposed to air, moisture or elevated temperatures. Therefore, our team focused the 
attention on developing analogues of these reagents which could be satisfactory 
employed in a safer manner. As first option, sulfur based compounds seemed to be the 
most appropriated molecules to start this new family of cyanating reagents, as sulfur atom 
possesses somewhat similar properties to iodine in terms of high electronegativity and 
polarizability. In addition, hypervalent sulfur species have already been described in the 
literature.[96,97] As explained afore, including an EWG in the reagent structucture will help 
to enhance the electrophilicity of the nitrile group, and based on previous experience of 
our research group, an imidazolium substituent was considered as first option.[98,99–101] 
Imidazolium thiocyanates synthesis was already described by Burgess and Arduengo.[96] 
First, cyclic thioureas 107 were synthesized through condensation of thioureas 106 with 
acetoin, and further oxidized by bromine generating hypervalent species 108. For the 
comparison, the general pathway to obtain hypervalent iodine(III) species is oxidation of 
phenyl iodide with chlorine.[102] As indicated above, preparation of every electrophilic 
cyanating reagent needs a cyanide source, and in this case trimethylsilyl cyanide 14 was 
added to hypervalent compounds 108, thus affording the desired imidazolium 
thiocyanates 109 (Scheme 53).[103,104]  
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Scheme 53. Synthesis of cyanating reagents 109a and 109b. 
 
The resulting products could be prepared in multigram scale from inexpensive and 
commercially available reagents through high yielding processes and could be stored 
under air for undefined time. As it is not trivial to assume that species 108 and 109 are in 
fact hypervalent molecules and not just simple cationic sulfides, both reagents 108b and 
109b were recrystallized and analyzed by X-Ray diffractometry (Figure 8).[103]  
 
 
Analogously to hypervalent iodine(III) species [90b], both structures are T-shaped, as do the 
similar hypervalent sulfur (II) compounds (Figure 8) [96,102]. The bromo and cyano 
substituents occupy the apical positions in respect to the plane of cyclic "thiouronium" 
moiety. In such a situation, the triads bromo-sulfur-bromo in 108b as well as bromo-sulfur-
cyano in 109b are aligned in a hypervalent 3c-4e– bond (Figure 9). On the basis of this 
information it can be postulated that 108 are hypervalent sulfur(II) species, and possibly 
109. 
 
Figure 8. T-shaped hypervalent sulfur(II) species 108b, 109b and selected similar structures. Hydrogen 
atoms are removed for clarity. 
 43 
 
 
Figure 9. Hypervalent orbitals of 108b and 109b. 
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Scheme 54. Cyanation scope using reagent 109b. 
Interestingly, reagent 109b demonstrated a remarkable ability to cyanate under basic 
conditions a wide variety of nucleophiles such as sulfur and nitrogen centers, enolate-type 
compounds and electron-rich aromatic rings (Scheme 54).[103] 
Most reports on electrophilic cyanations require basic conditions due to the nature of the 
starting materials. Another approach to achieving successful electrophilic cyanations can 
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be accomplished under acidic conditions by activation of the cyanating reagent via Lewis 
adduct formation, as has been exemplified in previous reports employing boranes.[105] 
Following these studies, compound 122b, which can successfully cyanate electron-rich 
aromatic rings when BF3.Et2O is used as catalyst, was designed in our group (Scheme 
55).[103] It should be emphasized that a counterion exchange of bromine to the non-
coordinating hexafluoroantimonate anion was necessary in order to avoid the quenching 
of the bromide anion by the Lewis acid catalyst.  
 
 
Scheme 55. BF3-catalyzed cyanation scope with the reagent 122b. 
 
These two protocols evidenced the potential benefits of compounds 109b and 122b in 
comparison to the cyanating reagents developed to date. As mentioned above, they are 
reactants that are stable towards air and moisture and be prepared in multigram scale 
from inexpensive starting materials under simple reaction conditions. Moreover, they do 
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not require metals for their activation and do not decompose violently under air or at 
elevated reaction temperatures. 
 
The future goal of the group is to expand the scope of the nucleophiles that can be 
cyanated with these types of reagents.  
 
 
2.4. Summary. 
 
Up to day, a tremendous amount of protocols to perform cyanations have been reported. 
Classical methodologies employ highly toxic cyanating reagents such metal cyanides, 
hydrogen cyanide or cyanogens. To avoid direct contact with these cyanating reagents, 
some procedures were developed for their in situ generation, through construction of C≡N 
bonds from different sources of carbon and nitrogen, or more importantly through transfer 
of the C≡N group from another non-toxic molecule. This last approach of transferring a 
cyano group generally requires transition metal catalysts, most frequently copper and 
palladium. Last efforts were focused on the development of hypervalent iodine species, 
possessing metal-type behavior and capable to perform “oxidative addtions”- or “reductive 
eliminations”-type transformations. However, their disadvantage of possessing high air 
and moisture sensitivity as well as thermal instability up to violent explosions limits their 
application. The most important cyanating sources that have been employed successfully 
until our days, as well as their advantages and disadvantages, are summarized in Figure 
10. 
As organonitriles are very important intermediates in organic chemistry, performing 
cyanations applying a cheap, non-toxic and safe procedure is nowadays still an important 
research topic in the laboratories. Our research group has centered the attention on this 
problem since 2015 by developing new electrophilic cyanating reagents based on cationic 
sulfides. 
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Figure 10. Summary of cyanation reagents, sources and selected strategies. 
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3. Regio- and Stereoselective Chlorocyanation of 
Alkynes. 
3.1. Introduction. 
Nucleophiles are compounds with ability to donate a pair of electrons and can be sorted in 
three main categories depending on the origin of these two electrons: lone pairs-type, σ-
bonds-type and π-bonds-type. Most of nucleophiles engaged in electrophilic cyanations 
belong to the lone pairs group, such thiolates, amides, alcoxides and carbanions. These 
species are usually generated in situ under basic conditions or by addition of 
organometallics. The second type, nucleophiles with participation of σ-bonds, is less 
common and occurs mostly in the cases of intramolecular reorganizations, such proton 
shifts or sigmatropic rearrangements. The third type, nucleophiles with π-bonds, includes 
enolates, enamines, aromatic rings, alkenes and alkynes. Electrophilic cyanations of 
nucleophiles of types I and III are summarized in Scheme 56. 
 
Scheme 56. Cyanation of different types of nucleophiles. 
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The electrophilic cyanation of alkynes and alkenes still remains a challenge because 
alkynes and alkenes belong to the group of weak nucleophiles. Moreover, regio- and 
stereomeric mixtures of products are often formed when an electrophile is added. Finally, 
they require the addition of an external nucleophile to trap the generated carbocationic 
intermediate.  
 
To the best of our knowledge, the first example of electrophilic cyanation of internal 
alkynes was reported by Studer and Wang in 2016.[95] This transformation is based upon 
employment of the hypervalent iodine(III) compound 101 with triflate as a suitable 
nucleophile to trap the cationic intermediate S57-VI which arises during the reaction. The 
conversion requires iron(II) catalyst S57-I that reduces 101 through a SET process,[32c] 
thus generating an iodanyl radical intermediate S57-III. The latter further reacts with 
alkyne 102 forming the iodonium radical S57-IV, which is then oxidized by the iron(III) 
complex to form the vinylic cation S57-V, simultaneously regenerating iron(II) catalyst 
S57-I. Finally, reductive elimination and triflate addition to vinylic cation S57-VI generates 
the desired products 103 (Scheme 57). Cooperative effect of stabilization in carbocation 
S57-VI provided by the aromatic substituent and of steric hindrance caused by an alkyl 
moiety justify the high regio- and stereoselectivity of the method. 
 
Scheme 57. Cyanotriflation of internal alkynes with hypervalent iodine compound 101. 
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Keeping in mind the excellent results obtained in our research team on the use of newly 
developed hypervalent sulfur reagents, we focused the attention on these underexplored 
transformations and envisioned the design of a protocol to perform effective and selective 
electrophilic cyanations of alkynes using imidazolium thiocyanates as cyanating reagents. 
 
3.2. Objective. 
 
The general objective of my dissertation is the development of metal-free methodologies 
for electrophilic cyanations of substrates with low nucleophilic character under mild 
conditions. More specific, developing an efficient methodology for performing electrophilic 
cyanations of alkynes, which will be attempted by using the novel imidazolium thiocyanate 
systems discussed in Section 2.[103] Hence. the main goal of my thesis is to study the 
chemical behavior of these imidazolium thiocyanate-based reagents from the viewpoint of 
efficient and selective electrophilic cyanations of alkynes.  
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3.3. Results and discussion. 
3.3.1. Reaction design.  
 
A general strategy for developing an efficient protocol of electrophilic cyanation of alkynes 
relies upon the initial generation of vinyl cation intermediates (S58-I or S58-II), which 
should be trapped with a specific nucleophile (Scheme 58). As a result of the substitution 
pattern of the alkyne 102 and the type of attack of the cyanating reagent, these 
transformations can produce four different diastereomers as main products: two pairs of 
regioisomers which differ on the direction of the initial electrophilic attack, and each 
consisting of a (E)- and (Z)-configurated stereoisomers, which depend on the favoured 
selectivity of the nucleophilic attack.  
 
Scheme 58. Electrophilic additions to alkynes 102. 
Designing a process which favors the formation of only one product requires a careful 
analysis of each participant of the reaction —Alkyne, Electrophile and Nucleophile — 
and rigorous control of the reaction conditions: 
Alkynes are by definition unsaturated hydrocarbons with a triple carbon-carbon bond.[106] 
As both carbon atoms possess similar electron density and hence reactivity, they need to 
be first differentiated in order to promote a proper regioselective cyanation. Desirable 
polarization of the triple bond can be accomplished by a reasonable selection of the 
substituents on this π-system, which can stabilize predominantly only one of the two 
possible carbocations S58-I or S58-II.[107] Thus, electron-rich groups directly linked to one 
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of the carbons polarize the triple bond making one of the carbons to exhibit an increased 
nucleophilicity as compared to the other one. One accessible alkyne, that fulfils all the 
above criteria is 1-methoxy-4-(phenylethynyl)benzene (102a), which was chosen as model 
substrate (Figure 11).[108]  
Electrophile: In line with the subject of this study – extending the scope for the 
electrophilic cyanations using imidazolium thiocyanates – and based on the excellent 
results discussed above, reagent 109b was employed (Figure 11). 
Nucleophile: The most efficient and atom-economical approach would be the case if the 
nucleophile is actually the counterion in thiocyanate; therefore bromide anion in 109b was 
initially tested as plausible nucleophilic source. (Figure 11). 
 
Figure 11. Selected alkyne, electrophile and nucleophile. 
 
3.3.2. Searching for appropriate reaction participants.   
With compounds 102a and 109b in hand, we started the investigation towards a 
regioselective bromocyanation of internal alkyne 102a. In the first attempt, a solution of 
102a and 109b (one equivalent each) in DCM was stirred at room temperature for 24 
hours. Unfortunately, no conversion of 102a was detected, and starting materials were 
recovered (Scheme 59). 
 
Scheme 59. Attempted bromocyanation of alkyne 102a with 109b. 
 
This result can be rationalized based on two arguments. First, generally alkynes are 
known as compounds with moderate nucleophilicity and may not be reactive enough 
under the selected conditions. Secondly, the nitrile group is probably not electrophilic 
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enough in the system. To enhance the electrophilicity of nitrile groups in similar situations, 
the employment of Lewis acids as activators has been investigated in great details. Lewis 
acids have the property of coordinating to the nitrogen center, thus enhancing 
electrophilicity of the carbon center.[77,109]  
 
It is noteworthy that another problem may arise when salt 109b is combined with a Lewis 
acid, as the formation of the corresponding adduct between the bromide anion and the 
added Lewis acid might occur. Thus, a non-coordinating hexafluoroantimonate counterion 
was included in the structure by performing a counterion exchange (Scheme 60).  
 
NaSbF6 (1.2 equiv.)
122b
S
N N
iPriPr
Me Me
CNSbF6
109b
S
N N
iPriPr
Me Me
CNBr
DCM, rt, 12 h,
74%
 
Scheme 60. Counterion exchange. 
As 122b is no source of bromide nucleophiles as was 109b, we rationalized the following 
idea:  if we assume that a cyanation is successfully performed, a carbocation intermediate 
like S61-I is generated forming a 107b as main by-product, which indeed possesses a 
certain nucleophilic character and will quench S61-I. Unfortunately, no reactivity was 
observed again, and the starting materials were recovered (Scheme 61).   
 
Scheme 61. Attempted thiocyanation of 102a with 122b. 
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In our previously reported cyanations with 122b,[103] BF3.Et2O as a Lewis acid successively 
promoted the cyanation of electron-rich aryl or heteroaryl molecules. But for this new 
system it proved to be not acidic enough. As a consequence, different Lewis acids with 
stonger acidity than of BF3.Et2O were screened in the model reaction (Scheme 55). The 
results are summarized in Table 1.  
 
 
 
 
 
 
 
 
 
 
Table 1. Screening of Lewis acids. 
 
FeCl3 and AlCl3 did not promote the transformation, and starting materials were recovered 
(Table 1, entries 2 and 3). Me3Si+ and Ag+ cations also do not promote the product 
formation (Table 1, entries 4 and 5). Interestingly, when another boron-based Lewis acid, 
but of a higher Lewis acidity was employed, such as in B(C6F5)3, the expected product 129 
was formed and isolated in an excellent 90% yield as a 9/1 mixture of (Z)- and (E)-
stereoisomers (Table 1, entry 6). This confirms our preliminary postulates. Even more 
interesting results were obtained when TiCl4 was selected as a Lewis acid. In this case, 
small amounts of the corresponding chlorocyanated product 130a were indeed formed 
and isolated. In this situation, the chlorine atoms embedded in the Lewis acid behave as 
Entry Lewis acid Isolated yield Z/E ratio 
1 BF3·Et2O n.r. n.a. 
2 FeCl3 n.r. n.a. 
3 AlCl3 n.r. n.a. 
4 TMSTfO n.r. n.a. 
5 AgTfO n.r. n.a. 
6 B(C6F5)3 90% of 129 9/1 
7 TiCl4 14% of (Z)-130a Only (Z) 
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suitable nucleophiles under this reaction conditions. Even more fascinating is the fact that 
almost total regio- and high stereoselectivity in the formation of 130a was accomplished 
(Table 1, entry 7). 
 
 
3.3.3. Chlorocyanation of alkynes. 
 
On the contrary to compound 129, product 130 contains now a versatile chloro substituent 
that allows the possibility of further derivatizing 130 into more complex architectures. 
Accounting that, and due to the remarkable regio- and stereoselectivity of the 
transformation, we decided to focus our attention on the optimization of chlorocyanation of 
alkynes. 
 
 
3.3.3.1. Optimization. 
 
In accordance with the tendency of reactivity summarized in Table 1, it can be concluded 
that the presence of a boron-based Lewis acid is advantageous for the transformation and 
that the chloride ion should be an integral part of the Lewis acid structure. With these 
results and combining both ideas, we could speculate that BCl3 would promote even more 
efficiently the desired transformation, with the additional advantage that it has a higher 
Lewis acidity than B(C6F5)3. Following this rational, BCl3 was tested under the reaction 
conditions described above. Indeed, the formation of the expected product (Z)-130a in a 
satisfactory 37% isolated yield, again with total regio- and stereoselectivity, was observed 
(Table 2, entry 1). Lowering the reaction temperature to ambient one and the employment 
of BCl3 in excess resulted in the best conditions. The reaction time could also be reduced 
to one hour (Table 2, entries 2–4). The optimized conditions are indicated in Table 2, 
entry 4. 
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Table 2. Optimization of reaction conditions. 
The scope of this new transformation was next investigated. We were intrigued about 
whether the reaction was only limited to chlorocyanations with BCl3, or could also be 
extended to other halocyanations (with BBr3 and BF3) or arylcyanations (with BAr3) (Table 
3). Thus, commercially available boranes were then tested in the transformation. In the 
case of BF3.Et2O, no fluorocyanation product 131 was detected (Table 3, entry 1). 
Triphenylborane exhibited no reactivity as well (Table 3, entry 2). When BBr3 was 
employed, the corresponding bromocyanation product 128 was obtained in only 9% 
isolated yield (Table 3, entry 3). Only traces of chlorocyanated product were detected 
when BPhCl2 was employed as a Lewis acid (Table 3, entry 4). 
 
 
 
 
 
 
 
Table 3. Boranes screening. 
Entry BCl3 (equiv.) T (°C) Isolated yield (%)  
1 1.0 50 37 
2 1.5 rt 65 
3 2.0 rt 97 
4 2.0 rt (1 h) 98 
Entry Lewis acid Expected products Isolated yield  
1 BF3-Et2O 129, 131 n.r. 
2 BPh3 129, 132 n.r. 
3 BBr3 128, 129  9% of 128 
4 BPhCl2 129, 130, 132 traces of 130 
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Once BCl3 was identified as the most appropriate borane, we decided to focus our efforts 
on expanding the scope of the product and examining the limitations of the 
chlorocyanation methodology. 
 
3.3.3.2. Scope and limitations. 
Regioselectivity of the method. Due to the remarkable regioselectivity observed for the 
substrate 102a in the course of optimization, we started our studies to enhance the 
reaction scope employing bisarylalkynes 102 bearing substituents with various electronic 
demands. These substrates 102b–102i were synthesized following reported 
procedures[108,110–114] and used for the chlorocyanations under optimized conditions.The 
results are summarized in Table 4. 
 
 
 
Table 4. Scope for the chlorocyanation of 102b–i. 
 
In the case of 102b, that depicts a reduced polarizability in comparison to 102a (due to the 
Entry Alkyne R1 R2 R3 R4 130b-i/130b'-i' 
ratio 
Isolated 
yield (%)  
1 102b Me H H H 9/1 50 
2 102c H H H H n.a. 22 
3 102d Me H H Et 1/1 68 
4 102e Me H H OMe 96/4 81 
5 102f H OMe H H n.a. n.a. 
6 102g H H OMe H 98/2 93 
7 102h Cl H H H  traces of 130h' n.a. 
8 102i H H Br H n.a. n.a. 
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lower inductive effect that the methyl group creates in comparison with a methoxy group), 
it was reflected a lower nucleophilicity of the starting material, and as a consequence it 
was considerably reduced the conversion to the desired product 130b, which could be 
isolated in moderate 50% yield. As a direct consequence of this low polarizability, a 
regiomeric ratio of 9:1 (Z)-130b versus (Z)-130b' was observed, and again the method 
showed an excellent stereoselectivity towards the formation of the Z isomers (Table 4, 
entry 1). Continuing the scope studies, a symmetric substrate without any polarizing 
substituent in the aromatic ring such tolane (102c) was tested in the reaction, where the 
corresponding chloroacrylate (Z)-130c could be formed again in a stereoselective manner, 
but in a modest yield of only 22% (Table 4, entry 2). On the contrary, alkyne 102d also 
with a low polarized triple bond (but with a higher nucleophilicity derived from the alkyl 
substituents) underwent more readily the derived transformation, increasing the yield up to 
68%. On the other hand, both products (Z)-130d and (Z)-130d' were isolated as an almost 
1/1 regiomeric mixture as could be expected as methyl and ethyl groups are basically 
identicals regarding inductive effects. The stereoselectivity still remained excellent (Table 
4, entry 3). Substrate 102e was prepared for a direct comparison of the effect of including 
a methoxy and a methyl group in the para position, which can be directly evaluated by 
observation of the regioselectivity, as each substituent is responsible for the formation of a 
different regioisomer product (130e from methoxy and 130e' from methyl). In this case, 
after performing the reaction, we observed a regioselectivity ratio of 96/4 in favour of the 
product that was consequence of including a methoxy substituent 130e, and this 
compound was isolated with a very good yield (81%) and an excellent stereoselectivity 
(Table 4, entry 4). As might be expected, an electron-donating group in the meta position 
(R2) of the phenyl group, as in 102f, behaved as a deactivating substituent lowering the 
nucleophilicity of the triple bond and completely suppressing the reactivity (Table 4, entry 
5). On the contrary, for ortho methoxy-substituted (R3) alkyne 102g, the group acts again 
as an activating substituent, favouring the formation of the desired product 130g, which 
could be isolated in excellent yield (92%), with very high regioselectivity (98/2 ratio) and 
excellent stereoselectivity towards the Z isomer (Table 4, entry 6). Intrigued about if we 
could polarize the triple bond only with electron-withdrawing groups in the para (R1) or in 
the ortho (R3) positions, compounds 102h and 102i were prepared, but unfortunately it 
resulted in only some traces formation of 130h' and no conversion of 102i (Table 4, 
entries 7–8). 
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Analyzing the information discussed above, one can conclude that the methodology 
seems to be applicable to internal bisarylalkynes, in which at least one of the aryl groups 
must contain an electron-donating group either in the ortho or para position. To test this 
thesis, differently decorated internal alkynes 102 bearing various sterically- and 
electronically-demanding groups[92,93] were employed in the reaction (Table 5). 
 
 
Table 5. Scope for the chlorocyanation of 102j–s. 
 
 
Halogen-substituted methoxytolanes 102j–102m reacted in all the cases with total 
regioselectivities producing (Z)-130j–(Z)-130m in very good to excellent yields. However, 
in each case the products were contaminated with small quantities of (E)-130j–(E)-130m 
stereomers (Table 5, entries 1–4). Methoxytolanes 102n and 102o, both decorated with 
electron-withdrawing groups, were converted into the corresponding chlorocyanated 
products (Z)-130n and (Z)-130o employing elevated temperature (60 °C, 3 h) and only in 
moderate yields. Both reactions are characterized by complete regioselectivity and high 
stereoselectivity, furnishing again the Z-stereomer in a remarkable excess versus the E 
Entry Alkyne R1 R2 T (°C) t (h) Isolated yield 
(%)  
Z/E ratio 
1 102j p-anisolyl F rt 1 77  99/1 
2 102k p-anisolyl Cl rt 1 98  98/2 
3 102l p-anisolyl Br rt 1 78  98/2 
4 102m p-anisolyl I rt 1 67 93/7 
5 102n p-anisolyl NO2 60 3 44 96/4 
6 102o p-anisolyl CO2Et 60 3 37 95/5 
7 102p p-anisolyl CHO 60 3 n.a. n.a. 
8 102q 1-naphthyl H rt 1 23 only Z 
9 102r 2-(1,3)-
benzodioxolyl 
H 60 3 n.a. n.a. 
10 102s p-anilinyl H 60 3 n.a. n.a. 
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competitor (Table 5, entries 5–6). No conversion of formyl-substituted methoxytolane 
102p was observe mainly to two different reasons; one is that the aldehyde acts as a 
deactivating substituent due to its inductive effect, and second one is that the borane 
might have been inactivated by coordination to the carbonyl group of the aldehyde. In any 
case the starting material could be recovered (Table 5, entry 7). An attempt using a 1-
naphthyl group as a potential electron-rich aryl group in alkyne 102q was not successful: 
the reactivity decreased because of the low nucleophilicity of the triple bond in 102q. 
Compound 130q was formed stereospecifically, however, isolated in a moderate (23%) 
(Table 5, entry 8). Surprisingly, electron-rich alkynes 102r and 102s did not undergo 
chlorocyanation (Table 5, entries 9 and 10). In the latter case this can result from the 
deactivation of the boron center upon forming an adduct with the primary amine group, 
whereas the reasons of a failure in the former one can only be speculated about.  
An unexpected reactivity was evidenced, when alkyne 102t was used under the above 
indicated conditions. Instead of forming the corresponding chloroacrylonitrile 130t, the 
chloroborylated product 133 was obtained in 53% yield. This compound was recently 
obtained and investigated using X-ray crystallography by Ingleson and co-workers, who 
used exactly the same conditions but without cyanating reagent 122b.[115] Formation of 
this product could be rationalized in the way that BCl3 preferentially coordinates to the 
tertiary amine center, subsequently reacting with the alkyne bond and afording the 
unusual chloroborylated product 133 as a zwitterionic specie (Scheme 62).  
 
 
Scheme 62. Attempted chlorocyanation of alkyne 102t. 
 
The scope of the chlorocyanation was further investigated with heteroaryl-substituted 
alkynes 102u–102w, which were synthesized applying the published protocols.[108,110–114] 
The results are summarized in Table 6. Thus, thiophene-substituted alkyne 102u was 
successfully transformed into product (Z)-130u with total regio- and stereoselectivity in 
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56% isolated yield (Table 6, entry 1). In contrast to this, no reaction occured with a donor-
acceptor-substituted alkyne 102v, probably due to basicity of a nitrogen atom in the 
substrate (Table 6, entry 2). Notable is the formation of indolyl-substituted product (Z)-
130w, as with in this type of substrate the cyanation of the pyrrole subunit could be 
favoured (Table 6, entry 3). 
 
 
 
Table 6. Scope for the chlorocyanation of 102u–w. 
 
Subsequently, next studies were focused on the usage  of internal alkynes containing alkyl 
groups as one of the substituents. As postulated above for this reaction, one of the 
carbons in a triple bond will be transformed into a carbocationic center, which needs to be 
stabilized by a neighboring electron-rich aromatic substituent. Due to the inability to 
perform such stabilization with aliphatic substituents, it is expected that only one of the two 
possible regiomers should be formed in all these transformations.[107] Hence, a wide 
variety of different alkylarylalkynes 102x–102ah was further tested (Table 7). 
 
 
 
 
 
 
Entry Alkyne HetAr Ar Isolated yield (%) 
1 102u 2-thiophenyl Ph 56  
2 102v p-pyridyl p-anisolyl n.a.  
3 102w 2-(NMe)-indolyl Ph 15  
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Table 7. Scope for the chlorocyanation of arylalkylalkynes 102x–ah. 
 
As anticipated, internal alkynes 102x and 102y with linear chains afforded the 
corresponding products (Z)-130x and (Z)-130y in 64 and 71% yield, respectively, with the 
expected complete regioselectivity and stereoselectivity in favor of (Z)-isomers (Table 7, 
entries 1 and 2). Benzyl (102z), cyclohexyl (102 aa) and cyclopentyl (102ab) substituents 
as well as silyl groups (102ac) or halogenated aliphatic chains (102ad) tolerated the 
chlorocyanation reaction, and successfully furnishing acrylonitriles (Z)-130z, (Z)-130aa, 
(Z)-130ab, (Z)-130ac and (Z)-130ad, respectively, again with a total regio- and 
stereoselectivity (Table 7, entries 3–7). Contrary to this, protected alcohols 102ae and 
102af did not form the corresponding acrylonitriles. Only deprotection of substrate was 
observed under these conditions (Table 7, entries 8 and 9). Excellent conversion was 
observed for alkyne 102ag, decorated with a thiophene group in combination with a 
cyclohexyl one. Once again, the reaction resulted in a total regio- and stereoselective 
formation of 130ag (82% yield, Table 7, entry 10). Similar to 102w, alkyne 102ah with an 
indole moiety entered the transformation, however, affording 130ah in very poor yield 
(Table 7, entry 11). 
Entry Alkyne Ar Alkyl Isolated yield (%) Z/E ratio 
1 102x Ph Et 64  only Z 
2 102y Ph Pr 71  only Z 
3 102z Ph Bn 63  only Z 
4 102aa Ph Cyclohexyl 80 only Z 
5 102ab Ph Cyclopentyl 76 only Z 
6 102ac p-(TMS)-C6H4 Bu 57 only Z 
7 102ad Ph 3-(Cl)-C3H6 62 only Z 
8 102ae Ph 4-(THPO)-C4H8 n.a. n.a. 
9 102af Ph 2-(PMBO)-C3H6 n.a. n.a. 
10 102ag 2-thiophenyl Cyclohexyl 82 only Z 
11 102ah 2-(NMe)-indolyl Bu   7 only Z 
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After an exhaustive study of the scope of internal alkynes, we further explored the 
reactivity of commercially available terminal alkynes 102ai–102am (Table 8).  
 
 
Table 8. Scope for the chlorocyanation of terminal alkynes 102ai–am. 
 
As a carbocation on the terminal carbon cannot be stabilized, a regioselective 
transformation could also be expected in this case. Indeed, terminal alkyne 102ai was 
efficiently converted to acrylonitrile (Z)-130ai in a stereoselective fashion in good yield 
(Table 8, entry 1). It should be emphasized that a complete conversion of the starting 
material 102ai occurred and no by-products was formed in this case, although yields were 
not spectacular. Presumably, the Lewis acid promoted partial polymerization of the 
starting material. This assumption was further confirmed by testing electron-rich alkyne 
102aj, which led to a fast decomposition of starting material (Table 8, entry 2). 
Chlorocyanation of para-tolyl analogue 102ak resulted in a single product formation along 
with decomposition of the starting material (Table 8, entry 3). Electron-deficient aromatic 
rings in alkyne 102al could increase the yield to a moderate value of 47% (Table 8, entry 
4). In addition, TMS-protected alkyne 102am afforded product 130am, but as a 
component of a complex non-separable mixture (Table 8, entry 5). Despite the low to 
moderate yields, the results discussed in this paragraph still constitute a remarkable total 
regio- and stereoselective transformations of inexpensive and commercially available 
starting materials. 
 
As aliphatic substituents on a triple bond cannot stabilize the carbocation proposed as 
intermediate on route to the derived products, dialkylalkynes were expected to be inert 
Entry Alkyne Ar R Isolated yield 
(%)  
Z/E ratio 
1 102ai Ph H 58  Z 
2 102aj p-anisolyl H n.a. n.a. 
3 102ak p-tolyl H 21  Z 
4 102al p-(Cl)-C6H4 H 47  Z 
5 102am Ph TMS n.a. n.a. 
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towards chlorocyanation. Indeed, no conversion of commercially available 1,2-di-n-
propylalkyne (102an) was detected under the optimized conditions. (Scheme 63).   
 
 
Scheme 63. Chlorocyanation of 102an. 
 
Alternatively, the intermediate carbocation could probably be stabilized by a neighboring 
heteroatom. To test this, compound 102ao was synthesized according to the protocol 
developed in our laboratories[116] and subjected to chlorocyanation. Product (Z)-130ao was 
formed successfully, with a complete regio- and stereoselectivity, thus indicating the 
efficient stabilization of the carbocation with the sulfur atom (Scheme 64).  
 
 
Scheme 64. Chlorocyanation of alkyne 102ao. 
 
Readily available 1,3-diynes 102[117] represent another group of potentially suitable 
substrates to expand the scope of the chlorocyanation method developed. However, when 
102ap and 102aq were subjected to the general cyanation conditions, both demonstrated 
lack of reactivity towards the desired product (Scheme 65). 
 
Scheme 65. Attempted chlorocyanation of 1,3-diynes 102ap and 102 aq. 
 
3.3.3.3. Structural studies.  
Stereoselectivity of the method. As underlined throughout the study of the scope of 
chlorocyanation, only one of the possible regioisomers was preferentially formed in most 
cases by the correct choice of the starting alkynes. In fact, the regioselectivity of the 
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transformation could have been predicted with certain confidence. The truly unexpected 
result was the excellent stereoselectivity, which led to the formation of stereomers with a 
(Z)-configuration. The latter was proved by several analytic methods as described below. 
NMR experiments. Unfortunately, the majority of the chlorocyanated products were not 
described in the literature before. Therefore, we had no opportunity for the direct 
comparison of the NMR in most cases. Only, in a single case all four possible 
chlorocyanated products derived from terminal alkyne 102ai appeared to be synthesized 
and completely characterized. It was then easy to assure that our product was neither any 
of the unexpected regiomers (Z)-130ai'[118] and (E)-130ai'[118] nor (E)-130ai,[119] but only 
the Z stereomer (Z)-130ai.[120] This result allowed us to assume that the other 
chloroacrylonitriles 130 would probably also exhibit a Z configuration.  
To corroborate the structure of (Z)-130ai and to be able to extend the analysis to other 
substrates, the interaction between the vinylic proton and C2 via an HMBC experiment 
was performed by the NMR department of the Institute. The value of of 3J {C-H} coupling 
constant of ~ 3 Hz undoubtedly indicates a Z stereoisomery (Figure 12).[121] Due to the 
structural similarity, every terminal alkyne could potentially be considered as forming the 
corresponding (Z)-3-chloroacrylonitrile.  
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Figure 12. HMBC spectrum of (Z)-130ai. 
X-Ray crystallography. Most of the products 130 were colorless solids at ambient 
temperature, and recrystallization of several compounds afforded suitable for X-ray 
diffractometry crystals. Thus, (Z)-configurations of compounds 130l, 130u and 130ao as 
well as regioselectivity of their formation were confirmed in all the cases by X-ray crystal 
structure analysis after recrystallization from n-heptane (Figure 13). 
 
 
 
 
 
 
 
 
 
 
 
153.4 ppm
134.4 ppm
Figure 13. Structures of chloroacrylates (Z)-130l, (Z)-130u and (Z)-130ao in the crystals. Hydrogen atoms are removed for 
clarity.  
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Isomerization of chloroacrylates (Z)-130. A very interesting chemical behavior was 
detected for the compound 130m. After the standard one hour reaction time, 1H NMR 
spectrum of the crude reaction mixture undoubtedly indicated the formation of only the Z 
stereomer, together with a small quantity of still unreacted starting material 102m (Figure 
14a). Once the crude product was worked-up and isolated by column chromatography, the 
formation of a new product was observed. The latter was proved to be an isomer of (Z)-
130m by HRMS analysis and could be no other than the corresponding stereomer (E)-
130m formed by rotation of the double bond, as the formation of regiomer (Z)-130m‘ 
would involve a shift of both Cl and CN moieties which is not favoured (Figure 14b). NRM 
measurements were repited after 3 hours and showed the formation of the E isomer which 
was now majority (Figure 14c). Interestingly, the spectrum was then re-measured after 
one month, and no significant changes could be determined indicating that the equilibrium 
was achieved. This experiment confirms the complete stereoselectivity of the developed 
method, but also indicates the tendency of the products to isomerize upon standing.   
 
Figure 14. 1H NMR spectra of 130m after indicated time. 
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This phenomenon was observed for several other products. Thus, chloroacrylonitrile 130a 
as reference was isolated in a pure form an identified as a single (Z)-isomer (Figure 15, 
compound A). After four weeks 1H NMR measurement indicated the formation of a new 
isomer (Figure 15, compound B), as was observed in the case of 130m. When the 
mixture of stereomers 130a was analyzed by means of the NOESY technique, ortho 
aromatic protons of compound B were detected in two different areas (7.63 and 7.79 
ppm), and no NOE interaction was observed between them. This identifies compound B 
as an (E)-isomer. Consequently, compound A should be identified as a (Z)-isomer. 
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Figure 15. 1H NMR spectrum for stereomeric mixture of 130a. 
To investigate the origin of this isomerization, the reaction was performed using the same 
conditions with and without the presence of light, obtaining similar isomeric ratios in both 
cases thus indicating that the process was not ejected by a photochemical process, and 
was probably due to a thermal one. Unfortunately, thermal conditions we employed 
(warming the isolated products up to 60 ºC) did not provoke any sifnificant alteration in the 
B  B  B    A    B    A                                                                              B A                      
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stereomer ratio. 
 
3.3.3.4. Mechanistic studies. 
For a complete understanding of the reaction mechanism and with a purpose to rationalize 
the possible pathways leading to such excellent stereoselectivities, various experiments 
were performed using internal alkyne (Z)-130a as a model substrate. 
 
3.3.3.4.1. Borylative cyclization. 
The recently reported results on borylative cyclization of compound 102g can be helpful to 
enquire, whether the transformation occurred in a concerted or stepwise process. 
According to Ingleson and co-workers,[115] when internal alkyne 102g is treated with one 
equivalent of BCl3, the corresponding borylated benzofurane 134 is formed. Alkyne is 
initially activated by coordination of BCl3 that promotes a borylative cyclization of S66-I by 
electrophilic attack of oxygen to the activated triple bond, forming zwitterionic specie S66-
II, followed by further elimination of methylchloride (Scheme 66). 
 
Scheme 66. Borylative cyclization of 102g. 
The conditions of this cyclization are almost identical to the optimized conditions used for 
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the chlorocyanation of alkynes 102, with the exception of the employment of our cyanating 
reagent 122b. To prove if benzofurane 134 was the precursor of the chlorocyanation 
product (Z)-130g, 134 was initially synthesized in situ as indicated above, and then it was 
treated with 1.3 equivalents of cyanating reagent 122b in one portion. No formation of 
acrylonitrile (Z)-130g was observed in this case, thus excluding 134 as a possible 
intermediate (Scheme 67).  
 
Scheme 67. Mechanistic experiment. 
 
No reaction was observed mixing starting material 102g with 1.3 equivalents of cyanating 
reagent 122b in the absence of BCl3. 
 
3.3.3.4.2. Cycloisomerization. 
Another plausible mechanism for this process might be the in situ generation of cyanogen 
chloride (39) in stoichiometric amounts from BCl3 and 122b. Focusing the attention on the 
above discussed formation of 129, it is observed that the cyanation also occurs when 
there are no chlorides present in the media. This excludes ClCN as cyanating reagent, 
and indicates that the alkyne is firstly cyanated, generating a carbocationic intermediate, 
which is further quenched by a selected nucleophile (such is the chloride in the 
chlorocyanation) 
Employing substrates such 135a, which include an extra phenyl ring, would result in a 
cyanative cyclization where the actual nucleophile is the new incorporated phenyl ring, 
when B(C6F5)3 is employed. This idea was tested and, as a result, cyanated phenanthrene 
136a was obtained as the major product in a moderate isolated yield of 54% (Scheme 
68).  
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Scheme 68. Cyanative cyclization of 135a with B(C6F5)3. 
Suprisingly, also employing BCl3 produced only cyanated phenanthrene 136a without any 
traces of the corresponding chlorocyanation product 137 (Scheme 69). 
 
 
Scheme 69. Cyanative cyclization of 135a with BCl3. 
From these cyclization reactions it could be concluded, that (a) boranes activate the cyano 
group instead of the alkyne bond and (b) the cyanation occurs initially, forming a stabilized 
carbocation that is next trapped by a nucleophilic source. To obtain a tangible proof that 
the nitrile group interacts with the borane, two experiments were carried out. Cyanating 
reagent 122b was reacted with one equivalent of B(C6F5)3 (Scheme 70a) and separately 
with one equivalent of BCl3 under otherwise identical conditions (Scheme 70b). After 5 
minutes the resulting crude products were recrystallized. In the case of B(C6F5)3, the 
formation of Lewis adduct 138 was confirmed by X-Ray crystal structure analysis. On the 
other hand, formation of a non-specific by-product 139 was observed with BCl3, thus 
indicating the mechanistic complexity of this cyanation reaction.[122]  
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Scheme 70. Reactivity of 122b towards BCl3 and B(C6F5)3. Formation of products 138 and 139.  
 
3.3.3.4.3. By-products isolation from reaction mixtures. 
Gas evolution directly after addition of BCl3 and formation of a big amount of almost 
insoluble orange solid were observed in each chlorocyanation experiment on larger scale. 
With the perspective of isolating the possible by-products, this solid was isolated and 
recrystallized under an inert atmosphere. The X-Ray crystal structure analysis disclosed 
an interesting bis(imidazolium)disulfide structure 140a (Scheme 71 and Figure 16) with a 
complex mixture of counterions. Hexafluoroantimonate and tetrachloroantimonate are 
observed in the X-ray-determined structure, and additional hexachloroantimonate in the 
HRMS analysis. This fact implies that an F–/Cl– exchange is taking place, presumably 
between BCl3 and SbF6– species. It should be noted that the cyanation reagent 122b, was 
completely converted to disulfide 140a. 
 
 
 Scheme 71. Formation of the salt 140a as a by-product. 
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3.3.3.4.4. Counterion effect. 
As indicated above, the counterion plays a crucial role in this transformation. Thus, 
various cyanating reagents with differently halogenated counterions, such 122c 
possessing a tetrafluoroborate anion and 122d with triflate counterion as a pseudohalide, 
were synthesized directly from 122b via counterion exchange, and tested for 102a in the 
chlorocyanation under optimized conditions (Scheme 72). 
In the case of 122c, 1H NMR spectrum of the crude reaction mixture, measured after one 
hour of reaction time, indicated a formation of small amount of product (Z)-130a as a part 
of complex mixture (Scheme 72a). Interestingly, disulfide 140b, but this time as the 
trichlorocyanoborate counterion, was also detected by Mass spectrometry. This trapping 
of the nitrile group by trichloroborane explains low formation of the product. The same 
experiment was conducted using the triflate-containing cyanating reagent 122d. In this 
case, after one hour stirring, the reaction mixture consisted of the starting material 102a 
and product (Z)-130a as approximately 1/1 mixture. 1H NMR spectrum of the crude 
mixture was very clean, but disulfide 140c was detected as a by-product as well (Scheme 
72b). 
Figure 16. Structure of the salt 140a in the crystal. 
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Scheme 72. Counterion effect experiments. 
 
From both experiments one can conclude that he participation of hexafluoroantimonate as 
a counter ion is not critical, but it is very useful for the obtention of the chlorocyanated 
alkynes in good yields. 
 
3.3.3.4.5. Proposed mechanism. 
 
Analyzing the experimental material accumulated in our laboratory, a satisfactory 
mechanistic rationalization can be proposed for the chlorocyanation (Scheme 73). It 
would start with the nitrile activation in 122b, thus generating Lewis Adduct S73-I. A F/Cl 
exchange in S73-I in some extent may occur as well. Next step would involve a 
regioselective addition of the corresponding alkyne 102 forming a stabilized carbocation 
S73-II. One of the chloride ions from BCl3 moiety is then transferred in a syn fashion to 
this carbocation, forming selectively iminoborane intermediate S73-III in a pre-established 
(Z)-configuration, before forming the desired chloroacrylate (Z)-130 by elimination of the 
imidazolium-thioborane moiety. As a side reaction, disulfide 140 can be formed. No 
evidence of fluoroacrylates formation was detected, as B–Cl bonds (~456 kJ/mol) are 
weaker that B–F bonds (~613 kJ/mol). 
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  Scheme 73. Proposed mechanism. 
 
 
 
 
 
 
 
 
3.3.3.5. Synthetic applications of chloroacrylonitriles. 
Once a family of products (Z)-130 was prepared, their synthetic utility in organic synthesis 
was investigated as well. Therefore, various experiments have been conducted to 
derivatize (Z)-acrylonitriles into more complex architectures using product (Z)-130a as 
model a substrate. 
 
3.3.3.5.1. Cross-couplings. 
Among vinyl halides, vinyl chlorides represent substrates with a lowest reactivity towards 
cross-coupling reactions.[123] Nonetheless, they can be successfully converted into 
synthetically useful tetrakis-substituted alkenes with high stereoselectivities. 
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3.3.3.5.1.1. Suzuki-Miyaura couplings. 
Following a standard procedure for the cross-coupling of vinyl chlorides,[124] products 
141a–141c were obtained in good to excellent yields with a remarkable stereoselectivity, 
thus affording an approach to synthetically useful tetrasubstituted alkenes bearing all-
carbon substituents (Scheme 74). (Z)-Configuration of structure 141b was confirmed by 
X-Ray crystal structure analysis (Figure 17). 
 
Scheme 74. Derivatization of chloroacrylonitroles (Z)-130a by Suzuki-Miyaura cross-coupling. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17. Structure of (Z)-141b in the crystal. 
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3.3.3.5.1.2. Sonogashira-Hagihara couplings.  
None from the published procedures[125] appeared to be appropriate for the Sonogashira-
Hagihara couplings of 130, as formation of 142 was not detected in any case (Scheme 
75).  
 
Scheme 75. Attempted derivatization of (Z)-130a by a Sonogashira-Hagihara cross-coupling. 
 
3.3.3.5.2. Solvolytic experiments. 
Vinyl chlorides S76-1 can be functionalized by substitution reactions executed by solvents, 
also denominated as solvolysis, thus being alcoholysis and aminolysis the most common 
approaches (Scheme 76).[2] 
 
Scheme 76. Solvolysis of chlorovinyl derivatives. 
 
 
3.3.3.5.2.1. Alcoholysis of chloroacrylonitriles.  
(Z)-Stereomerically pure acrylonitrile (Z)-130a was refluxed in ethanol for 12 hours in the 
presence of NaOH as a base according to the procedure reported in literature[126] affording 
the desired alcoholysis product 144 in good yield. Unfortunately, this transformation 
appeared to be not stereoselective affording a 2/1 stereomeric mixture of the alcoholysis 
products 144. (Scheme 77). 
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Scheme 77. Alcoholysis of chloroacrylonitrile (Z)-130a. 
 
3.3.3.5.2.2. Aminolysis of chloroacrylonitriles. 
In an analogous way to alcoholysis, several aminolyses were examined for substrate (Z)-
130a as summarizes Table 9. 
  
Table 9. Aminolysis of chloroacrylonitrile (Z)-130a. 
Neither primary amines in the presence of a strong base nor amides afforded the desired 
products (Table 9, entries 1–2). In the first case the starting material (Z)-130a was in part 
re-isolated, whereas in the second one it completely decomposed. More successful was 
the aminolysis using cyclic secondary amines such as piperidine and morpholine in the 
presence of a base. The first transformation was accomplished in excellent yields but 
without selectivity, as an almost 1/1 mixture of isomeric products (E)- and (Z)-145c was 
isolated (Table 9, entry 3). The same result was obtained in the case of morpholine (91% 
yield) with an 1.5:1 ratio of compounds in favor of compound (E)-145d (Table 9, entry 4).  
Entry Amine Base T (°C) t (h) Product Isolated yield 
(%) 
Z/E ratio 
1 EtNH2 NaH 130 1 (Z)-130a   n.a. n.a. 
2 NaNH2 n.a. 60 12 decomp.  n.a. n.a. 
3 piperidine NaOH 100 1 145c 95  1/1.2 
4 morpholine NaOH 130 9 145d 91  1/1.5 
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3.3.3.5.2.3. Synthesis of heterocycles.  
Thiophenes. Albeit the inconveniency of obtaining mixtures of stereomers, the products 
of these solvolyses discussed above had the definitive potential of being further employed 
for the synthesis of heterocycles. Following this principle, Thomae et al. reported the 
synthesis of thiophenes starting from chloroacrylonitriles (Scheme 78).[127] 
 
Scheme 78. Thiophenes synthesis from chloroacrylonitriles 130. 
Model substrate (Z)-130a was then employed under the same conditions as in Scheme 
78. The results including possible intermediates, generated in each step, are depicted in 
Scheme 79.  
In the first step, the non-stereoselective addition/dehydrochlorination afforded thioles (Z)-
S79-I and (E)-S79-I, which are directly condensed with one equivalent of 
chloroacetonitrile, forming intermediates (Z)-S79-II and (E)-S79-II. After deprotonation of 
the latter with a base, only anionic intermediate (Z)-S79-III is able to afford the 
corresponding thiophene 146a via nucleophilic addition to the cyano group followed by 
hydrolysis, thus being reflected in a lower yield than expected. The intermediate (E)-S79-
III generated compound 147, which contaminated the final product. For the comparison, 
all the substrates employed by Thomae et al. contained sterically not demanding 
substituents R2 such as H or Me. This increased the proportion of intermediate of the type 
(Z)-S79-I, which can additionally be stabilized by a S•••N through-space interaction, and 
thus the yield of final thiophene. In contrast to this, the intermediates S79-I contained 
bulkier aryl substituents. Nonetheless, the developed route for the synthesis of thiophenes 
from alkynes is shorted (5 steps) than the reported by Thomae et al. (7 steps).  
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Scheme 79. Synthesis of thiophene 146a from (Z)-130a. 
 
Furanes. Exploiting the same idea, it was envisioned to realize an equivalent synthesis of 
furanes using alcohol in combination with a base. Unfortunately, only traces of 148 could 
be detected and no product was isolated (Scheme 80).  
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Scheme 80. Attempted synthesis of furane 148 from (Z)-130a. 
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Pyrazoles and pyrazolopyrimidines. Based on the work published by Almansa et al.,[128] 
pyrazole derivatives were prepared by reaction of (Z)-130a with hydrazines. In the case of 
the methylhydrazine, the isomeric mixture of the pyrazole 149a and its regioisomer 149b 
in a favorable 5.6:1 ratio was obtained in 73% yield (Scheme 81a). This inconveniency 
could be further avoided using a symmetric hydrazine, which afforded 149c in excellent 
yields (Scheme 81b).  
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N NH2Me
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N NH2
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Scheme 81. Pyrazoles synthesis from (Z)-130a. 
As a synthetic extension, it is possible to further derivatize 149c by converting it into 
pyrazolopyrimidine 150 via condensation with acetylacetone following the procedure 
reported by Almansa et al.,[128] also in a very good yield (Scheme 82). 
 
Scheme 82. Synthesis of 150 from 149c. 
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3.3.3.5.2.4. Natural products derivatization. 
Another direct application of the newly developed methodology was by derivatization of a 
natural product containing an alkyne unit.[117d–c] For this purpose, mestranol (151), a 
commercially available and inexpensive alkyne derivative of estradiol, was chosen as a 
model substrate. After simple derivatization to 152 by a Sonogashira-Hagihara cross-
coupling and alcohol protection affording 153, this alkyne was further subjected to the 
optimized chlorocyanation conditions. Lamentably, but only decomposition of the starting 
material was observed, while product 154 was not detected (Scheme 83). 
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Scheme 83. Attempted chlorocyanation of estradiol derivative 153. 
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3.3.3.6. Summary. 
In summary, a new methodology for the chlorocyanation of alkynes, based on a combined 
action of BCl3 and cyanating reagent 122b, has been developed. Final products, the 
synthetically interesting 3-chloroacrylonitriles 130, were formed with excellent regio- and 
stereoselectivities. The reaction tolerates a wide variety of functionally substituted alkynes, 
including terminal and internal ones, as summarized in Scheme 84. The newly described 
products could be successfully converted into more complex molecules, hence validating 
the synthetic interest to this process. 
 
Scheme 84. Scope for the regio- and stereoselective chlorocyanation of alkynes. [a] Isolated as a mixture of 
stereomers (ratio expressed as Z/E), [b] Isolated as a mixture of regiomers. [c] Reaction performed at 60 °C 
during 3 h. 
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4. Cyanative Cyclizations. 
 
4.1. Introduction. 
Organic cycles represent, with no doubt, the most important type of molecules in organic 
chemistry as they are present in almost every natural product, reason why they are 
subject of study in important scientific fields such medicine, pharmacology, materials 
science, industry, etc… Due to their importance, a plethora of synthetic procedures have 
been developed to achieve their synthesis and its further derivatization. Among them, gain 
more power those new routes which lower the environmental impact and the atom 
economy of the process. As special interest worths mentioning the denomatinated as 
intramolecular cyclization, which can be defined as a type of reaction that implies the 
formation of one or more cycles by a rearrangement of the starting material.[129] One of the 
most attractive points which derives from them, comes from the excellent atom economy 
which they exhibit, as every atom present in the starting material is also present in the 
final product.  
Intramolecular cyclizations (also denominated cycloisomerizations) can be accomplished 
by addition of catalytic amounts of Lewis acid or transition metal to the desired substrate, 
resulting as above indicated, in the generation of at least one new cycle. The 
transformation involves the generation of new σ-bonds at the expence of another π-bonds 
included in the substrate.[130] Of particular interest are those associated with the formation 
of a new C–C bond, as they are a simple tool to construct polycyclic compounds (Scheme 
85). 
 
Scheme 85. Cycloisomerization involving the generation of a new C-C bond. 
 
As a small summary, some of the most representative cycloisomerization cases reported 
in literature are detailed in the following page. One classical way is denominated as ene-
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type cyclizations, where a π-bond nucleophile which usually is an alkyne (Scheme 86a) or 
an alkene (Scheme 86b) attacks another π-bond (electrophile) present in the molecule.[131]  
 
Scheme 86. Ene-type cyclization. 
Alternatively, intramolecular cyclizations can be accomplished when a π-allyl group is 
initially activated by a transition metal, and subsequently acts as a nucleophile reacting 
with another double bond on the molecule (Scheme 87).[132]  
 
 
Scheme 87. Cycloisomerization by π-allyl activation. 
 
One of the other many ways to achieve cycloisomerizations is the situation in which, two 
alkynes from the same molecule react with each other forming a new cycle (Scheme 
88).[133]  
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Scheme 88. Cycloisomerizations. 
 
Internal alkynes seem to play an important role on this type of transformations, therefore 
we decided to investigate if could extend our developed methodology of cyanation of 
alkynes to processes which involve a cyclization step.  
Internal alkynes such 135, which represent one of the classical substrates used in 
cycloisomerizations brought our attention. The mechanism of the transformation is 
detailed in Scheme 89.[134]  
First, the formation of metal-alkyne complex S89-I occurs, which increases the triple bond 
electrophilicity in 135. Next step is the nucleophilic attack by the arene moiety, leading to 
the formation of intermediates S89-IIa or S89-IIb with a 6- or 5-membered ring, 
respectively. The regioselectivity of this step can be controlled by a proper selection of the 
substituents R, metals and/or ligands.[135] Both carbocationic intermediates S89-IIa and 
S89-IIb rearrange via a [1,3]-H shift step, which is strongly favored by a bencene ring 
formation process which leads to the corresponding metal-alkene complexes S89-IIIa and 
S89-IIIb, respectively. Finally, products 6-endo-dig 163 or 5-exo-dig 164 are generated 
after demetalation. 
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Scheme 89. The two possible pathways in the cycloisomerization of ene-yne type substrates like 135. 
 
Analyzing the generally accepted mechanism we came with interesting conclusions. We 
can observe that to proceed from S89-IIa and S89-IIb to 163 and 164 respectively, a 
proton needs to be shifted, and that if this proton is conveniently trapped by a suitable 
base, another electrophilic source could take its place and be incorporated in the final 
product.[136] In theory, when the reaction is performed with stoichiometric amounts of any 
suitable electrophile in combination with a proper base, products like S90-IIIa and S90-IIIb 
will be formed (Scheme 90). 
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Scheme 90. Electrophile-promoted cyclization of ene-ynes 135. 
 
The latter methodology has an obvious advantage, since synthetic versatile halides, 
silanes or boranes substituents can be introduced in the final products, thus allowing their 
further functionalization by cross-coupling methodologies. In the most ideal case, the 
electrophile is reactive enough for the direct activation of the alkyne and for promoting the 
cyclization, such is the case of protic acids which can promote efficient cascade 
cyclizations.[137] This idea has been already exploited by Larock and co-workers in 2005, 
who have prepared regioselectively iodo-, bromo- and sulfur-substituted phenanthrenes 
165–167 (Scheme 91).[138] 
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Scheme 91. Electrophile-promoted synthesis of phenanthrenes 165–167 via cyclization of ene-ynes 135. 
 
Another well-developed cyclization procedure is the so-called borylative cyclization, where 
borane electrophiles are incorporated in the final cyclic products. In most cases, the 
boron-based electrophile must be activated by a transition metal, as in the intermediate 
169, and then incorporated after the reductive elimination step (Scheme 92a).[139] Ingleson 
and co-workers reported on one of the first examples of metal-free borylative cyclizations 
by using trichloroborane as the selected electrophile (Scheme 92b).[140] 
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Scheme 92. Palladium-catalyzed and metal-free borylative cyclizations. 
Analogous silylative cyclizations are still underexplored. A rare example is shown in 
Scheme 93, where the main product (E)-174 is formed together with a complex mixture of 
its various regio- and stereomers.[141]  
 
Scheme 93. Rhodium-catalyzed silylative cyclization of 173. 
As already mentioned, all these protocols described above have one general synthetic 
perspective, that the final products can be transformed into more complex structures, for 
example, when creating a new C–C bond by performing cross-coupling. The whole 
process requires a two steps sequence, namely initial electrophile-promoted cyclization 
followed by a cross-coupling process catalyzed by a transition metal complex (Scheme 
94a). This transformation, however, can be optimized by direct employment of a carbon-
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based electrophile which would promote both reactions – cyclization and C–C bond 
formation – in one step. The electrophilic cyano species would represent an ideal option 
for this purpose (Scheme 94b). So far, to the best of our knowledge, there are no 
examples of cyclizations promoted by electrophiles such [+CN], and this question has 
become one of the main research topics in our laboratory. 
 
Scheme 94. Cyanative cyclization strategy. 
 
 
4.2. Objective. 
The topic of this Chapter is focused on the development of an efficient protocol for the 
metal-free cyanative cyclization of ene-yne-type substrates by employment of imidazolium 
thiocyanates as cyanating reagents. 
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4.3. Results and discussion. 
After efficiently developing a metal-free methodology for the regio- and stereoselective 
chlorocyanation of alkynes,[142] the possibility of extending the scope of transformations 
with cyanating reagent 122b was further explored. As evidenced before in the course of 
mechanistic studies, substrate 135a could successfully produce cyanated phenanthrene 
136a via a cyanative cyclization procedure. As no base participated in this process, the 
formation of undesired cycloisomerized product 163a was observed as well (Scheme 95). 
 
Scheme 95. Cyanative cyclization and cycloisomerization of 135a. 
 
4.3.1. Synthesis and screening.   
To further corroborate how 163a can be formed, two test experiments were initially carried 
out. In the first experiment, the substrate 135a was mixed with BCl3 in a ratio of 1:1, and in 
the second one – with one equivalent of TfOH (Scheme 96). In both cases, a quantitative 
cycloisomerization of substrate 135a was observed. 
 
 
Scheme 96. BCl3- and TfOH-promoted cyclosiomerizations of 135a. 
These types of cycloisomerizations are favored by an aromatization process, which allows 
the reaction to be terminated in a very short time under the action of an acid. Thus, 
different Lewis acids were screened for this transformation (Table 10). Unfortunately, 
none of the tested transition metal-based Lewis acids tested stimulated the formation of 
cyanated product 136a.  
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Table 10. Screening of Lewis acids for the cyanative cyclization of 135a.[a] Determined by 1H NMR. [b] L = 
phenyl-bis(di isopropylaminecycloproprenium)phosphine. 
 
In the case of AlCl3, only starting material was recovered (Table 10, entries 1 and 2), 
Lewis acids like Al(TfO)3, AuL, CuI and Y(TfO)3 resulted in the conversion to the undesired 
cycloisomerized product 163a without any traces of 136a (Table 10, entries 3, 5, 8, 9 and 
13). TiCl4 produced decomposition of starting material (Table 10, entry 4). As already 
known from our previous study, borane-based Lewis acids like BF3, BCl3 or B(C6F5)3 can 
efficiently activate 122b to promote electrophilic cyanations. Thus, BF3 was tested in the 
reaction, but only 163a was detected again (Table 10, entries 10–12). Similar to the 
methodology for chlorocyanation of internal alkynes, only B(C6F5)3 and BCl3 appeared to 
be suitable for the formation of the cyanated product 136a, however, in circa a 1:1 mixture 
with 163a (Table 10, entries 13–14). 
 
 
Entry Lewis acid Solvent T (°C) Conversion Product[a] 
1 AlCl3 DCM rt n.r. n.a. 
2 AlCl3 1,2-DCE 80 n.r. n.a. 
3 Al(TfO)3 DCM rt Full 163a 
4 TiCl4 DCM rt Full n.a. 
5 AuL[b]+ AgSbF6 DCM rt Full 163a 
6 PdCl2 1,2-DCE 80 n.r. n.a. 
7 CuI DCM rt n.r. n.a. 
8 CuI 1,2-DCE 80 Full 163a 
9 Y(TfO)3 DCM rt Full 163a 
10 BF3·Et2O DCM rt Full 163a 
11 BF3·Et2O DCM 0 Full 163a 
12 BF3·THF DCM rt Full 163a 
13 B(C6F5)3 DCM rt Full 136a/163a (~1/1) 
14 BCl3 DCM rt Full 136a/163a (~1/1) 
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To further develop an efficient method for the cyanative cyclization of alkynes and in 
accordance with the mechanism shown in Scheme 90, the reaction was probed in the 
presence of an appropriate base which does not form adducts with a Lewis acid. As 
borane B(C6F5)3 features a sterically surrounded boron atom, it was chosen as Lewis acid 
for this transformation in combination with different bases (Table 11). Unfortunately, 
neither inorganic (Table 11, entries 1 and 2) nor organic bases (Table 11, entries 3–7) 
appeared to be efficient, they all seem to deactivate the borane by formation of a Lewis 
adduct. DABCO base was not suitable also and the starting material 135 remained 
unchanged (Table 11, entries 5–7).  
 
 
 
 
 
 
 
 
 
 
 
Table 11. Bases screeining for the cyanative cyclization of 135a. 
 
Ingleson and co-workers[140] reported 2,6-di-tert-butyl-4-methylpyridine (175) as an 
efficient base to avoid the cycloisomerization of substrates 135 into 163 in the presence of 
excess of BCl3. In this borylative cyclization procedure, the hydrogen atom in intermediate 
S97-II which should undergo a [1,3]-H shift is trapped by the sterically hindered pyridine 
175, generating the corresponding product of the borylative cyclization 176 and pyridinium 
salt 177 (Scheme 97). 
 
Entry Base Conversion Product 
1 K2CO3 n.r. n.a. 
2 NaAcO n.r. n.a. 
3 MeiPr2N n.r. n.a. 
4 P(tBu)3 n.r. n.a. 
5 DABCO n.r. n.a. 
6 2,6-ditertbutylpyridine n.r. n.a. 
7 1,8-naphthalenediamine n.r. n.a. 
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Scheme 97. Borylative cyclization of 135b. 
This type of base may be perfectly suitable for our reaction system as well, taking into 
account the similarity of the reaction conditions (cf. Table 10, entry 14). Indeed, 
employing slightly modified version of 175, such is 2,6-di-tert-butylpyridine (178), we 
observed a remarkably high conversion of 135a to the desired compound product 136a as 
a single product and without any traces of cycloisomerized side-product 163a. The 
unreacted starting material 135a could be further recovered (Scheme 98).  
 
 
Scheme 98. Cyanative cyclization of alkyne 135a. 
 
4.3.2. Optimization of reaction conditions.   
Once the formation of side product 163a was successfully suppressed, the reaction was 
next optimized as shown in Table 12. By varying the reaction stoichiometry (Table 12, 
entries 1–5), it was concluded that an advantageous conversion is observed when the 
ratio of borane and cyanating reagent is close to 1:1, while the preferable temperature is 0 
°C (Table 12, entries 6–8). The required quantities of 122b and BCl3 could be 
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successfully reduced to 1.2 equivalents (Table 12, entries 6–8). Therefore, conditions 
from entry 8 in Table 10 were chosen as optimal, providing 136a in 95% isolated yield.  
 
 
Table 12. Optimization of conditions for the cyclization of 135a. 
 
The bis(imidazolium)disulfide 140d was again isolated as by-products of this 
transformation, however, this time with hexafluoroantimonate as a single counterion, 
instead of tetra- or hexachloroantimonate anions. The protonated pyridine 
hexafluoroantimonate 179 was detected as well (Figure 18). Both 140d and 179 were 
confirmed by HRMS. Compound 136a was recrystallized and analyzed by X-Ray analysis 
(Figure 19).  
 
 
Figure 18. By-products 140d and 179 in the cyanative cyclization of 135. 
 
 
Entry BCl3 equiv. 122b equiv. Temperature Conversion 
1 1.0 1.0 rt 78% 
2 1.1 1.1 rt 80% 
3 1.5 1.1 rt 83% 
4 3.0 1.1 rt full 
5 2.0 1.3 rt full 
6 2.0 1.3 0 °C full 
7 1.3 1.3 0 °C full 
8 1.2 1.2 0 °C full (95% yield) 
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Figure 19. Structure of cyanophenanthrene 136a in the crystal. 
 
Counterion effect. To evaluate the effect of the counterion on the reactivity, various 
cyanidation reagents with different counterions were tested under optimized reaction 
conditions (Table 13).  
 
 
 
 
 
 
 
 
Table 13. Counterion effect in the cyanative cyclization of 135a. [a] Determined by 1H NMR. 
Using tetrafluoroborate (122c) or triflate (122d) as a counterion, only 5% of substrate was 
converted into the desired product 136a in each reaction (Table 13, entries 2 and 3). In 
the former case (entry 2) dimer 140b with two trichlorocyanoborates counterions was 
detected as a main product (cf. Scheme 70), but no electrophilic cyanation could be 
detected. At last, 20% conversion was obtained for 122e with a hexafluorophosphate 
Entry Reagent Counterion Conversion to 136a[a] 
1 122b SbF6 Full 
2 122c BF4 5% 
3 122d TfO 5% 
4 122e PF6 20% 
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counterion (Table 13, entry 4). As different counterions appeared not to be beneficial for 
the reaction, the hexafluoroantimonate system 122b was used in the subsequent study of 
the scope of the reaction.   
Selectivity of the method. Three possible products might be formed in this 
transformation; the two regiomers 6-endo-dig (136) and 5-exo-dig (180), and the 
corresponding chlorocyanated products (130). Taking into account the experience 
accumulated during the chlorocyanation of alkynes, five representative substrates with 
different degree of polarization in the alkyne bond 135b–135f were synthesized to start 
the scope and limitations studies.[143] Compound 135b possesses a slightly polarized triple 
bond, in 135c the triple bond is not polarized, and 135d–f have the opposite effects 
benefiting the formation of the 5-exo-dig product (Figure 20). 
 Figure 20. Polarization in substrates 135b–135f. 
Under the optimized cyanative cyclization conditions; substrate 135b afforded the 
formation of product 136b in a moderate yield of 51% with the opportunity of recovering 
unreacted starting material (Table 14, entry 1). Alkyne 135c underwent low conversion to 
a 10:1 mixture of chlorocyanated product 130ar and phenanthrene 136c (Table 14, entry 
2). In the case of 135d only traces of 136d were detected (Table 14, entry 3), as well as 
only traces of chlorocyanated product were observed with the closely related substrate 
102h (cf. Table 4, entry 7). Alkyne 135e surprisingly afforded the chlorocyanated product 
130as in excellent yield (97%) (Table 14, entry 4), and in the case of terminal alkyne 135f 
chloroacrylate 130at in 44% yield and unreacted starting material 135f were isolated 
(Table 14, entry 5). 
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Table 14. Scope of the cyanative cyclization of 135b–f. 
 
4.3.3. Scope and limitations. 
4.3.3.1. Synthesis of phenanthrenes. 
 
Figure 21. Cyanated phenanthrenes 136. 
The reaction scope appeared to be limited to internal alkynes decorated with a biphenyl 
moiety on one side and an electron rich system on the other side. As mentioned above, 
the closely related substrates 102 with similar polarization showed an almost similar 
reactivity in the chlorocyanation reactions. Taking this into account, the efforts were 
initially focused on the decoration of the biphenyl moiety in the starting material 135.  
Two main routes were followed for the substrate synthesis.[100,101,143] Method 1 consisted 
in the initial Suzuki-Miyaura cross-coupling with aldehyde S99-I to produce biaryl products 
181, followed by homologation of the latter to generate 182 and final Sonogashira-
Entry Compound R 136/180/130 ratio Isolated yield (%) 
1 135b p-tolyl only 136b 51 
2 135c Ph 136c/0/130ar 25 
3 135d p-(Cl)-C6H4 n.a. n.a. 
4 135e nBu only 130as 97 
5 135f H only 130at 44 
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Hagihara cross-coupling providing substrates 135. Method 2 was started with a 
Sonogashira-Hagihara cross-coupling with S99-II; the resulting internal alkynes 102 were 
converted to compounds employing a Suzuki-Miyaura reaction (Scheme 99). 
 
Scheme 99. Methods for the synthesis of substrates 135. 
Substrates 135g–s were prepared as indicated in Scheme 99 (see Experimental Section), 
and further tested in the cyanative cyclization transformation, whose details and results 
are summarized in Table 15. At including electron-withdrawing groups in substituent R1, 
we were able to obtain the corresponding products in moderate to very good yields (Table 
15, entries 1–3). However, in the case of including benzyloxy group as substituent, only 
deprotection of the benzyl group (135k) and decomposition was detected (Table 15, entry 
4). It was also tolerated a TMS group in the position 4' of the biphenyl moiety, which 
formed product 136l with an isolated yield of 56% (Table 15, entry 5). Regarding the 
reactivity of a bromomethyl-substituted biphenyl like 135m, only resulted in the formation 
of product 135n as a result from a Br/Cl exchange (Table 15, entry 6). Unfortunately,  
heteroaromatic-substituted alkynes such 135o and 135p appeared to be less efficient in 
this transformation, leading to a very low conversion to 136o and 136p, respectively, 
remaining a majority of unreactive starting material in the reaction mixture (Table 15, 
entries 7 and 8). Even more unproductive was including various electron-donating groups 
in the aromatic rings (135q and 135r), where a quick decomposition of substrates was 
detected (Table 15, entries 9 and 10). On the other hand, employment of starting material 
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135s resulted in a complex mixture, from which product 136s was isolated in a moderate 
42% yield (Table 15, entry 11). 
 
 
Table 15. Scope of the cyanative cyclization of alkynes 135g–s 
. 
Aware of the limitations that the method seemed to show so far, we decided to slightly 
change the structure of the substrate. Thus, it was synthesized 135u which included a 
heteroatom directly linked to the alkyne moiety. Terminal alkyne 135f was brominated 
forming 135t,[144] and further transformed into substrate 135u after heating in 
tetrahydrothiophene (Scheme 100).[145]    
 
Entry Alkyne R1 R2 R3 R4 R5 Product Isolated 
yield (%) 
1 135g CF3 H H p-tolyl H 136g 52 
2 135h CF3 H H p-anisolyl H 136h 67 
3 135i Cl H H p-anisolyl H 136i 86 
4 135j H H H p-(BnO)-C6H4 H 135k n.a. 
5 135l H H TMS p-anisolyl H 136l 56 
6 135m H H CH2Br p-anisolyl H 135n n.a. 
7 135o H H H 2-thiophenyl H 136o 22 
8 135p H H H 2-benzo- 
thiophenyl 
H 136p 15 
9 135q CO2Me MeO MeO p-anisolyl H n.a. n.a. 
10 135r H MeO H p-anisolyl CF3 n.a. n.a. 
11 135s H MeO H Ph H 136s 42 
 101 
 
 
Scheme 100. Procedure for the synthesis of 135t and 135u. 
 
Compounds 135t and 135u were tested under the optimized conditions obtaining the 
following results: 135t was decomposed, while alkyne 135u could be succesfully 
transformed into the desired product 136u in very good yield (86%) (Scheme 101). 
 
Scheme 101. Cyanative cyclization of alkynes 135t and 135u. 
 
As a summary of the scope and limitations, a new metal-free method has been developed 
for the synthesis of 9-cyanophenanthrenes, where different electron-demanding groups 
could be incorporated in the biphenyl core. At this stage of the investigation, the reaction 
is only limited to the formation of 6-endo-dig products, as when 5-exo-dig cyclizations are 
favoured chlorocyanations occur in faster way avoiding their formation and forming the 
corresponding chlorocyanated product instead. The scope is summarized in Scheme 102. 
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Scheme 102. Scope for synthesis of cyanated phenantrenes 136. 
 
4.3.3.2. Synthesis of heterocycles. 
 
Figure 22. Cyanated heterocycles. 
Similarly to the preparation of phenanthrenes already discussed, the synthesis of 
condensed heterocyclic structures showed in Figure 22 could be envisaged by simply 
modifying the biphenyl framework used as starting material. Some attempts were then 
made to synthesize cyano-substituted naptho[1,2-b]furane (136v) and pyrrolo[1,2-
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a]naphthalene(136x) from the corresponding substrates 135v and 135w, which were 
prepared following the reported procedures.[100,101] Unfortunately, in the first case no 
formation of naphtofurane product 136v was observed, the starting material decomposed 
directly after the borane addition. In the second case, the only isolated product was 
compound 135x resulted from cyanation of the pyrrole ring in position 2, in a similar way 
as previously reported in the group.[103] Re-submitting 135x to the same reaction 
conditions again did not result in its further formation (Scheme 103).  
 
Scheme 103. Attempted cyanative cyclization of heterocycle-substituted tolanes 135v and 135w. 
 
 
4.3.3.3. Synthesis of helicenes. 
Helicenes represent a group of poliaromatic helical systems that feature chiral axis. Their 
interesting electronic and optical properties make them unique for certain applications in 
material chemistry.[146] The scope of the cyanative cyclization could potentially be used for 
the metal-free synthesis of different types of substituted carbohelicenes. 
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Cyano-substituted [4]carbohelicenes (Figure 23). 
 
Figure 23. Cyanated [4]carbohelicenes. 
To access cyano-substituted [4]carbohelicenes, the same approach as for the synthesis of 
phenanthrenes 135 was followed. Thus, acetylene 135y was synthesized and then 
submitted to the cyanative cyclization conditions. The reaction successfully afforded 
product 136y in an excellent isolated yield of 97% (Scheme 104). After recrystallization, 
its structure was verified by X-ray crystal structure analysis (Figure 24). 
 
 
Scheme 104. Synthesis of 136y. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24. Structure of cyano-substituted [4]carbohelicene 136y in the crystal. 
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Cyano-substituted [5]carbohelicenes (Figure 25). 
 
Figure 25. Cyanated [5]carbohelicene. 
In a similar way, [5]carbohelicene 136z was also synthetized from readily available 
substrate 135z in a good yield as well (Scheme 105). 
 
Scheme 105. Synthesis of cyanated [5]carbohelicene 136z. 
 
Cyano-substituted [6]carbohelicenes (Figure 26). 
 
Figure 26. Cyanated [6]carbohelicene. 
More synthetically interesting is the preparation of [6]carbohelicenes. Recently our 
research group published the enantioselective synthesis of [6]carbohelicenes 184 based 
on a double cycloisomerization of substrates 183 catalyzed by gold(I) catalyst coordinated 
to a chiral cationic phosphonite ligand 185 (Scheme 106).[99] 
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Scheme 106. Enantioselective synthesis of [6]carbohelicenes 184. 
 
Hence, substrate 183a was prepared according to the published method[99] and tested in a 
double cyanative cyclization. Surprisingly, only monocyanated product 187a, as confirmed 
by X-ray crystallography of the recrystallized compound, was formed in an excellent yield 
of 93% (Scheme 107 and Figure 27). 
 
 
Scheme 107. Synthesis of compound 187a. 
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Figure 27. Structure of compound 187a in the crystal. 
 
This unexpected result opened the door for the synthesis of [6]carbohelicenes, both in 
unsymmetric as well as asymmetric variants. To synthesize unsymmetric 
[6]carbohelicenes, 187a needs to be reacted with a selected electrophile which is able to 
promote the second cyclization (H, Cl, Br, I, etc…). Moreover, as the second cyclization is 
the one that determines the enantioselectivity, using asymmetric methods can lead to the 
formation of [6]carbohelicenes in an enantioselective manner.[99]  
As a proof of concept, employing stoichiometric amounts of BF3.Et2O as Lewis acid could 
successfully perform the cycloisomerization of intermediate 187a, generating quantitative 
amounts of [6]carbohelicene 188a (Scheme 108), thus implying that a chiral Lewis acid 
could successfully perform the same reaction in an enantioselective way. 
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Scheme 108. Synthesis of cyanated [6]carbohelicene 188a. 
Interestingly the same transformation of 187a could not be achieved using BCl3 (Scheme 
108); however, cyanative cyclization of 187a appeared to be successful, resulting in the 
conversion of starting material to the dicyanated [6]carbohelicene 189a (Scheme 109). 
Unfortunately, compound 189a exhibited an extreme insolubility in all common solvents 
and could only be confirmed by High Resolution Mass Spectrometry. 
 
Scheme 109. Synthesis of dicyanated [6]carbohelicene 189a. 
Continuing this study, differently substituted substrates were prepared and further tested 
under these conditions, affording in all the cases the corresponding cyclization products 
187b–d in poor to moderate yields (Table 16, entries 1–3). The re-isolation of unreacted 
starting materials 183 was possible as well.  
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Table 16. Synthesis of [4]helicenes 187. 
Compound 187d could be consequently virtually quantitative cycloisomerized upon 
treatment with BF3.Et2O using the same protocol as indicated above (Scheme 110). 
 
Scheme 110. Synthesis of [6]carbohelicene 188d. 
4.3.3.4. Synthesis of pyrenes (Figure 28). 
 
Figure 28. Cyanated pyrenes. 
Entry Alkyne R1 R2 R3 Product Isolated yield (%) 
1 183b p-anisolyl Me H 187b 52 
2 183c p-tolyl H Cl 187c 18 
3 183d p-anisolyl H Cl 187d 47 
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Diyne 190 was prepared with the idea of testing the double cyanation as for the synthesis 
of [6]carbohelicenes. In this case, however, decomposition of starting material was 
observed, and no formation of product 191 could be detected (Scheme 111). 
 
Scheme 111. Attempted synthesis of dicyanated pyrene 191. 
 
4.3.3.5. Synthesis of non-aromatic cycles. 
In all the cases shown so far, it was always involved an aromatization process, that 
probably makes the reaction to occur in such a fast fashion. Intrigued about whether this 
concept could be applied in a cyanative cyclization where no aromatization is involved, the 
following cycles were attempted to be synthesized: 
5,6,7,8-Tetrahydro-2H-λ2-quinolines (Figure 29). 
 
Figure 29. 5,6,7,8-Tetrahydro-2H-λ2-quinolines. 
 
A number of cycloisomerizations are based on reorganization of ene-yne-type substrates, 
where a nucleophilic alkene fragment reacts with an activated triple bond which acts as 
the electrophile. To this family of substrates belongs also compound 170a, which was 
prepared and then tested under the optimized conditions for cyanative cyclization. 
However, formation of the product 192a was not indicated, as the starting material 
underwent decomposition (Scheme 112). 
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Scheme 112. Attempted synthesis of hexahydroquinoline 192a. 
 
2,3-Dihydro-1H-fluorenes (Figure 30). 
 
Figure 30. 2,3-dihydro-1H-fluorenes. 
The next substrate investigated of the yne-yne type was dialkyne 193. In this compound, 
one alkyne moiety can be activated with the Lewis acid, while the second triple bond may 
act as a nucleophile. Upon attempted cyanative cyclization of diyne 193, complete 
decomposition of starting material was observed again (Scheme 113). 
 
Scheme 113. Attempted synthesis of 194. 
 
1,2-Dihydronaphthalenes (Figure 31). 
 
Figure 31. 1,2-Dihydronaphthalenes. 
Since substrates of aryl-yne type proved to be more appropiate for the cyanative 
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cyclizations, alkyne 170b was prepared and then used in cyanation under standard 
conditions. Product 195 was successfully isolated in poor yields (39%), and unreacted 
starting material was recovered. However, employment of borane in excess was enough 
to obtain the desired product in excellent yields (90%), as shown in Scheme 114. 
Structure of 195 was confirmed by X-ray crystal structure analysis (Figure 32). 
 
 
Scheme 114. Synthesis of dihydronaphthalene 195. 
 
Figure 32. Structure of dihydronaphthalene 195 in the crystal. 
 
 
2H-Chromenes (Figure 33). 
 
Figure 33. 2H-Chromenes. 
 
Using the same idea as for the synthesis of 1,2-dihydronaphthalene 195, the preparation 
of 2H-chromene 196 was attempted applying the starting material 170c with an oxygen 
atom instead of methylene moiety. Unfortunately, this compound appeared ot to be 
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inappropriate for the transformation, as only decomposition of 170c was detected 
(Scheme 115). 
 
Scheme 115. Attempted synthesis of 2H-chromene 196. 
 
7-Dihydro-5H-benzo[7]annulene (Figure 34). 
 
 
Figure 34. 7-Dihydro-5H-benzo[7]annulenes. 
Mimicking the reaction for the 1,2-dihydronaphthalenes synthesis, one more methylene 
group was added to the framework of alkyne 170b. When the reaction of this homologous 
compound 102au was performed, only formation of chlorocyanated compound 130au in 
an excellent isolated yield of 97% was observed predominantly, whereas the desired 
product 197a was detected only as traces (Scheme 116).   
 
Scheme 116. Attempted synthesis of dihydroannulene 197a. 
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5H-Dibenzo[a,d][7]annulene (Figure 35). 
 
Figure 35. 5H-Dibenzo[a,d][7]annulene. 
Attachment of a second aromatic ring in the propper position but separated by a 
methylene unit, as in substrate 102av, promotes the formation of the desired 7-membered 
ring. Thus, cyanative cyclization of 102av furnished the product 197b in very good isolated 
yield (82%) (Scheme 117), which structure was confirmed by X-Ray crystallography 
(Figure 36).     
 
Scheme 117. Synthesis of dibenzo[a,d][7]annulene 197b. 
 
Figure 36. Structure of dibenzo[a,d][7]annulene 197b in the crystal. 
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4.3.4. Proposed mechanism.   
By analyzing the experience gained from all the experiments discussed above and taking 
into account the information on the chlorocyanation of alkynes, a plausible mechanistic 
rationalization for the cyanative cyclization of alkynes can be proposed. The 
transformation starts with activation of the cyanating reagent 122b by Lewis acid affording 
a complex S118-I, which underwent a regioselective electrophilic addition to the triple 
bond forming intermediate S118-II. In the next step, an electrophilic Friedel-Crafts-type 
attack on the aromatic ring furnished intermediate S118-III. Aromatization of S118-III, 
which is facilitated by action of 2,6-di-tert-butylpyridine (178) as a base, afforded the 
corresponding cyanated products 136. On this stage, pyridinium salt 179 and, probably, 
boreneylthioimidazolium S118-IV are formed. The latter is presumably a parent compound 
for the formation of isolated dithiouronium disulfide 140d (Scheme 118). 
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Scheme 118. Proposed mechanic rationalization of the cyanative cyclization. 
 
Some conclusions can be derived from the proposed mechanism. Upon direct comparison 
with the chlorocyanation reaction one can conclude, that both start in exactly the same 
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way, differentiating at the stage of nucleophilic addition. The latter, in fact, is a competition 
between trapping the cationic center with an aromatic moiety followed by aromatization 
and trapping with a chlorine atom associated with the BC3 fragment (Figure 37).  
 
 
Figure 37. Selectivity of the process. 
Extraction of a chlorine atom from the borane would impede the recovery of the Lewis acid 
in a catalytic process, explaining why stoichiometric amounts of Lewis acid are employed 
(Scheme 119a). It is also notable that no F–/Cl– counterion exchange was observed in this 
reaction. This might indicate that this process occurs in a late stage as a side reaction in 
already formed dithiouronium disulfide is (Scheme 119b). 
 
Scheme 119. Mechanistic aspects. 
4.3.5. Summary.  
As an extension of the twofold functionalization of alkynes using electrophilic cyanating 
reagents, a new methodology for the formation of various types of cyanated rings has 
been developed. The process is metal-free and proceeds with total regioselectivity when it 
is combined with stoichiometric amounts of Lewis acid. Thus, the transformation was 
successfully employed for the synthesis of phenanthrenes 136 with different substitution 
patterns, synthesis of [4]-, [5]- and [6]-carbohelicenes 136 and 188, 1,2-dihydronaph-
thalenes 195 and 5H-dibenzo[a,d][7]annulenes 197b, as summarized in Scheme 120. 
This process paves the way for the synthesis of plethora of organic cycles – constituents 
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of natural compounds and other practically useful products. 
 
Scheme 120. Cyanative cyclization scope. [a] 2.5 equiv. of BCl3 and 2.5 equiv. of 122b were employed. [b] 
2.0 equiv. of BCl3 were employed. Reaction conditions of a) 1.0 equiv. of BF3.Et2, DCM (1 mL), rt, 5 min. 
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5. Conclusion. 
The ability of electrophilic sulfur imidazolium thiocyanates salts to serve as a remarkable 
source of cyano groups, thus promoting cyanations of internal and terminal alkynes. The 
methods described are performed under mild conditions in a metal-free environment, 
making these type of salts as interesting reagents for further investigations in the field. 
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6. Experimental. 
 
6.1. Instrumentation and chemicals. 
 
All solvents used in reactions with hydrolysis-sensitive substances (THF, 
dichloromethane, toluene) were purified with the MBraun Solvent Purification System 
(SPS) (or by distillation over the drying agents as indicated below) and stored under a 
protective gas atmosphere. Anhydrous ethanol was supplied by Fisher Chemicals and 
used without further purification. All reactions were carried out using pre-dried glassware 
under Ar atmosphere unless otherwise stated. IR: Nicolet FT-7199, JASCO FT-4100 
spectrometers with an ATR measuring device, software OPUS 6, wavenumbers in cm−1. 
Microwave: Biotage Initatior. MS (EI): Finnigan MAT 8200 (70 eV), ESIMS: Finnigan MAT 
95; accurate mass determinations: Bruker APEX III FT-MS (7 T magnet). NMR: Spectra 
were recorded on a Bruker AV 500, 400 or DPX 300; 1H and 13C chemical shifts (δ) are 
given in ppm with TMS as a standard, coupling constants (J) in Hz. The residual solvent 
signals were used as references, and the chemical shifts converted to the TMS scale. 
Flash chromatography was performed on Merck 60 silica gel (40–63 μm). Thin-layer 
chromatography (TLC) analysis was performed using Merck silica gel 60 F254 TLC plates 
and visualized by UV irradiation and/or ceric ammonium molybdate, KMnO4 or p-
anysaldehyde dip.  
Compounds 109b,[103] and alkynes 102a, 102b, 102f, 102u, 102z,[108] 102e, 102l,[110] 102g, 
102n,[111] 102h, 102j, 102k,[112] 102m,[113] 102w,[114] 102ao,[116] 102d,[147a] 102ab,[147b] 
102aa,[147c] 102ad,[147d] 102ag,[147e] 102o[147f] and 102p[147i] were prepared accordingly to 
previously published procedures (see below). All commercially available compounds 
(Acros, ABCR, Alfa Aesar, Aldrich, Fluorochem) were used as received. 
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6.2. Regio- and stereoselective chlorocyanation of alkynes. 
 
6.2.1. Synthesis of starting materials. 
1,3-Diisopropyl-4,5-dimethyl-2-thiocyanato-1H-imidazol-3-ium Hexafluoroantimonate 
(122b) 
1,3-Diisopropyl-4,5-dimethyl-2-thiocyanato-1H-imidazol-3-ium 
bromide (109b) (9.115 g, 28.64 mmol) and sodium 
hexafluoroantimonate (8.899 g, 34.39 mmol, 1.2 equiv.) were charged 
into a round-bottomed flask and solved in 50 ml of DCM. The reaction 
mixture was stirred overnight at room temperature. The solid was 
filtered off; the mother liquor was concentrated under vacuum and the residue redissolved 
in acetonitrile. The solution was filtered and concentrated under vacuum again. The 
residue solid was washed with methanol affording product 122b as a pale yellow solid 
(10.053 g, 21.20 mmol, 74%). 1H NMR (400 MHz, CD3CN, ppm) δ = 1.64 (12H, d, J = 7.0 
Hz), 2.40 (6H, s), 5.19 (2H, hept, J = 6.9 Hz). 13C NMR (101 MHz, CD3CN, ppm) δ =10.7, 
20.9, 55.1, 106.8, 124.7, 133.7. 19F NMR (282 MHz, CD3CN) δ= –124.05 (sext, JF-121Sb = 
1947 Hz). IR (neat, cm–1) = 905, 1114, 1139, 1217, 1381, 1397, 1460, 1600, 2173, 2999. 
HRMS: calcd. for C12H20N3S+ [M–SbF6]+ = 238.1372; found = 238.1372.  
The spectral data are identical to those reported in the literature.[103] 
 
1,3-Diisopropyl-4,5-dimethyl-2-thiocyanato-1H-imidazol-3-ium Tetrafluoroborate 
(122c) 
Compound 109b (1000 mg, 3.14 mmol) and sodium tetrafluoroborate 
(346 mg, 3.15 mmol, 1.0 equiv) and DCM (15 ml) were charged into a 
round-bottomed flask. The reaction mixture was stirred for 3 hours at 
room temperature. The solid was filtered off; the mother liquor was 
concentrated under vacuum and the residue solid was washed with diethyl ether affording 
product 122c as a pale yellow solid (998 mg, 3.01 mmol, 98%). 1H NMR (500 MHz, 
CD3CN, ppm) δ = 1.76 (12H, d, J = 7.1 Hz), 2.43 (6H, s), 5.41 (2H, hept, J = 7.0 Hz). 13C 
NMR (101 MHz, CD3CN, ppm) δ = 10.9, 21.0, 55.2, 107.7, 130.6. 11B NMR (128 MHz, 
CDCl3, ppm) δ = –1.5. 19F NMR (376 MHz, CDCl3, ppm) δ = –153.0, –153.0. 
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1,3-Diisopropyl-4,5-dimethyl-2-thiocyanato-1H-imidazol-3-ium Trifluoromethylsulfo-
nate (122d)  
Compound 109b (1000 mg, 3.14 mmol) and potassium 
trifluoromethanesulfonate (592 mg, 3.16 mmol, 1.0 equiv) were 
charged in a round-bottomed flask and solved in 15 ml of DCM. The 
reaction mixture was stirred for 3 hours at room temperature. The 
solid was filtered off; the mother liquor was concentrated under vacuum and the residue 
solid was washed with diethyl ether affording product 122d as a pale yellow solid (1.213 g, 
3.13 mmol, 99%). 1H NMR (500 MHz, CD3CN, ppm) δ = 1.63 (12H, d, J = 7.1 Hz), 2.39 
(6H, s), 5.19 (2H, hept, J = 7.1 Hz). 13C NMR (126 MHz, CD3CN, ppm) δ = 10.8, 20.9, 
55.2, 106.7, 122.1 (d, JC-F = 323 Hz), 133.8. 19F NMR (470 MHz, CDCl3, ppm) δ = –79.3. 
IR (neat, cm–1): 660, 752, 908, 1027, 1116, 1141, 1222, 1251, 1277, 1380, 1397, 1463, 
1602, 2106, 2297. HRMS: calcd. for C12H20N3S+ [M]+ = 238.1372; found = 238.1376 
 
6.2.2. Synthesis of new products. 
6.2.2.1. Synthesis of chloroacrylonitriles 130. 
 
Scheme 121. Chlorocyanation of alkynes (Z)-102. 
General procedure (GP1): A dry Schlenk flask was charged with the corresponding 
alkyne 102 (1.0 equiv.) and 1,3-diisopropyl-4,5-dimethyl-2-thiocyanato-1H-imidazol-3-
ium Hexafluoroantimonate (122b) (1.3 equiv.). The mixture was suspended in 1,2-DCE 
(ca. 1 mL), and a 1 M solution of BCl3 or BBr3 in DCM (2.0 equiv.) was added dropwise. 
The reaction mixture was stirred at the corresponding temperature for the indicated 
time. All volatiles were removed under reduced pressure and finally under high 
vacuum, then the remaning solid was suspended in ethyl acetate, filtered through a 
Silica pad and concentrated in vacuo. The mixture was further purified by column 
chromatography (n-hexane /EtOAc) affording the corresponding products (Z)-130. 
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(Z)-3-Chloro-3-(4-methoxyphenyl)-2-phenylacrylonitrile [(Z)-130a] 
Using GP1, compound (Z)-130a was prepared from 102a (115 mg, 
0.55 mmol), 122b (341 mg, 0.72 mmol) and trichloroborane (1.11 ml, 
1 M in DCM, 1.11 mmol) in 1,2-DCE (1.11 ml) [rt, 1 h] as yellow 
crystals (147 mg, 0.54 mmol, 98%) after flash chromatography (n-
hexane/EtOAc 9:1). 1H NMR (500 MHz, CDCl3, ppm) δ = 3.79 (3H, 
s), 6.72 – 6.77 (2H, m), 7.19 – 7.27 (7H, m). 13C NMR (126 MHz, CDCl3, ppm) δ = 55.5, 
112.5, 113.9, 118.0, 127.4, 128.9, 129.0, 129.4, 131.5, 133.1, 147.0, 161.4. IR (neat, cm–
1): 587, 695, 759, 819, 839, 901, 1026, 1173, 1252, 1444, 1506, 1603, 2213, 2839, 3058. 
HRMS: calcd. for C16H12ClNO+ [M]+ = 269.0607; found = 269.0601. 
(Z)-3-Chloro-2-phenyl-3-(p-tolyl)acrylonitrile [(Z)-130b] 
Using GP1, compound (Z)-130b was prepared from 102b (100 mg, 
0.52 mmol), 122b (321 mg, 0.68 mmol) and trichloroborane (1.04 ml, 1 
M in DCM, 1.04 mmol) in 1,2-DCE (1.04 ml) [60 °C, 3 h] as a pale 
yellow solid (66 mg, 0.26 mmol, 50%) after flash chromatography (n-
hexane/EtOAc 9:1). 1H NMR (500 MHz, CDCl3, ppm) δ = 2.33 (3H, s), 
7.05 – 7.08 (2H, m), 7.16 – 7.29 (7H, m). 13C NMR (126 MHz, CDCl3, ppm) δ = 21.5, 
113.4, 117.6, 128.8, 129.0, 129.1, 129.2, 129.4, 132.3, 132.7, 141.1, 147.1. IR (neat, cm–
1): 511, 548, 652, 693, 757, 808, 902, 1020, 1183, 1444, 1507, 1588, 1606, 2213, 2919. 
HRMS: calcd. for C16H12ClN+ [M]+ = 253.0658; found = 253.0656. 
(Z)-3-Chloro-2,3-diphenylacrylonitrile [(Z)-130c] 
Using GP1, compound (Z)-130c was prepared from 102c (200 mg, 1.12 
mmol), 122b (693 mg, 1.46 mmol) and trichloroborane (2.25 ml, 1 M in 
DCM, 2.25 mmol) in 1,2-DCE (2.25 ml) [rt, 1 h] as a a pale yellow solid 
(58 mg, 0.24 mmol, 22%) after flash chromatography (n-hexane/EtOAc 9:1). 1H NMR (500 
MHz, CDCl3, ppm) δ = 7.16 – 7.37 (10H, m). 13C NMR (126 MHz, CDCl3, ppm) δ = 114.2, 
117.4, 128.5, 128.8, 129.1, 129.3, 129.5, 130.5, 132.5, 135.3, 146.9. IR (neat, cm–1): 507, 
548, 658, 690, 752, 825, 898, 1157, 1203, 1271, 1443, 1488, 1588, 2213, 3066. HRMS: 
calcd. for C15H11ClN+ [M+H]+ = 240.0575; found = 240.0569. The spectral data correspond 
to those reported in the literature.[126] 
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(Z)-3-Chloro-3-(4-ethylphenyl)-2-(p-tolyl)acrylonitrile [(Z)-130d, left] and(Z)-3-chloro-
2-(4-ethylphenyl)-3-(p-tolyl)acrylonitrile [(Z)-130d', right] 
Using GP1, compounds (Z)-130d and (Z)-
130d' were prepared from 102k (87 mg, 0.40 
mmol), 122b (244 mg, 0.51 mmol) and 
trichloroborane (0.79 ml, 1 M in DCM, 0.79 
mmol) in 1,2-DCE (0.79 ml) [rt, 1 h] as a pale yellow oil (77 mg of a 1/1 regioisomer 
mixture, 0.27 mmol, 68%) after flash chromatography (n-hexane/EtOAc 9:1). (Z)-130d: 1H 
NMR (500 MHz, CDCl3, ppm) δ = 1.21 (3H, t, J = 7.6 Hz), 2.33 (3H, s), 2.61 (2H, m), 7.06 
– 7.22 (6H, m), 7.31 – 7.36 (2H, m). 13C NMR (126 MHz, CDCl3, ppm) δ = 15.6, 31.3, 
28.7, 113.5, 117.8, 128.0, 129.2, 129.5, 129.6, 129.9, 132.8, 139.2, 146.4, 147.2. (Z)-
130d': 1H NMR (500 MHz, CDCl3, ppm) δ = 1.20 (3H, t, J = 7.6 Hz), 2.30 (3H, s), 2.59 (2H, 
m), 7.06 – 7.22 (6H, m), 7.31 – 7.36 (2H, m). 13C NMR (126 MHz, CDCl3, ppm) δ = 15.2, 
21.5, 28.6, 113.5, 117.8, 128.3, 129.2, 129.2, 129.5, 130.0, 132.6, 141.0, 145.4, 146.3. IR 
(neat, cm–1): 551, 759, 813, 903, 1019, 1058, 1185, 1273, 1413, 1455, 1510, 1587, 1607, 
2216, 2966. HRMS: calcd. for C18H17ClN+ [M+H]+ = 282.1044; found = 282.1042.  
(Z)-3-Chloro-3-(4-methoxyphenyl)-2-(p-tolyl)acrylonitrile [(Z)-130e] 
Using GP1, compound (Z)-130e was prepared from 102e (59 mg, 
0.27 mmol), 122b (164 mg, 0.35 mmol) and trichloroborane (0.53 
ml, 1 M in DCM, 0.53 mmol) in 1,2-DCE (0.53 ml) [rt, 1 h] as a pale 
yellow solid (62 mg, 0.22 mmol, 81%) after flash chromatography 
(n-hexane/EtOAc 9:1). 1H NMR (500 MHz, CDCl3, ppm) δ = 2.30 (3H, s), 3.19 (3H, s), 
6.71 – 6.80 (2H, m), 7.02 – 7.13 (4H, m), 7.20 – 7.29 (2H, m).13C NMR (126 MHz, CDCl3, 
ppm) δ = 21.3, 55.4, 112.5, 113.9, 118.0, 127.5, 129.2, 129.6, 130.1, 130.8, 131.4, 139.1, 
146.1, 161.2. IR (neat, cm–1): 587, 729, 768, 812, 829, 902, 1027, 1116, 1173, 1252, 
1300,, 1504, 1601, 2213, 2922. HRMS: calcd. for C17H14ClNO+ [M]+ = 283.0764; found = 
283.0774. 
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(Z)-3-Chloro-3-(2-methoxyphenyl)-2-phenylacrylonitrile [(Z)-130g] 
Using GP1, compound (Z)-130g was prepared from 102g (63 mg, 
0.30 mmol), 122b (187 mg, 0.39 mmol) and trichloroborane (0.61 
ml, 1 M in DCM, 0.61 mmol) in 1,2-DCE (0.61 ml) [rt, 1 h] as a pale 
yellow solid (75 mg, 0.28 mmol, 93%) after flash chromatography (n-
hexane/EtOAc 9:1). 1H NMR (500 MHz, CDCl3, ppm) δ = 3.67 (3H, s), 6.90 (1H, dd, J = 
8.3, 1.0. Hz), 7.02 (1H, td, J = 7.5, 1.0 Hz), 7.23 – 7.35 (6H, m), 7.45 (1H, ddd, J = 8.4, 
7.4, 1.0 Hz). 13C NMR (126 MHz, CDCl3, ppm) δ = 55.4, 111.5, 116.2, 117.3, 120.8, 124.8, 
128.2, 128.9, 130.3, 132.1, 133.1, 144.1, 156.1. IR (neat, cm–1): 655, 695, 754. 904, 1022, 
1254, 1434, 1463, 1488, 1592, 1603, 2218, 2341, 2360, 2837. HRMS: calcd. for 
C16H13ClNO+ [M+H]+ = 270.0680; found = 270.0679. 
(Z)-3-Chloro-2-(4-fluorophenyl)-3-(4-methoxyphenyl)acrylonitrile [(Z)-130j] 
Using GP1, compound (Z)-130j was prepared from 102j (120 mg, 
0.53 mmol), 122b (327 mg, 0.69 mmol) and trichloroborane (1.06 ml, 
1 M in DCM, 1.06 mmol) in 1,2-DCE (1.06 ml) [rt, 1 h] as a pale 
yellow solid (117 mg, 0.41 mmol, 76%) after flash chromatography 
(n-hexane/EtOAc 9:1). 1H NMR (300 MHz, CDCl3, ppm) δ = 3.79 (1H, s), 6.74 – 6.79 (2H, 
m), 6.91 – 6.98 (2H, m), 7.15 – 7.24 (4H, m). 13C NMR (126 MHz, CDCl3, ppm) δ = 55.5, 
111.3, 114.0, 116.1 (d, J = 22.0 Hz), 117.7, 127.0, 129.1 (d, J = 3.6 Hz), 131.3 (d, J = 8.4 
Hz), 131.4, 147.2, 161.0, 161.4, 164.3. 19F NMR (282 MHz, CDCl3, ppm) δ = –110.9.  IR 
(neat, cm–1): 524, 587, 827, 902, 1026, 1160, 1174, 1231, 1253, 1301, 1461, 1504, 1599, 
2214, 2962. HRMS: calcd. for C16H11ClFNO+ [M]+ = 287.0513; found = 287.0520. 
(Z)-3-Chloro-2-(4-chlorophenyl)-3-(4-methoxyphenyl)acrylonitrile [(Z)-130k] 
Using GP1, compound (Z)-130k was prepared from 102k (42 mg, 
0.17 mmol), 122b (107 mg, 0.23 mmol) and trichloroborane (0.35 
ml, 1 M in DCM, 0.35 mmol) in 1,2-DCE (0.35 ml) [rt, 1 h] as a pale 
yellow solid (52 mg, 0.17 mmol, 98%) after flash chromatography 
(n-hexane/EtOAc 9:1). 1H NMR (300 MHz, CDCl3, ppm) δ = 3.80 (3H, s), 6.75 – 6.81 (2H, 
m), 7.11 – 7.16 (2H, m), 7.19 – 7.25 (4H, m). 13C NMR (126 MHz, CDCl3, ppm) δ = 55.5, 
111.3, 114.1, 117.5, 127.0, 129.2, 130.6, 131.4, 131.5, 135.0, 147.6, 161.5. (neat, cm–1): 
633, 721, 813, 909, 1012, 1026, 1089, 1176, 1254, 1302, 1508, 1582, 1603, 2209, 2957. 
HRMS: calcd. for C16H11Cl2NO+ [M]+ = 303.0218; found = 303.0216. 
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(Z)-3-Chloro-2-(4-bromophenyl)-3-(4-methoxyphenyl)acrylonitrile [(Z)-130l] 
Using GP1, compound (Z)-130l was prepared from 102l (91 mg, 
0.32 mmol), 122b (195 mg, 0.41 mmol) and trichloroborane (0.63 
ml, 1 M in DCM, 0.63 mmol) in 1,2-DCE (0.30 ml) [rt, 1 h] as a 
white solid (88 mg, 0.25 mmol, 78%) after flash chromatography 
(n-hexane/EtOAc 9:1). 1H NMR (500 MHz, CDCl3, ppm) δ = 3.80 
(3H, s), 6.76 – 6.79 (2H, m), 7.06 – 7.09 (2H, m), 7.20 – 7.23 (2H, m), 7.37 – 7.40 (2H, m). 
13C NMR (126 MHz, CDCl3, ppm) δ = 55.5, 111.3, 114.1, 117.5, 123.3, 126.9, 130.9, 
131.4, 132.0, 132.2, 147.8, 161.6. IR (neat, cm–1): 548, 804, 1007, 1027, 1074, 1173, 
1248, 1458, 1485, 1507, 1604, 1729, 2209, 2922, 2922. HRMS: calcd. for C16H11BrClNO+ 
[M]+ = 346.9713; found = 346.9725. 
(Z)-3-Chloro-2-(4-iodophenyl)-3-(4-methoxyphenyl)acrylonitrile [(Z)-130m]  
Using GP1, compound (Z)-130m was prepared from 102m (48 mg, 
144 μmol), 122b (89 mg, 0.19 mmol) and trichloroborane (0.29 ml, 1 
M in DCM, 290 µmol) in 1,2-DCE (0.29 ml) [rt, 1 h] as a white solid 
(38 mg, 96 μmol, 67%) after flash chromatography (n-
hexane/EtOAc 9:1). 1H NMR (400 MHz, CDCl3, ppm) δ = 3.81 (3H, 
s), 6.76 – 6.80 (2H, m), 6.92 – 6.95 (2H, m), 7.20 – 7.24 (2H, m), 7.57 – 7.60 (2H, m). 13C 
NMR (100 MHz, CDCl3, ppm) δ = 55.5, 95.1, 111.5, 114.1, 117.5, 127.0, 131.0, 131.4, 
132.6, 138.1, 147.7, 161.6. IR (neat, cm–1): 571, 776, 809, 908, 1003, 1021, 1177, 1245, 
1310, 1390, 1460, 1509, 1603, 2209, 2918. HRMS: calcd. for C16H11ClINNaO+ [M+Na]+ = 
417.9466; found = 417.9452. 
(Z)-3-chloro-3-(4-methoxyphenyl)-2-(4-nitrophenyl)acrylonitrile [(Z)-130n] 
Using GP1, compound (Z)-130n was prepared from 102n (106 
mg, 419 μmol), 122b (245 mg, 577 μmol) and trichloroborane 
(0.80 ml, 1 M in DCM, 0.80 mmol) in 1,2-DCE (8.80 ml) [60°C, 3 h] 
as a pale yellow solid (58 mg, 184 μmol, 44%) after flash 
chromatography (n-hexane/EtOAc 9:1). 1H NMR (300 MHz, 
CDCl3, ppm) δ = 3.83 (1H, s), 6.78 – 6.83 (2H, m), 7.21 – 7.28 (2H, m), 7.39 – 7.43 (2H, 
m), 8.10 – 8.15 (2H, m).13C NMR (126 MHz, CDCl3, ppm) δ = 55.5, 110.3, 114.3, 117.0, 
124.1, 126.4, 130.4, 130.5, 131.5, 139.5, 147.5, 150.6, 162.1. IR (neat, cm–1): 701, 752, 
821, 855, 915, 1022, 1183, 1236, 1270, 1306, 1346, 1520, 1603, 2210, 3074. HRMS: 
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calcd. for C16H11ClN2NaO3+ [M+Na]+ = 337.0350; found = 337.0341. 
Ethyl (Z)-4-[2-Chloro-1-cyano-2-(4-methoxyphenyl)vinyl]benzoate [(Z)-130o] 
Using GP1, compound (Z)-130o was prepared from 102o (74 
mg, 264 μmol), 122b (165 mg, 348 μmol) and trichloroborane 
(0.52 ml, 1 M in DCM, 0.52 mmol) in 1,2-DCE (0.52 ml) [60°C, 3 
h] as a pale yellow solid (33 mg, 97 μmol, 37%) after flash 
chromatography (n-hexane/EtOAc 9:1). 1H NMR (500 MHz, 
CDCl3, ppm) δ = 1.38  (3H, t, J = 7.1 Hz), 3.80 (3H, s), 4.36 (2H, q, J = 7.2 Hz), 6.72 – 
6.79 (2H, m), 7.18 – 7.24 (2H, m), 7.27 – 7.31 (2H, m), 7.88 – 7.95 (2H, m).13C NMR (126 
MHz, CDCl3, ppm) δ = 14.4, 55.5, 61.4, 111.6, 114.1, 117.5, 127.0, 129.4, 130.1, 130.8, 
131.5, 137.4, 148.8, 161.7, 165.8. IR (neat, cm–1): 547, 703, 764, 824, 907, 1018, 1102, 
1184, 1265, 1279, 1513, 1604, 1723, 2208, 2917. HRMS: calcd. for C19H17ClNO3+ [M+H]+ 
= 342.0891; found = 342.0886. 
(Z)-3-Chloro-2-(naphthalen-1-yl)-3-phenylacrylonitrile [(Z)-130q] 
Using GP1, compound (Z)-130q was prepared from 102q (82 mg, 
359 μmol), 122b (222 mg, 468 μmol) and trichloroborane (0.72 ml, 1 
M in DCM, 0.72 mmol) in 1,2-DCE (0.72 ml) [rt, 1 h] as a pale yellow 
solid (24 mg, 83 μmol, 23%) after flash chromatography (n-
hexane/EtOAc 9:1). 1H NMR (300 MHz, CDCl3, ppm) δ = 7.22 – 7.35 (5H, m), 7.45 – 7.58 
(2H, m), 7.71 – 7.80 (2H, m), 8.05 – 8.09 (2H, m), 8.14 – 8.18 (1H, m). 13C NMR (126 
MHz, CDCl3, ppm) δ = 117.1, 117.6, 124.7, 125.3, 126.9, 127.4, 127.6, 128.4, 128.6, 
128.9, 129.2, 130.0, 130.9, 132.0, 132.0, 133.2, 133.7. IR (neat, cm–1): 552, 634, 693, 
757, 769, 798, 901, 1087, 1231, 1257, 1339, 1445, 1589, 2220, 3056. HRMS: calcd. for 
C19H12ClN+ [M]+ = 289.0658; found = 289.0669. 
(Z)-3-Chloro-2-phenyl-3-(thiophen-2-yl)acrylonitrile [(Z)-130u] 
Using GP1, compound (Z)-130u was prepared from 102u (100 mg, 543 
μmol), 122b (335 mg, 707 μmol) and trichloroborane (1.09 ml, 1 M in 
DCM, 1.09 mmol) in 1,2-DCE (1.09 ml) [rt, 1 h] as a white solid (75 mg, 
305 μmol, 56%) after flash chromatography (n-hexane/EtOAc 9:1). 1H 
NMR (300 MHz, CDCl3, ppm) δ = 6.92 (1H, dd, J = 5.1, 3.9 Hz), 7.27 (1H, dd, J = 3.9, 1.3 
Hz), 7.35 – 7.47 (6H, m).13C NMR (126 MHz, CDCl3, ppm) δ = 110.8, 117.8, 127.1, 129.7, 
129.7, 130.2, 132.1, 132.5, 133.5, 137.1, 140.1. IR (neat, cm–1): 655, 694, 713, 756, 814, 
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828, 1047, 1176, 1232, 1353, 1414, 1443, 1566, 2205, 3102. HRMS: calcd. for 
C13H8ClNS+ [M]+ = 245.0066; found = 245.0060. 
(Z)-3-Chloro-3-(1-methyl-1H-indol-3-yl)-2-phenylacrylonitrile [(Z)-130w] 
Using GP1, compound (Z)-130w was prepared from 102w (122 mg, 
527 μmol), 122b (325 mg, 685 μmol) and trichloroborane (1.06 ml, 1 
M in DCM, 1.06 mmol) in 1,2-DCE (1.06 ml) [rt, 1 h] as a yellow solid 
(23 mg, 79 μmol, 15%) after flash chromatography (n-hexane/EtOAc 
9:1). 1H NMR (400 MHz, C6D6, ppm) δ = 2.53 (3H, s), 6.52 (1H, s), 6.69 (1H, dt, J = 8.2, 
0.9 Hz), 6.75 – 6.80 (3H, m), 6.88 (1H, ddd, J = 8.1, 7.1, 1.0 Hz), 6.99 (1H, ddd, J = 8.3, 
7.1, 1.2 Hz), 7.13 (1H, dt, J = 8.1, 1.0 Hz), 7.19 – 7.22 (2H, m). 13C NMR (101 MHz, C6D6, 
ppm) δ = 32.1, 110.0, 110.1, 111.7, 118.8, 121.5, 121.7, 122.9, 125.3, 128.4, 128.8, 
129.3, 133.5, 134.5, 137.2, 141.2. IR (neat, cm–1): 564, 699, 741, 824, 1047, 1076, 1203, 
1245, 1361, 1461, 1564, 1581, 2200, 2923, 3052. HRMS: calcd. for C18H13ClN2+ [M]+ = 
292.0767; found = 292.0756. 
(Z)-2-[Chloro(phenyl)methylene]butanenitrile [(Z)-130x] 
Using GP1, compound (Z)-130x was prepared from 102x (93 mg, 714 
μmol), 122b (441 mg, 930 μmol) and trichloroborane (1.43 ml, 1 M in DCM, 
1.43 mmol) in 1,2-DCE (1.43 ml) [rt, 1 h] as a yellow oil (88 mg, 459 μmol, 
64%) after flash chromatography (n-hexane/EtOAc 9:1). 1H NMR (500 
MHz, CDCl3, ppm) δ = 0.77 (3H, t, J = 7.3 Hz), 1.75 (2H, q, J = 7.3 Hz), 6.89 – 6.96 (5H, 
m).13C NMR (126 MHz, CDCl3, ppm) δ = 13.3, 25.7, 116.0, 117.0, 128.3, 128.7, 130.3, 
135.4, 144.7. IR (neat, cm–1): 649, 695, 756, 797, 899, 1027, 1239, 1259, 1444, 1459, 
1489, 1594, 1606, 2219, 2975. HRMS: calcd. for C11H10ClN+ [M]+ = 191.0502; found = 
191.0505. 
(Z)-2-[Chloro(phenyl)methylene]valeronitrile (Z)-130y 
Using GP1, compound (Z)-130y was prepared from 102y (75 mg, 520 
μmol), 122b (322 mg, 679 μmol) and trichloroborane (1.04 ml, 1 M in 
DCM, 1.04 mmol) in 1,2-DCE (1.04 ml) [rt, 1 h] as a yellow oil (76 mg, 369 
μmol, 71%) after flash chromatography (n-hexane/EtOAc 9:1). 1H NMR 
(300 MHz, CDCl3, ppm) δ = 0.89 (3H, t, J = 7.4 Hz), 1.54 – 1.71 (2H, m), 2.28 – 2.32 (2H, 
m), 7.31 – 7.38 (2H, m), 7.40 – 7.46 (3H, m).13C NMR (126 MHz, CDCl3, ppm) δ = 13.3, 
21.8, 33.6, 114.7, 117.1, 128.4, 128.7, 130.3, 135.4, 145.1. IR (neat, cm–1): 540, 648, 659, 
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754, 807, 900, 914, 1075, 1130, 1236, 1445, 1489, 1591, 2217, 2963. HRMS: calcd. for 
C12H12ClN+ [M]+ = 205.0658; found = 205.0663. 
(Z)-2-Benzyl-3-chloro-3-phenylacrylonitrile [(Z)-130z] 
Using the GP1, compound (Z)-130z was prepared from 102z (74 mg, 385 
μmol), 122b (237 mg, 500 μmol) and trichloroborane (0.76 ml, 1 M in DCM, 
0.76 mmol) in 1,2-DCE (0.76 ml) [rt, 1 h] as an orange solid (58 mg, 229 
μmol, 60%) after flash chromatography (n-hexane/EtOAc 9:1). 1H NMR 
(500 MHz, C6D6, ppm) δ = 3.10 (2H, s), 6.83 – 6.93 (7H, m), 6.99 – 7.07 (3H, m).  13C 
NMR (126 MHz, C6D6, ppm) δ = 37.5, 114.1, 117.1, 127.5, 128.4, 128.5, 128.7, 129.1, 
130.2, 135.4, 136.5, 145.6. IR (neat, cm–1): 562, 650, 671, 695, 761, 909, 1029, 1073, 
1237, 1453, 1494, 1604, 2219, 3029, 3061. HRMS: calcd. for C16H13ClN+ [M+H]+ = 
254.0731; found = 254.0739. 
(Z)-3-Chloro-2-cyclohexyl-3-phenylacrylonitrile [(Z)-130aa] 
Using GP1, compound (Z)-130aa was prepared from 102aa (58 mg, 315 
μmol), 122b (194 mg, 409 μmol) and trichloroborane (0.63 ml, 1 M in 
DCM, 0.63 mmol) in 1,2-DCE (0.63 ml) [rt, 1 h] as a pale yellow solid (62 
mg, 252 μmol, 80%) after flash chromatography (n-hexane/EtOAc 9:1). 
1H NMR (300 MHz, CDCl3, ppm) δ = 1.05 – 1.25 (3H, m), 1.53 – 1.78 (7H, m), 2.35 (1H, tt, 
J = 11.8, 13.6, 1.0 Hz), 7.30 – 7.37 (2H, m), 7.42 – 7.47 (3H, m). 13C NMR (126 MHz, 
CDCl3, ppm) δ = 25.2, 25.6, 31.7, 40.5, 116.2, 120.8, 128.1, 128.8, 130.3, 135.8, 144.0. IR 
(neat, cm–1): 548, 646, 694, 706, 755, 896, 913, 996, 1130, 1236, 1445, 1489, 1591, 2217, 
2926. HRMS: calcd. for C15H16ClN+ [M]+ = 245.0971; found = 253.0973. 
(Z)-3-Chloro-2-cyclopentyl-3-phenylacrylonitrile [(Z)-130ab] 
Using GP1, compound (Z)-130ab was prepared from 102ab (69 mg, 405 
μmol), 122b (250 mg, 527 μmol) and trichloroborane (0.80 ml, 1 M in 
DCM, 0.80 mmol) in 1,2-DCE (0.80 ml) [rt, 1 h] as a white solid (71 mg, 
306 μmol, 76%) after flash chromatography (n-hexane/EtOAc 9:1). 1H 
NMR (300 MHz, CDCl3, ppm) δ = 1.49 – 1.57 (2H, m), 1.64 – 1.87 (6H, m), 2.69 – 2.77 
(1H, tt, J = 9.2, 7.6, 1.0 Hz), 7.33 – 7.38 (2H, m), 7.40 – 7.45 (3H, m). 13C NMR (126 MHz, 
CDCl3, ppm) δ = 25.5, 32.6, 41.6, 116.2, 119.7, 128.3, 128.7, 130.2, 135.6, 143.6. IR 
(neat, cm–1): 547, 696, 695, 732, 754, 888, 914, 1239, 1444, 1489, 1592, 1607, 2218, 
2869, 2953. HRMS: calcd. for C14H15Cl+ [M+H]+ = 232.0888; found = 232.0886. 
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(Z)-2-{Chloro[4-(trimethylsilyl)phenyl]methylene}capronitrile [(Z)-130ac] 
Using GP1 compound (Z)-130ac was prepared from 102ac (138 mg, 
599 μmol), 122b (370 mg, 780 μmol) and trichloroborane (1.20 ml, 1 M 
in DCM, 1.20 mmol) in 1,2-DCE (1.20 ml) [rt, 1 h] as a colorless oil (99 
mg, 339 μmol, 57%) after flash chromatography (n-hexane/EtOAc 9:1). 
1H NMR (300 MHz, C6D6, ppm) δ = 0.14 (9H, s), 0.50 – 0.70 (3H, m), 
0.90  (2H, dt, J = 15.7, 7.3 Hz), 1.23 – 1.41 (2H, m), 1.86 – 2.05 (2H, m), 7.02 (2H, m), 
7.28 – 7.32 (2H, m).  13C NMR (76 MHz, C6D6, ppm) δ = -1.3, 13.7, 22.0, 30.6, 31.7, 115.7, 
117.1, 133.7, 133.8, 136.1, 143.5, 144.3. IR (neat, cm–1): 546, 624, 702, 721, 756, 816, 
836, 912, 1108, 1248, 1384, 1466, 1593, 2218, 2930, 2957. HRMS: calcd. For 
C16H22ClNSi+ [M]+ = 291.1210; found = 291.1217. 
(Z)-5-Chloro-2-[chloro(phenyl)methylene]valeronitrile [(Z)-130ad] 
Using GP1, compound (Z)-130ad was prepared from 102ad (104 
mg, 582 μmol), 122b (359 mg, 757 μmol) and trichloroborane (1.16 
ml, 1 M in DCM, 1.16 mmol) in 1,2-DCE (1.16 ml) [rt, 1 h] as a 
colorless oil (87 mg, 362 μmol, 62%) after flash chromatography (n-
hexane/EtOAc 9:1). 1H NMR (400 MHz, CDCl3, ppm) δ = 1.98 – 2.13 (2H, m), 2.39 – 2.55 
(2H, m), 3.50 (2H, t, J = 6.2 Hz), 7.28 – 7.41 (2H, m), 7.41 – 7.50 (3H, m). 13C NMR (100 
MHz, CDCl3, ppm) δ = 29.0, 30.9, 43.3, 113.0, 116.7, 128.3, 128.8, 130.6, 135.0, 146.5. 
IR (neat, cm–1): 696, 757, 796, 867, 909, 1016, 1076, 1258, 1444, 1489, 1594, 1612, 
2218, 2853, 2962. HRMS: calcd. For C12H11Cl2N+ [M]+ = 239.0269; found = 239.0266. 
(Z)-3-Chloro-2-cyclohexyl-3-(thiophen-2-yl)acrylonitrile [(Z)-130ag] 
Using GP1, compound (Z)-130ag was prepared from 102ag (88 mg, 
462 μmol), 122b (286 mg, 603 μmol) and trichloroborane (0.93 ml, 1 M 
in DCM, 0.93 mmol) in 1,2-DCE (0.93 ml) [rt, 1 h] as a yellow solid (95 
mg, 377 μmol, 82%) after flash chromatography (n-hexane/EtOAc 9:1). 
1H NMR (400 MHz, C6D6, ppm) δ = 0.82 – 0.97 (3H, m), 1.31 – 1.52 (7H, m), 2.62 (1H, dt, 
J = 9.8, 4.7 Hz), 6.49 (1H, q, J = 4.6, 3.6 Hz), 6.76 (1H, t, J = 4.1 Hz), 6.97 (1H, t, J = 3.2 
Hz).  13C NMR (100 MHz, C6D6, ppm) δ = 25.2, 25.7, 31.7, 40.9, 116.4, 120.4, 127.4, 
129.9, 131.2, 136.1, 137.1. IR (neat, cm–1): 628, 710, 724, 813, 899, 993, 1241, 1351, 
1416, 1455, 1584, 2208, 2851, 2931, 3105. HRMS: calcd. For C13H14ClNS+ [M]+ = 
251.0535; found = 251.0532. 
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(Z)-2-[Chloro(1-methyl-1H-indol-2-yl)methylene]capronitrile [(Z)-130ah] 
Using GP1, compound (Z)-130ah was prepared from 102ah (75 mg, 
355 μmol), 122b (218 mg, 460 μmol) and trichloroborane (0.71 ml, 1 M 
in DCM, 0.17 mmol) in 1,2-DCE (0.71 ml) [rt, 1 h] as a brown oil (7 mg, 
26 μmol, 7%) after flash chromatography (n-hexane/EtOAc 9:1). 1H 
NMR (300 MHz, C6D6, ppm) δ = 0.84 (3H, t, J = 7.3 Hz), 1.28 (2H, hept., 
J = 7.3 Hz), 1.58 (2H, pent., J = 7.5 Hz), 2.63 (3H, s), 2.41 (2H, t, J = 7.5 Hz), 6.82 (1H, d, 
J = 7.7 Hz), 7.24 – 7.14 (3H, m), 8.11 (1H, d, J = 7.9 Hz). 13C NMR (125 MHz, C6D6, ppm) 
δ = 14.1, 22.6, 30.3, 32.2, 32.3, 108.7, 110.3, 111.6, 119.3, 121.3, 121.7, 123.0, 126.7, 
131.4, 137.3, 143.8. IR (neat, cm–1): 571, 739, 934, 1069, 1133, 1254, 1363, 1463, 1524, 
1590, 2205, 2870, 2927, 2956, 3052, 3112. HRMS: calcd. For C16H17ClN2+ [M]+ = 
272.1080; found = 272.1079. 
(Z)-3-Chloro-3-phenylacrylonitrile [(Z)-130ai] 
Using GP1, compound (Z)-130ai was prepared from 102ai (31 mg, 304 
μmol), 122b (187 mg, 394 μmol) and trichloroborane (0.60 ml, 1 M in 
DCM, 0.60 mmol) in 1,2-DCE (0.60 ml) [rt, 1 h] as a yellow oil (29 mg, 
177 μmol, 58%) after flash chromatography (n-hexane/EtOAc 9:1) 1H 
NMR (300 MHz, CDCl3, ppm) δ = 6.03 (1H, s), 7.42 – 7.46 (1H, m), 7.47 – 7.55 (2H, m), 
7.65 – 7.69 (2H, m). 13C NMR (126 MHz, CDCl3, ppm) δ = 96.3, 115.5, 127.0, 129.1, 
132.0, 134.4, 153.4. IR (neat, cm–1): 575, 616, 651, 676, 753, 804, 902, 999, 1229, 1445, 
1489, 1575, 1597, 2220, 3060. HRMS: calcd. For C9H6ClN+ [M]+ = 163.0189; found = 
163.0185.  
 
(Z)-3-Chloro-3-(p-tolyl)acrylonitrile [(Z)-130ak] 
Using GP1, compound (Z)-130ak was prepared from 102ak (79 mg, 680 
μmol), 122b (420 mg, 886 μmol) and trichloroborane (1.36 ml, 1 M in 
DCM, 1.36 mmol) in 1,2-DCE (1.36 ml) [rt, 1 h] as a yellow oil (26 mg, 
0.14 μmol, 21%) after flash chromatography (n-hexane/EtOAc 9:1) a 
yellow solid (26 mg, 146 μmol, 21%). 1H NMR (300 MHz, CDCl3, ppm) δ 
= 2.41 (3H, s), 5.98 (1H, s), 7.23 – 7.26 (2H, m), 7.54 – 7.57 (2H, m). 13C NMR (126 MHz, 
CDCl3, ppm) δ = 21.5, 95.1, 115.7, 126.9, 129.7, 131.5, 142.8, 153.4. IR (neat, cm–1): 673, 
719, 730, 903, 1019, 1186, 1239, 1373, 1463, 1597, 1736, 2218, 2847, 2916, 2916. 
HRMS: calcd. For C10H9ClN+ [M+H]+ = 177.0418; found = 178.0417.  
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(Z)-3-Chloro-3-(4-chlorophenyl)acrylonitrile [(Z)-130al] 
Using GP1, compound (Z)-130al was prepared from 1-chloro-4-
ethynylbenzene (102al) (56 mg, 410 μmol), 122b (252 mg, 532 μmol) and 
trichloroborane (0.82 ml, 1 M in DCM, 0.82 mmol) in 1,2-DCE (0.82 ml) [rt, 
1 h] as a white solid (38 mg, 192 μmol, 47%) after flash chromatography 
(n-hexane/EtOAc 9:1). 1H NMR (500 MHz, CDCl3, ppm) δ = 6.01 (1H, s), 
7.41 – 7.45 (2H, m), 7.59 – 7.62 (2H, m). 13C NMR (126 MHz, CDCl3, ppm) δ = 96.8, 
115.2, 128.2, 129.4, 132.7, 138.4, 152.1. IR (neat, cm–1): 670, 721, 803, 833, 903, 1009, 
1094, 1234, 1402, 1489, 1591, 2217, 2341, 2361, 3043. HRMS: calcd. For C9H5Cl2N+ [M]+ 
= 196.9799; found = 196.9792.  
(Z)-3-Chloro-2-phenyl-3-(p-tolylthio)acrylonitrile [(Z)-130ao] 
Using GP1, compound (Z)-130ao was prepared from 102ao 
(23 mg, 103 μmol), 122b (63 mg, 133 μmol) and 
trichloroborane (0.20 ml, 1 M in DCM, 0.20 mmol) in 1,2-DCE 
(0.20 ml) [rt, 1 h] as a pale yellow solid (19 mg, 66 μmol, 
64%)obtaining after flash chromatography (n-hexane/EtOAc 9:1). 1H NMR (300 MHz, 
CDCl3, ppm) δ = 2.39 (3H, s), 7.18 – 7.23 (2H, m), 7.31 – 7.36 (2H, m), 7.42 – 7.50 (3H, 
m), 7.52 – 7.56 (2H, m).13C NMR (126 MHz, CDCl3, ppm) δ = 21.6, 112.8, 117.0, 125.6, 
128.9, 129.2, 129.6, 130.2, 132.2, 135.0, 146.8, 147.7. IR (neat, cm–1): 511, 648, 691, 
754, 803, 916, 1015, 1180, 1257, 1442, 1488, 1532, 1595, 2210, 2921. HRMS: calcd. For 
C16H12ClNS+ [M]+ = 285.0379; found = 285.0386. 
(Z)-2,2-Dichloro-3-[chloro(phenyl)methylene]-1,1-dimethyl-2,3-dihydro-1H-1λ4,2λ4-
benzo[d][1,2]azaborole (133) 
Using GP1, compound 133 was prepared from 102t (79 mg, 357 
μmol), 122b (220 mg, 464 μmol) and trichloroborane (0.71 ml, 1 M 
in DCM, 0.71 mmol) in 1,2-DCE (0.71 ml) [rt, 1 h] as a pale yellow 
solid (64 mg, 189 μmol, 53%) after flash chromatography (n-
hexane/EtOAc 2:1) 1H NMR (400 MHz, CD2Cl2, ppm) δ = 3.01 (6H, 
s), 7.37 – 7.49 (6H, m), 7.64 – 7.74 (2H, m), 8.48 (1H, dd, J = 7.9, 1.5 Hz). 13C NMR (126 
MHz, CD2Cl2, ppm) δ = 50.1, 117.6, 128.0, 128.1, 128.7, 195.5, 129.5, 129.6, 130.0, 
136.6, 141.1, 149.7. 11B NMR (128 MHz, CD2Cl2, ppm) δ = 10.5. The spectral data 
correspond to those reported in the literature.[115] 
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6.2.2.2. Isolated by-products. 
2,2'-Disulfanediylbis(1,3-diisopropyl-4,5-dimethyl-1H-imidazol-3-ium) Hexafluoro-
antimonate Tetrachloroantimonate (140a) 
Using GP1, compound (Z)-130a was prepared from 102a 
(1.000 g, 4.80 mmol), 122b (2.963 g, 6.25 mmol) and 
trichloroborane (9.61 ml, 1 M in DCM, 9.61 mmol) in 1,2-
DCE (9.61 ml) [rt, 1 h] as a yellow solid (1.055 g, 3.91 
mmol, 81%) after flash chromatography (n-hexane/EtOAc 
9:1). The solid remaning after filtration of the ethyl acetate 
solution was stirred with DCM, filtered again, concentrated under reduced pressure and 
recrystallized from a 1/1 mixture of acetonitrile and diethyl ether affording 140a as 
yellow crystals. 1H NMR (300 MHz, CD3CN, ppm) δ = 1.47 (24H, d, J = 7.0 Hz), 2.42 
(12H, s), 5.02 (4H, hept, J = 7.0 Hz). 13C NMR (126 MHz, CD3CN, ppm) δ = 11.0, 21.1, 
55.3, 133.6, 134.4. IR (neat, cm–1): 651, 748, 804, 905, 979, 1116, 1147, 1216, 1264, 
1377, 1395, 1414, 1457, 1592, 2987. HRMS: calcd. For C22H40F6N4S2Sb+ [M–SbCl4]+ = 
659.1631; found = 659.1624.  
 
6.2.2.3. Bromocyanations. 
(Z)-3-Bromo-3-(4-methoxyphenyl)-2-phenylacrylonitrile [(Z)-128] 
Using GP1, compound (Z)-128 was prepared from 102a (100 mg, 
480 μmol) and 122b (252 mg, 532 μmol) tribromoborane (0.48 ml, 1 
M in DCM, 0.48 mmol) in 1,2-DCE (1.92 ml) at rt for 3 h. In this case 
was used as promoter. After flash chromatography (n-
hexane/EtOAc 9:1) 6 was obtained as a yellow solid (14 mg, 45 
μmol, 9%). 1H NMR (300 MHz, C6D6, ppm) δ = 3.03 (3H, s), 6.25 – 6.33 (2H, m), 6.75 – 
6.81 (3H, m), 6.83 – 6.91 (2H, m), 6.95 – 7.01 (2H, m). 13C NMR (126 MHz, C6D6, ppm) δ 
= 54.8, 113.9, 117.5, 119.3, 128.7, 128.8, 129.4, 129.7, 131.8, 134.4, 138.4, 161.1. IR 
(neat, cm–1): 695, 753, 800, 1028, 1174, 1255, 1300, 1363, 1439, 1505, 1602, 1684, 2206, 
2359, 2962. HRMS: calcd. for C16H12BrNO+ [M]+ = 313.0102; found = 313.0109. 
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6.2.2.4. Thiocyanations. 
(Z/E)-2-{[2-Cyano-1-(4-methoxyphenyl)-2-phenylvinyl]thio}-1,3-diisopropyl-4,5-
dimethyl-1H-imidazol-3-ium Hexafluoroantimonate (129) 
Compound 129 was prepared from 102a (35 mg, 168 μmol), 122b 
(95 mg, 200 μmol) in 1,2-DCE (0.67 ml) according to GP1 [50 °C, 
3 h], but employing tris(pentafluorophenyl)borane (88 mg, 172 
μmol) as a Lewis acid. The reaction mixture was filtered through a 
pad of silica gel and concentrated in vacuo. Compound 129 (103 
mg, 151 μmol, 90 %) was obtained as a Z/E mixture which could 
not be separated by chromatography. (Z)-129, content 80%: 1H 
NMR (400 MHz, CD3CN, ppm) δ = 1.53 (12H, d, J = 7.0 Hz), 2.32 (6H, s), 3.73 (3H, s), 
5.29 (2H, hept, J = 7.0 Hz), 6.77 – 6.88 (2H, m), 7.08 – 7.14 (2H, m), 7.14 – 7.19 (2H, m), 
7.22 – 7.30 (3H, m). (E)-129, content 20%: 1H NMR (400 MHz, CD3CN, ppm) δ = 1.35 
(12H, d, J = 7.0 Hz), 2.22 (6H, s), 3.81 (3H, s), 4.92 (2H, hept, J = 7.0 Hz), 6.94 – 7.04 
(2H, m), 7.34 – 7.37 (2H, m), 7.57 – 7.65 (3H, m), 7.65 – 7.70 (2H, m). IR (neat, cm–1): 
680, 763, 972, 1028, 1084, 1175, 1256, 1378, 1460, 1513, 1602, 1644, 2341, 2360, 2980. 
HRMS: calcd. for C27H32N3OS+ [M–SbF6]+ = 446.2261; found = 446.2261. 
 
6.2.2.5. Cyanoarylations. 
10-(4-Methoxyphenyl)phenanthrene-9-carbonitrile (135a) 
 
Alkyne 135a (100 mg, 352 μmol, 1.0 equiv.) was treated 
with 122b (217 mg, 458 μmol, 1.3 equiv.) and tris-
(pentafluorophenyl)borane (179 mg, 350 μmol, 1.0 
equiv.) in 1,2-DCE (1.4 ml) according to GP1. [rt, 1 h]. 
The reaction mixture was filtered through a pad of silica gel, filtrate was concentrated in 
vacuo and purified by flash chromatography (n-hexane/EtOAc 9:1) affording compound 
136a as colorless crystals (59 mg, 191 μmol, 54%). 1H NMR (400 MHz, CDCl3, ppm) δ 
= 3.93 (3H, s), 7.08 – 7.17 (2H, m), 7.40 – 7.49 (2H, m), 7.58 (1H, ddd, J = 8.2, 6.9, 1.2 
Hz), 7.74 – 7.83 (4H, m), 8.35 – 8.42 (1H, m), 8.73 – 8.79 (2H, m). 13C NMR (101 MHz, 
CDCl3, ppm) δ = 55.5, 109.8, 114.2, 117.6, 123.0, 126.5, 127.5, 128.1, 128.4, 128.9, 
129.1, 129.2, 129.5, 129.7, 130.6, 131.4, 131.9, 147.2, 160.2. IR (neat, cm–1): 538, 647, 
 134 
 
669, 722, 756, 1028, 1034, 1066, 1173, 1247, 1508, 2341, 2360, 2900, 2972. HRMS: 
calcd. for C22H15NO+ [M]+ = 309.1154; found = 309.1162. 
 
6.2.2.6. Derivatization of chloroacrylonitriles. 
6.2.2.6.1. Suzuki-Miyaura couplings. 
 
 
Scheme 122. Suzuki-Miyaura cross-coupling of (Z)-130a.  
 
General procedure (GP2):[124] Under N2 atmosphere, a Schlenk tube was charged with (Z)-
130a (1.0 equiv.), the corresponding boronic acid (1.2 equiv.), Pd2(dba)3 (0.05 equiv.), 
tBu3P (0.20 equiv.), 3 M KOH aqueous solution (3.0 equiv.) and THF (ca. 0.5 ml). The 
mixture was stirred at 60 °C for 3 hours. The reaction was quenched with an aqueous 
ammonium chloride solution and extracted with diethylether. The extract was washed with 
water, dried over MgSO4 and concentrated in vacuum affording a brown solid crude 
product. The latter was purified by column chromatography (n-hexane/EtOAc 9:1) or 
recrystallized from a 1/1 mixture of DCM and n-pentane.  
 
3,3-Bis(4-methoxyphenyl)-2-phenylacrylonitrile (141a)  
Using GP2, compound 141a was prepared from (Z)-130a (25 mg, 93 
μmol), Pd2(dba)3 (4.3 mg, 4.6 μmol, 5 mol%), tBu3P (4 mg, 20 μmol), 
KOH (16 mg, 95 μl, 3 M in H2O, 285 μmol) and para-anisolylboronic 
acid (14 mg, 0.09 μmol) in THF (0.50 ml) as a yellow solid (29 mg, 
85 μmol, 91%) after flash chromatography (n-hexane/EtOAc 9:1). 1H 
NMR (300 MHz, CDCl3, ppm) δ = 3.77 (3H, s), 3.86 (3H, s), 6.66 – 
6.72 (2H, m), 6.90 – 6.95 (4H, m), 7.18 – 7.26 (4H, m), 7.26 – 7.29 
(2H, m), 7.37 – 7.43 (2H, m).13C NMR (126 MHz, CDCl3, ppm) δ = 55.4, 55.5, 108.9, 
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113.7, 113.9, 121.2, 128.0, 128.6, 129.8, 131.6, 132.0, 132.9, 133.1, 135.6, 157.4, 160.3, 
161.1. HRMS: calcd. for C23H19NO2+ [M]+ = 341.1416; found = 341.1423. 
 (Z)-3-(4-Fluorophenyl)-3-(4-methoxyphenyl)-2-phenylacrylonitrile [(Z)-141b]  
Using GP2, compound (Z)-141b was prepared from (Z)-130a (100 
mg, 371 μmol), Pd2(dba)3 (17 mg, 18.5 μmol, 5 mol%), tBu3P (15 mg, 
74 μmol), KOH (62 mg, 368 μl, 3 M in H2O, 1.10 mmol) and 4-
fluorophenylboronic acid (63 mg, 450 μmol) in THF (0.40 ml) as a 
white solid (113 mg, 343 μmol, 92%) after flash chromatography (n-
hexane/EtOAc 9:1). 1H NMR (500 MHz, CDCl3, ppm) δ = 3.77 (3H, 
s), 6.63 – 6.77 (2H, m), 6.83 – 6.97 (2H, m), 7.04 – 7.17 (2H, m), 
7.23 – 7.30 (5H, m), 7.42 – 7.48 (2H, m).13C NMR (126 MHz, CDCl3, ppm) δ = 55.3, 55.5, 
108.8, 113.6, 113.8, 121.1, 128.0, 128.6, 129.8, 131.5, 131.9, 132.8, 133.0, 153.6, 157.3, 
160.3, 161.1. 19F NMR (376 MHz, CDCl3, ppm) δ = –110.5. IR (neat, cm–1): 701, 765, 831, 
1030, 1159, 1183, 1226, 1252, 1275, 1297, 1457, 1505, 1601, 2200, 3069. HRMS: calcd. 
for C22H16FNO+ [M]+ = 329.1216; found = 329.1206. 
 
(Z)-3-(Furan-2-yl)-3-(4-methoxyphenyl)-2-phenylacrylonitrile [(Z)-141c]  
Using GP2, compound (Z)-141c was prepared from (Z)-130a (33 mg, 
122 μmol), Pd2(dba)3 (5.5 mg, 6 μmol, 4.9 mol%), tBu3P (5 mg, 24.7 
μmol), KOH (21 mg, 125 μl, 3 M in H2O, 374 μmol) and 2-furylboronic 
acid (63 mg, 563 μmol) in THF (0.50 ml) as a yellow solid (25 mg, 
0.08 μmol, 68%) after flash chromatography (n-hexane/EtOAc 9:1). 
1H NMR (400 MHz, C6D6, ppm) δ = 3.11 (3H, s), 6.00 (1H, dd, J = 
3.5, 1.8 Hz), 6.41 – 6.49 (2H, m), 6.55 (1H, dd, J = 3.6, 0.8 Hz), 6.75 – 6.80 (2H, m), 6.80 
– 6.89 (3H, m), 7.06 (1H, dd, J = 1.8, 0.8 Hz), 7.17 – 7.22 (2H, m).13C NMR (101 MHz, 
C6D6, ppm) δ = 54.8, 107.3, 112.2, 113.9, 116.8, 120.3, 127.9, 128.5, 128.6, 130.2, 132.4, 
135.8, 143.3, 144.7, 152.9, 160.4. IR (neat, cm–1): 590, 696, 759, 838, 1017, 1028, 1175, 
1250, 1293, 1462, 1509, 1605, 1783, 2360, 2958. HRMS: calcd. for C20H15NO2+ [M]+ = 
301.1103; found = 301.1104. 
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6.2.2.6.2. Solvolysis of chloroacrylonitriles. 
(E)- and (Z)-3-Ethoxy-3-(4-methoxyphenyl)-2-phenylacrylonitriles [(E)-144 and (Z)-
144] 
Following the reported procedure,[126] 
substrate (Z)-130a (14 mg, 52 μmol) and 
NaOH (10 mg, 250 μmol, 5.0 equiv.) were 
refluxed in ethanol (1 ml) for 12 hours. The 
reaction mixture was filtered through a silica 
pad. After evaporation of volatiles, the crude 
product was washed with hexanes affording the desired product as a 2/1 mixture of (E)-
144 and (Z)-144 as a yellow solid (11 mg, 39 μmol, 75%). (E)-144: 1H NMR (400 MHz, 
C6D6, ppm) δ = 0.80 (3H, t, J = 7.1 Hz), 3.21 (3H, s), 3.33 (2H, q, J = 7.1 Hz), 6.63 – 6.71 
(2H, m), 7.17 – 7.24 (3H, m), 7.24 – 7.31 (2H, m), 7.95 – 8.02 (2H, m). (Z)-144: 1.06 (3H, 
t, J = 7.0 Hz), 3.10 (3H, s), 3.57 (2H, q, J = 7.1 Hz), 6.37 – 6.50 (2H, m), 6.83 – 6.92 (5H, 
m), 7.07 (2H, ddt, J = 8.6, 6.9, 1.3 Hz). 13C NMR (126 MHz, C6D6, ppm) δ = 14.8, 15.0, 
54.4, 54.5, 66.6, 66.9, 96.5, 113.9, 113.9, 118.3, 119.7, 123.6, 124.9, 127.0, 127.3, 127.9, 
128.2, 128.4, 129.4, 130.6, 131.2, 133.1, 133.5, 160.9, 161.2, 167.3, 167.3. 
(E)- and (Z)-3-(4-Methoxyphenyl)-3-morpholino-2-phenylacrylonitrile [(E)-145d 
and (Z)-145d] 
Substrate (Z)-130a (24 mg, 89 μmol) and 
NaOH (18 mg, 450 μmol, 5.0 equiv.) were 
solved in morpholine (1 ml) and heated by 
the microwave irradiation for 9 hours. After 
evaporation of volatiles, the residue was 
purified by flash chromatography (n-
hexane/EtOAc 4:1) affording the desired products as a 1.5/1 mixture of (E)-145d and (Z)-
145d as a yellow oil (26 mg, 81 μmol, 91%). (E)-145d: 1H NMR (400 MHz, CDCl3, ppm) δ 
= 2.85 (4H, dd, J = 5.4, 4.2 Hz), 3.58 – 3.65 (4H, m), 3.85 (3H, s), 6.94 – 7.01 (4H, m), 
7.23 – 7.28 (3H, m), 7.51 – 7.58 (2H, m). (Z)-145d: 1H NMR (400 MHz, CDCl3, ppm) δ = 
3.42 – 3.47 (4H, m), 3.76 (3H, s), 3.77 – 3.81 (4H, m), 6.73 – 6.78 (2H, m), 7.02 – 7.07 
(2H, m), 7.12 – 7.17 (2H, m), 7.32 – 7.39 (3H, m). 13C NMR (101 MHz, C6D6, ppm) δ = 
51.1, 51.3, 55.4, 55.5, 67.2, 67.5, 84.6, 86.6, 114.3, 114.5, 123.6, 125.4, 126.7, 126.8, 
EtO
CN
MeO
EtO CN
MeO
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128.1, 128.1, 128.6, 128.8, 129.3, 132.1, 132.8, 136.1, 136.4, 161.2, 161.5, 162.0, 163.1.  
6.2.2.6.3. Synthesis of heterocycles 
3-Amino-5-(4-methoxyphenyl)-4-phenylthiophene-2-carbonitrile (146a) 
Following the reported procedure,[127] a suspension of 
Na2S·9H2O (77 mg, 321 μmol, 1.0 equiv.) in DMF (4 mL) was 
heated at 40 °C for 30 min. A solution of (Z)-130a (86 mg, 319 
μmol, 1.0 equiv.) in DMF (2 mL) was added to the former 
solution, and the reaction mixture was stirred at 50 °C for 50 
min. Chloroacetonitrile (0.02 ml, 320 μmol, 1.0 equiv.) in DMF (1 mL) was then added, and 
the solution was stirred at 50 °C for 90 additional minutes. Subsequently, a solution of 
NaOEt (22 mg, 323 μmol, 1.0 equiv.) in absolute EtOH (2 mL) was added, and the mixture 
was stirred at 50 °C for 1 h. The reaction was then cooled to rt and poured into ice-cold 
water (10 mL). The precipitate was filtered off and washed with cold water and dried. 
Finally, the solid was purified by column chromatography (n-hexane/EtOAc 10:1 to 1:1) 
affording 146a as a yellow solid (22 mg, 72 μmol, 23%) and 147 as a yellow oil (29 mg, 95 
μmol, 30%). 
Compound 146a: 1H NMR (500 MHz, C6D6, ppm) δ = 3.11 (3H, s), 3.70 (2H, s), 6.37 – 
6.47 (2H, m), 6.85 – 6.91 (2H, m), 6.93 – 7.04 (5H, m). 13C NMR (126 MHz, C6D6, ppm) δ 
= 30.2, 54.7, 79.8, 114.3, 115.1, 125.5, 128.2, 129.4, 130.2, 130.3, 134.0, 145.7, 154.1, 
160.4. IR (neat, cm–1): 780, 833, 1035, 1049, 1066, 1175, 1252, 1417, 1514, 1603, 1630, 
2341, 2360, 2987, 3471. HRMS: calcd. for C18H14N2OS+ [M]+ = 306.0827; found = 
306.0832. 
(E)- and (Z)-3-[(Cyanomethyl)thio]-3-(4-methoxyphenyl)-2-phenylacrylonitrile [(E)-
147 and (Z)-147] 
Compound 147 was isolated as a 10/1 E/Z diastereomeric mixture. 1H 
NMR (600 MHz, C6D6, ppm) δ = 1.99 (2H, s), 3.20 (3H, s), 6.64 – 6.71 
(2H, m), 6.99 – 7.05 (1H, m), 7.06 – 7.12 (2H, m), 7.27 – 7.32 (2H, m), 
7.45 – 7.52 (2H, m). 13C NMR (126 MHz, C6D6, ppm) δ = 18.0, 55.1, 
114.7, 115.0, 115.5, 118.3, 126.8, 129.1, 129.4, 129.5, 131.2, 134.3, 
153.1, 161.7. 
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Compounds 149a and 149b 
Following literature conditions,[128] 
Compound (Z)-130a (90 mg, 0.33 mmol, 
1.0 equiv.) and methylhydrazine (77, 1.67 
mmol, 5 equiv.) were refluxed in ethanol 
(2 ml) for 24 hours. After completition, the 
mixture was diluted in water and the 
product extracted with DCM, the organic phase was separated, dried with Na2SO4, filtered 
and concentrated in vacuo. The solid was purified by column chromatography 
(Et2O/EtOAc 10/1 to 1/1) affording a mixture of regiomers 149a/149b (86/14) as a yellow 
oil that solidifies on standing (68 mg, 0.24 mmol, 73%). Washing the product with DCM 
allowed the isolation of pure 149a: 1H NMR (400 MHz, CDCl3, ppm) δ = 3.62 (3H, s), 3.81 
(3H, s), 6.84 – 6.92 (2H, m), 7.07 – 7.19 (5H, m), 7.20 – 7.26 (2H, m). 13C NMR (126 MHz, 
CDCl3, ppm) δ = 36.4, 55.4, 107.0, 114.2, 122.4, 126.0, 128.7, 128.9, 129.7, 131.3, 141.7, 
151.1, 159.8. IR (neat, cm–1): 596, 701, 768, 822, 1030, 1173, 1247, 1386, 1524, 1601, 
2341, 2360, 2924, 2957, 3402. HRMS: calcd. for C17H17N3O [M]+ = 279.1372; found = 
279.1371. 
Compound 149c 
Following the reported procedure,[128] compound (Z)-130a (28 mg, 
0.10 mmol, 1.0 equiv.) and hydrazine monohydrate (10 mg, 0.20 
mmol, 2.0 equiv.) were refluxed in ethanol (1 ml) for 18 hours. After 
completition, the mixture was concentrated and solved in a 
water/ethylacetate mixture, the organic phase was separated, dried 
and concentrated in vacuo. The solid was purified by column chromatography (n-
hexane/EtOAc 4/1 to 1/1) affording product 149c as a white solid (25 mg, 0.93 mmol, 
90%). 1H NMR (400 MHz, CDCl3, ppm) δ = 3.77 (3H, s), 5.83 (2H, bs), 6.72 – 6.88 (2H, 
m), 7.18 – 7.39 (7H, m). 13C NMR (101 MHz, CDCl3, ppm) δ = 55.3, 105.85 114.2, 122.8, 
126.5, 128.9, 129.0, 129.6, 132.9, 141.6, 152.5, 159.7. IR (neat, cm–1): 775, 832, 1030, 
1244, 1507, 1604, 1915, 2115, 2281, 2343, 2372, 2579, 2924, 2958, 3197. HRMS: calcd. 
for C16H15N3O+ [M]+ = 265.1215; found = 265.1222.  
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Compound 150 
Follwing reported conditions,[128] compound 149c (20 mg, 0.07 
mmol, 1.0 equiv.), acetylacetone (23 mg, 0.22 mmol, 3.0 equiv.) 
and piperidine (6 mg, 0.07 mmol, 1.0 equiv.) were solved in 
ethanol (1 ml) and heated in the microwave for 80 minutes at 85 
°C. The mixture was concentrated and purified by column 
chromatography (n-hexane/EtOAc 4/1 to 1/1) affording product 
150 as a white solid (19 mg, 0.06 mmol, 81%). 1H NMR (400 MHz, CDCl3, ppm) δ = 2.54 
(3H, s), 2.77 (3H, s), 3.80 (3H, s), 6.54 (1H, s), 6.76 – 6.94 (2H, m), 7,23 (1H, s), 7.34 (2H, 
t, J = 7.7 Hz), 7.45 – 7.63 (4H, m). 13C NMR (101 MHz, CDCl3, ppm) δ = 17.1, 25.0, 55.3, 
107.7, 108.8, 113.9, 126.2, 126.4, 128.4, 130.1, 130.4, 132.6, 144.9, 146.8, 153.4, 158.7, 
159.9. IR (neat, cm–1): 599, 697, 734, 777, 834, 961, 1028, 1091, 1179, 1248, 1433, 1556, 
1613, 2924, 2960. HRMS: calcd. for C21H19N3O [M-H] = 328.1450; found = 328.1458.  
6.2.2.6.4. Attempted derivatization of natural products. 
 
 (8R,9S,13S,14S,17S)-3-Methoxy-13-methyl-17-(phenylethynyl)-7,8,9,11,12,13,14,15, 
16,17-decahydro-6H-cyclopenta[a]phenanthren-17-ol (152) 
 
Commertially available mestranol 151 (200 mg, 
644 μmol, 1.0 equiv.), Pd(PPh3)4 (19 mg, 16 μmol, 
8 mol%), CuI (6 mg, 31 μmol, 15 mol%) and phenyl 
iodide (134 mg, 657 μmol, 1.0 equiv.) were solved 
in a previously degassed iPr2NH/THF 2:1 mixture 
and stirred at rt for 3 h. The reaction mixture was filtered through a silica and Celite pad, 
filtrate was concentrated and purified by flash chromatography (n-hexane/EtOAc 9:1) 
affording 152 as a pale yellow solid (222 mg, 574 μmol, 89%). 1H NMR (400 MHz, CDCl3, 
ppm) δ = 0.94 (3H, d, J = 0.7 Hz), 1.34 – 1.58 (4H, m), 1.77 – 1.83 (2H, m), 1.92 (2H, s), 
2.00 (1H, td, J = 13.1, 4.4 Hz), 2.11 (1H, td, J = 13.7, 12.6, 3.4 Hz), 2.25 (1H, t, J = 11.3 
Hz), 2.35 – 2.47 (2H, m), 2.87 (2H, t, J = 8.2 Hz), 3.78 (3H, s), 6.64 (1H, d, J = 2.8 Hz), 
6.72 (1H, dd, J = 8.6, 2.8 Hz), 7.20 – 7.25 (1H, m), 7.29 – 7.35 (3H, m), 7.43 – 7.48 (2H, 
m). 13C NMR (101 MHz, CDCl3, ppm) δ = 13.1, 23.1, 26.7, 27.4, 30.0, 33.2, 39.2, 39.7, 
43.8, 47.8, 49.9, 55.4, 80.5, 86.1, 92.9, 111.6, 113.9, 123.1, 126.5, 128.4, 128.4, 131.8, 
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132.7, 138.1, 157.6.  
(8R,9S,13S,14S,17S)-3,17-Dimethoxy-13-methyl-17-(phenylethynyl)-7,8,9,11,12,13,14, 
15,16,17-decahydro-6H-cyclopenta[a]phenanthrene (153) 
Compound 152 (43 mg, 111 μmol), methyl iodide 
(32 mg, 225 μmol, 2.0 equiv.) and sodium hydride 
(9 mg, 375 μmol, 3.4 equiv.) were solved in 
anhydrous THF (5 ml) and stirred at room 
temperature for 3 hours. After solvent evaporation, 
the residue was purified by column chromatography (n-hexane/EtOAc 9:1) affording 
product 153 as a white solid (30 mg, 75 μmol, 68%). 1H NMR (400 MHz, CDCl3, ppm) δ = 
0.95 (3H, s), 1.35 – 1.61 (4H, m), 1.77 – 1.97 (4H, m), 2.10 (2H, tdd, J = 12.2, 7.1, 3.8 
Hz), 2.25 (1H, td, J = 11.2, 4.1 Hz), 2.36 (2H, ddt, J = 14.1, 9.0, 4.2 Hz), 2.87 (2H, dd, J = 
9.9, 6.4 Hz), 3.50 (3H, s), 3.79 (3H, s), 6.64 (1H, d, J = 2.9 Hz), 6.73 (1H, dd, J = 8.6, 2.8 
Hz), 7.23 (1H, d, J = 8.6 Hz), 7.28 – 7.40 (3H, m), 7.49 (2H, dd, J = 6.7, 3.0 Hz). 13C NMR 
(101 MHz, CDCl3, ppm) δ = 13.0, 23.0, 26.8, 27.4, 30.0, 34.6, 37.0, 39.4, 43.8, 48.1, 50.0, 
53.6, 55.3, 86.3, 88.0, 90.4, 111.6, 113.9, 123.3, 126.5, 128.3, 128.4, 131.8, 132.7, 138.1, 
157.5.  
 
6.3. Cyanative cyclizations. 
6.3.1. Synthesis of starting materials. 
6.3.1.1. Terminal alkynes 182 by Seyferth-Gilbert homologation. 
 
 
Scheme 123. Seyferth-Gilbert homologation of 181. 
General procedure (GP3): A round-bottomed flask was flushed with nitrogen and charged 
with the corresponding aldehyde 181 (1.0 equiv.), Ohira-Bestmann reagent (1.5 equiv.), 
potassium carbonate (2.0 equiv.), suspended in anhydrous methanol (ĉ ~ 0.1 M with 
H
H
H
MeO
OMe
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respect to 181) and stirred at room temperature for the indicated time. All volatiles were 
removed; the remaining solid was taken up with DCM and washed with brine. The organic 
layer was dried with Na2CO3, evaporated and purified by flash chromatography.[100,101] 
 
2-Ethynyl-1,1'-biphenyl (135f) 
 
From [1,1'-biphenyl]-2-carbaldehyde (900 mg, 4.94 mmol, 1.0 equiv.), 
Ohira-Bestmann reagent (1.424 g, 7.44 mmol, 1.50 equiv.) and potassium 
carbonate (1.365 g, 9.88 mmol, 2.0 equiv.) in methanol (49 ml), 135f (863 
mg, 4.84 mmol, 98%) was obtained according to GP3 [3 h] as a colorless oil 
after purification by column chromatography (n-hexane). 1H NMR (400 
MHz, CDCl3, ppm) δ = 3.04 (1H, s), 7.31 (1H, ddd, J = 7.7, 6.9, 1.9 Hz), 7.34 – 7.48 (5H, 
m), 7.55 – 7.65 (3H, m). 13C NMR (126 MHz, CDCl3, ppm) δ = 80.3, 83.2, 120.6, 127.0, 
127.6, 128.0, 129.0, 129.3, 129.7, 133.9, 140.3, 144.5. IR (neat, cm–1): 505, 567, 615, 
696, 735, 755, 1007, 1074, 1261, 1430, 1448, 1473, 2104, 3021, 3058, 3281. HRMS: 
calcd. for C14H10+ [M]+ = 178.0783; found = 178.0784.  
2-Ethynyl-2'-(trifluoromethyl)-1,1'-biphenyl (182g) 
 
Compound 182g was cordially supplied by Dr. Javier Carreras. 1H 
NMR (400 MHz, CDCl3, ppm) δ = 2.90 (1H, s), 7.24 – 7.32 (1H, m), 
7.32 – 7.45 (3H, m), 7.51 (1H, tdq, J = 7.6, 1.7, 0.9 Hz), 7.54 – 7.67 
(2H, m), 7.78 (1H, ddt, J = 7.8, 1.3, 0.6 Hz). 13C NMR (101 MHz, 
CDCl3, ppm) δ = 80.8, 82.2, 122.0, 122.8, 125.5, 126.1 (q, J = 5.2 Hz), 127.9 (d, J = 2.2 
Hz), 128.1, 129.7 (q, J = 1.8 Hz), 131.2, 132.1, 132.7, 139.6, 139.6, 142.4. IR (neat, cm–1): 
523, 632, 663, 758, 1033, 1070, 1107, 1177, 1312, 1366, 1471, 1738, 2361, 2969, 3273. 
19F NMR (376 MHz, CDCl3, ppm) δ = –58.2. HRMS: calcd. for C15H9F3+ [M]+ = 246.0656; 
found = 246.0656. 
2-Chloro-2'-ethynyl-1,1'-biphenyl (182i) 
From 181i (157 mg, 725 μmol, 1.0 equiv.), Ohira-Bestmann reagent 
(209 mg, 1088 μmol, 1.5 equiv.) and potassium carbonate (200 mg, 145 
μmol, 2.0 equiv.) in methanol (7.3 ml), compound 182i (137 mg, 644 
μmol, 89%) was obtained according to GP3 [1 h] as a pale yellow oil 
F3C
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after purification by column chromatography (n-hexane). 1H NMR (400 MHz, CDCl3, ppm) 
δ = 2.95 (1H, s), 7.28 – 7.45 (6H, m), 7.45 – 7.53 (1H, m), 7.59 – 7.67 (1H, m). 13C NMR 
(101 MHz, CDCl3, ppm) δ = 80.4, 82.3, 122.0, 126.5, 127.8, 128.6, 129.1, 129.6, 130.0, 
131.5, 133.1, 133.4, 139.5, 142.5. IR (neat, cm–1): 519, 618, 651, 733, 754, 1004, 1033, 
1070, 1259, 1435, 1462, 1567, 2106, 3059, 3286. HRMS: calcd. for C14H9Cl+ [M]+ = 
212.0393; found = 212.0398. 
2-Ethynyl-3',5'-dimethoxy-1,1'-biphenyl (182s) 
Compound 182s (58 mg, 243 μmol, 41%) was obtained from 181s 
(143 mg, 590 μmol, 1.0 equiv.), Ohira-Bestmann reagent (170 mg, 
885 μmol, 1.5 equiv.) and potassium carbonate (163 mg, 1.18 mmol, 
2.0 equiv.) in methanol (5.9 ml) according to GP3 [1.5 h] as a 
colorless oil after purification by column chromatography (n-
hexane/EtOAc 9:1). 1H NMR (400 MHz, CDCl3, ppm) δ = 3.09 (1H, s), 3.84 (6H, s), 6.50 
(1H, t, J = 2.3 Hz), 6.76 (2H, d, J = 2.3 Hz), 7.28 – 7.34 (1H, m), 7.37 – 7.42 (2H, m), 7.62 
(1H, dt, J = 7.8, 1.0 Hz) 13C NMR (101 MHz, CDCl3, ppm) δ = 55.5, 80.6, 83.2, 100.1, 
107.6, 120.5, 127.3, 129.1, 129.6, 134.1, 142.3, 144.5, 160.4. IR (DCM, cm–1): 653, 695, 
760, 837, 1027, 1063, 1154, 1204, 1349, 1418, 1457, 1591, 2835, 2937, 3279. HRMS: 
calcd. for C16H14O2+ [M]+ = 238.0994; found = 238.0996. The spectral data correspond to 
those reported in the literature.[134] 
2-(2-Ethynylphenyl)furan (182v) 
Compound 182v (196 mg, 1.17 mmol, 63%) was obtained from 181v (320 
mg, 1.86 mmol, 1.0 equiv.), Ohira-Bestmann reagent (536 mg, 2.79 mmol, 
1.5 equiv.) and potassium carbonate (513 mg, 3.71 mmol, 2.0 equiv.) were 
suspended in methanol (18 ml) according to GP3 [1.5 h] as a pale yellow oil 
after purification by column chromatography (n-hexane) 1H NMR (400 MHz, CDCl3, ppm) 
δ = 3.40 (1H, s), 6.51 (1H, dd, J = 3.5, 1.8 Hz), 7.22 (1H, td, J = 7.6, 1.3 Hz), 7.36 – 7.44 
(2H, m), 7.50 (1H, dd, J = 1.8, 0.8 Hz), 7.58 (1H, ddd, J = 7.8, 1.4, 0.5 Hz), 7.85 (1H, ddd, 
J = 8.1, 1.3, 0.5 Hz). 13C NMR (126 MHz, CDCl3, ppm) δ = 82.2, 83.7, 109.8, 111.7, 117.2, 
125.6, 126.7, 129.2, 132.4, 134.7, 142.0, 151.7. IR (neat, cm–1): 512, 530, 561, 597, 667, 
757, 901, 1066, 1216, 1228, 1366, 1738, 2341, 2362, 2969. 
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2-Ethynyl-1,1'-binaphthalene (182z) 
Compound 182z (130 mg, 467 μmol, 88%) was obtained from 181z 
(150 mg, 531 μmol, 1.0 equiv.), Ohira-Bestmann reagent (153 mg, 796 
μmol, 1.5 equiv.) and potassium carbonate (146 mg, 1.06 mmol, 2.0 
equiv.) in methanol (5.3 ml) according to GP3 [40 min] as a white foam 
after purification by column chromatography (n-hexane). 1H NMR (400 
MHz, CDCl3, ppm) δ = 2.81 (1H, s), 7.23 – 7.33 (4H, m), 7.46 – 7.52 (3H, m), 7.64 (1H, 
dd, J = 8.3, 7.0 Hz), 7.73 (1H, d, J = 8.6 Hz), 7.89 – 7.94 (2H, m), 7.64 (2H, ddq, J = 11.0, 
8.4, 0.7 Hz). 13C NMR (101 MHz, CDCl3, ppm) δ = 81.0, 83.3, 120.3, 125.5, 126.0, 126.2, 
126.2, 126.8, 126.8, 127.1, 128.0, 128.0, 128.2, 128.3, 128.3, 129.1, 132.7, 133.0. 133.3, 
133.7, 136.6, 142.2. IR (neat, cm–1): 627, 746, 779, 817, 1028, 1174, 1243, 1284, 1508, 
1590, 1603, 2205, 2535, 2833, 3052. HRMS: calcd. for C22H142+ [M–2H]2+ = 276.0928; 
found = 276.0945. 
 
6.3.1.2. Alkynes 135 by Sonogashira-Hagihara coupling. 
 
 
Scheme 124. Sonogashira-Hagihara coupling with alkyne 182. 
 
General procedure (GP4): A 2/1 mixture of diisopropylamine and THF (ĉ ~ 0.01 M with 
respect to 182) was degassed in a round-bottomed flask for 10 min under a N2 
atmosphere. The corresponding Ar-I or Ar-Br (1.0 equiv.), Pd(PPh3)4 (2.5 mol%) and 
CuI (5 mol%) were added in one portion and stirred for 15 min. After addition of the 
corresponding alkyne (1.0 equiv.), the reaction mixture was stirred at rt for indicated 
time. Filtration through a silica and Celite pad afforded a clear solution that was 
concentrated and further purified by column chromatography.[143] 
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2-[(4-chlorophenyl)ethynyl]-1,1'-biphenyl (135d) 
 
Following GP4, 135d was prepared from 2-iodo-1,1'-biphenyl 
(308 mg, 1.10 mmol), Pd(PPh3)4 (32 mg, 28 μmol, 2.5 mol%), 
CuI (9 mg, 47 μmol, 4.3 mol%) and 1-chloro-4-ethynylbenzene 
(150 mg, 1.10 mmol) [rt, 3 h] as a pale yellow solid (201 mg, 
0.70 mmol, 64%) after flash chromatography (n-hexane). 1H NMR (400 MHz, CDCl3, ppm) 
δ = 7.24 – 7.27 (4H, m), 7.34 (1H, ddd, J = 7.7, 6.6, 2.3 Hz), 7.37 – 7.49 (5H, m), 7.61 – 
7.67 (3H, m). 13C NMR (101 MHz, CDCl3, ppm) δ = 90.5, 91.2, 121.4, 122.1, 127.2, 127.7, 
128.0, 128.8, 128.9, 129.5, 129.7, 132.7, 132.9, 134.2, 140.7, 144.2. IR (neat, cm–1): 503, 
697, 733, 753, 774, 824, 1012, 1088, 1431, 1487, 1591, 1738, 2216, 3021, 3056. HRMS: 
calcd. for C20H13Cl+ [M]+ = 288.0706; found = 288.0717. The spectral data correspond to 
those reported in the literature.[143] 
Compound 135g 
 
Following GP4, 135g (91 mg, 271 μmol, 72%) was 
prepared from 4-methyliodobenzene (104 mg, 477 μmol), 
Pd(PPh3)4 (12 mg, 10 μmol, 2.7 mol%), CuI (4 mg, 21 
μmol, 5.6 mol%) and 182g (92 mg, 374 μmol) [rt, 1 h] as a 
pale yellow solid after flash chromatography (n-hexanes/EtOAc 9:1). 1H NMR (500 MHz, 
CDCl3, ppm) δ = 2.30 (3H, s), 6.94 – 6.98 (2H, m), 6.98 – 7.06 (2H, m), 7.31 (1H, dtd, J = 
6.7, 1.6, 0.7 Hz), 7.33 – 7.46 (3H, m), 7.47 – 7.56 (1H, m), 7.56 – 7.63 (2H, m), 7.78 (1H, 
ddd, J = 7.5, 1.5, 0.8 Hz). 13C NMR (126 MHz, CDCl3, ppm) δ = 21.6, 87.8, 93.6, 120.2, 
123.4, 124.3 (q, J = 239.4 Hz), 126.0 (q, J = 5.1 Hz), 127.4, 127.7, 127.9, 128.9, 129.0, 
129.4 – 129.4 (m), 131.1, 131.3, 131.5, 132.4, 138.4, 140.0 (q, J = 2.1 Hz), 142.0. 19F 
NMR (471 MHz, CDCl3, ppm) δ = –58.2. IR (neat, cm–1): 509, 761, 810, 1030, 1068, 1101, 
1170, 1313, 1366, 1436, 1738, 2212, 2360, 2920, 2969. HRMS: calcd. for C22H15F3+ [M]+ = 
336.1126; found = 336.1118. 
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2-[(4-Methoxyphenyl)ethynyl]-2'-(trifluoromethyl)-1,1'-biphenyl (135h) 
 
Following GP4, 135h (104 mg, 295 μmol, 93%) was 
prepared from 4-iodoanisole (75 mg, 317 μmol), 
Pd(PPh3)4 (9 mg, 8 μmol, 2.5 mol%), CuI (3 mg, 16 
μmol, 5.0 mol%) and 182h (78 mg, 317 μmol) [rt, 40 min] 
as a white solid after flash chromatography (n-hexane). 1H NMR (400 MHz, CDCl3, ppm) δ 
= 3.77 (3H, s), 6.70 – 6.78 (2H, m), 6.95 – 7.05 (2H, m), 7.27 – 7.38 (3H, m), 7.38 – 7.44 
(1H, m), 7.47 – 7.55 (1H, m), 7.55 – 7.63 (2H, m), 7.75 – 7.81 (1H, m). 13C NMR (126 
MHz, CDCl3, ppm) δ = 55.4, 87.2, 93.5, 113.9, 115.4, 123.5, 124,0 (q, (q, J = 289.9 Hz), 
125.82 – 126.34 (m), 127.1, 127.6, 127.8, 128.9, 129.32 (q, J = 1.9 Hz), 131.0, 131.2, 
132.4, 132.8, 140.1, 141.8, 159.5. 19F NMR (376 MHz, CDCl3, ppm) δ = –58.2. IR (neat, 
cm–1): 513, 533, 649, 766, 830, 1025, 1066, 1109, 1158, 1246, 1313, 1438, 1507, 1603, 
2357. HRMS: calcd. for C22H15F3O+ [M]+ = 352.1075; found = 352.1065. 
 
2-Chloro-2'-[(4-methoxyphenyl)ethynyl]-1,1'-biphenyl (135i) 
 
Following GP4, 135i (146 mg, 458 μmol, 75%) was 
prepared from 4-iodoanisole (158 mg, 675 μmol, 1.1 
equiv.), Pd(PPh3)4 (29 mg, 25 μmol, 4.1 mol%), CuI (5 
mg, 26 μmol, 4.3 mol%) and 182i (130 mg, 611 μmol) [rt, 
1 h] as a colorless oil after flash chromatography (n-hexane/EtOAc 9:1). 1H NMR (400 
MHz, CDCl3, ppm) δ = 3.79 (3H, s), 6.77 – 6.84 (2H, m), 7.17 (2H, dd, J = 8.7, 1.6 Hz), 
7.36 – 7.42 (5H, m), 7.43 – 7.47 (1H, m), 7.52 – 7.58 (1H, m), 7.63 – 7.69 (1H, m). 13C 
NMR (101 MHz, CDCl3, ppm) δ = 55.3, 87.3, 92.9, 114.0, 115.5, 123.5, 126.3, 127.7, 
127.8, 128.9, 129.4, 129.8, 131.7, 131.8, 132.9, 133.6, 139.9, 141.9, 159.6. IR (neat, cm–
1): 513, 682, 744, 829, 944, 1028, 1173, 1245, 1286, 1462, 1509, 1605, 2213, 2834, 3055. 
HRMS: calcd. for C21H15ClO+ [M]+ = 318.0811; found = 318.0815. 
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2-([1,1'-Biphenyl]-2-ylethynyl)thiophene (135o) 
Following GP4, 135o (75 mg, 288 μmol, 51%) was prepared from 2-
bromothiophene (92 mg, 564 μmol), Pd(PPh3)4 (16 mg, 14 μmol, 2.5 
mol%), CuI (5 mg, 26 μmol, 4.6 mol%) and 135f (100 mg, 561 μmol) 
[rt, 1 h] as a yellow oil after flash chromatography (n-hexane). NMR 
(400 MHz, CDCl3, ppm) δ = 6.98 (1H, dd, J = 5.1, 3.6 Hz), 7.14 (1H, 
dd, J = 3.6, 1.2 Hz), 7.23 – 7.27 (1H, m), 7.35 (1H, ddd, J = 7.6, 7.2, 1.7 Hz), 7.39 – 7.52 
(5H, m), 7.65 (1H, ddd, J = 7.6, 1.5, 0.6 Hz), 7.67 – 7.70 (2H, m). 13C NMR (101 MHz, 
CDCl3, ppm) δ = 85.8, 93.3, 121.4, 123.6, 127.1, 127.2, 127.3, 127.6, 128.1, 128.8, 129.4, 
129.6, 131.6, 132.6, 140.5, 143.8. IR (neat, cm–1): 556, 693, 733, 753, 828, 852, 1007, 
1034, 1074, 1212, 1419, 1473, 1520, 2203, 3057. HRMS: calcd. for C18H11S+ [M–H]+ = 
259.0576; found = 259.0590. 
 
2-([1,1'-Biphenyl]-2-ylethynyl)benzo[b]thiophene [135p] 
Following GP4, 135p (165 mg, 532 μmol, 83%) was prepared 
from 2-bromobenzothiophene (150 mg, 704 μmol, 1.1 equiv.), 
Pd(PPh3)4 (19 mg, 16 μmol, 2.5 mol%), CuI (6 mg, 32 mmol, 5.0 
mol%) and 135f (114 mg, 640 μmol) [rt, 3 h] as a yellow oil after 
flash chromatography (n-hexane). 1H NMR (400 MHz, CDCl3, 
ppm) δ = 7.36 – 7.44 (4H, m), 7.44 – 7.61 (5H, m), 7.72 – 7.83 (5H, m). 13C NMR (101 
MHz, CDCl3, ppm) δ = 86.0, 95.2, 121.0, 122.0, 123.5, 123.8, 124.7, 125.4, 127.2, 127.7, 
128.1, 128.3, 129.1, 129.4, 129.6, 132.8, 139.2, 140.4, 140.4, 144.1. IR (neat, cm–1): 511, 
560, 697, 723, 826, 856, 906, 1007, 1079, 1155, 1181, 1434, 1472, 2203, 3055.  
 
Methyl 3,4,5-Trimethoxy-2'-[(4-methoxyphenyl)ethynyl]-[1,1'-biphenyl]-2-carboxyla-
te (135q) 
Following GP4, 135q (43 mg, 99 μmol, 49%) was 
prepared from 4-iodoanisole (52 mg, 222 μmol, 1.1 
equiv.), Pd(PPh3)4 (6 mg, 5 μmol, 2.5 mol%), CuI (2 
mg, 11 μmol, 5.4 mol%) and 182q (66 mg, 202 
μmol) [rt, 4 h] as a yellow oil after flash 
chromatography (n-hexane/EtOAc 9:1). 1H NMR 
(400 MHz, CDCl3, ppm) δ = 3.55 (3H, s), 3.79 (3H, s), 3.84 (3H, s), 3.95 (3H, s), 3.98 (3H, 
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s), 6.77 – 6.82 (2H, m), 6.83 (1H, s), 7.20 – 7.25 (2H, m), 7.28 – 7.34 (3H, m), 7.54 – 7.59 
(1H, m). 13C NMR (101 MHz, CDCl3, ppm) δ = 52.0, 55.4, 56.3, 61.1, 62.2, 87.4, 93.2, 
110.3, 114.0, 115.6, 121.7, 122.7, 127.5, 127.7, 129.2, 132.1, 132.9, 135.8, 141.6, 142.4, 
151.8, 154.0, 159.7, 167.4. IR (neat, cm–1): 756, 831, 1027, 1106, 1245, 1272, 1344, 
1396, 1454, 1510, 1592, 1725, 2212, 2836, 2937. HRMS: calcd. for C26H24O6+ [M]+ = 
432.1573; found = 432.1577. 
3',5'-Dimethoxy-2-(phenylethynyl)-1,1'-biphenyl (135s) 
Following GP4, 135s (42 mg, 134 μmol, 64%) was prepared 
from iodobenzene (43 mg, 211 μmol), Pd(PPh3)4 (7 mg, 6 
μmol, 2.9 mol%), CuI (2 mg, 10 μmol, 4.8 mol%) and 182s 
(50 mg, 210 μmol) [rt, 2 h] as a white solid after flash 
chromatography (n-hexane/EtOAc 9:1). 1H NMR (400 MHz, 
CDCl3, ppm) δ = 3.83 (6H, s), 6.54 (1H, t, J = 2.3 Hz), 6.85 (2H, d, J = 2.3 Hz), 7.28 – 7.43 
(7H, m), 7.43 – 7.48 (1H, m), 7.63 – 7.69 (1H, m). 13C NMR (101 MHz, CDCl3, ppm) δ = 
55.5, 89.5, 92.8, 100.2, 107.6, 121.7, 123.6, 127.3, 128.3, 128.4, 128.6, 129.5, 131.5, 
133.1, 142.6, 143.9, 160.4. IR (neat, cm–1): 690, 753, 773, 1027, 1060, 1154, 1202, 1260, 
1348, 1417, 1587, 1737, 2362, 2960, 3015. HRMS: calcd. for C22H18O2+ [M]+ = 314.1307; 
found = 314.1309. 
2-{2-[(4-methoxyphenyl)ethynyl]phenyl}furan (135v) 
Following GP4, 135v (119 mg, 434 μmol, 88%) was prepared 
from 4-iodoanisole (167 mg, 714 μmmol, 1.45 equiv.), 
Pd(PPh3)4 (17 mg, 15 μmol, 3.0 mol%), CuI (5 mg, 26 μmol, 
5.3 mol%) and 182v (83 mg, 493 μmol) [rt, 1 h] as a pale 
yellow oil after flash chromatography (n-hexane/EtOAc 50/1). 
1H NMR (400 MHz, CDCl3, ppm) δ = 3.84 (3H, s), 6.57 (1H, dd, J = 3.4, 1.8 Hz), 6.90 – 
6.98 (2H, m), 7.23 – 7.29 (1H, m), 7.40 (1H, ddd, J = 7.9, 7.4, 1.4 Hz), 7.46 (1H, dd, J = 
3.5, 0.8 Hz), 7.50 – 7.58 (3H, m), 7.63 (1H, ddd, J = 7.7, 1.5, 0.5 Hz), 7.88 – 7.96 (1H, m). 
13C NMR (101 MHz, CDCl3, ppm) δ = 55.4, 88.4, 94.1, 109.5, 111.8, 114.2, 115.5, 118.7, 
125.6, 126.8, 128.4, 131.7, 133.0, 133.7, 141.9, 152.3, 159.9. IR (neat, cm–1): 528, 733, 
756, 828, 1004, 1027, 1173, 1245, 1287, 1462, 1508, 1604, 2210, 2834, 2932. HRMS: 
calcd. for C19H14O2+ [M]+ = 274.0994; found = 274.0993. 
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1-{2-[(4-methoxyphenyl)ethynyl]phenyl}-1H-pyrrole (135w) 
From 4-ethynylanisol (103 mg, 779 μmol, 1.05 equiv.), 
PdCl2(PPh3)2 (26 mg, 37 μmol, 5.0 mol%), CuI (7 mg, 37 
μmol, 5.0 mol%) and 1-(2-iodophenyl)-1H-pyrrole (200 mg, 
743 μmol) in MeCN (40 ml) [60 °C, 12 h], 135w (104 mg, 380 
μmol, 51%) was prepared as a colorless oil after flash 
chromatography (n-hexane/EtOAc 9:1). 1H NMR (300 MHz, CDCl3, ppm) δ = 3.82 (3H, s), 
6.35 (2H, t, J = 2.2 Hz), 6.81 – 6.89 (2H, m), 7.16 – 7.19 (2H, m), 7.33 – 7.41 (4H, m), 
7.61 (1H, ddd, J = 7.6, 1.6, 0.6 Hz). 13C NMR (126 MHz, CDCl3, ppm) δ = 55.5, 85.4, 94.1, 
109.2, 114.1, 115.2, 118.7, 121.9, 125.0, 126.3, 128.9, 133.0, 133.4, 141.9, 159.8. IR 
(neat, cm–1): 729, 756, 800, 1024, 1078, 1172, 1247, 1451, 1511, 1603, 1710, 2342, 2361, 
2923, 2961. HRMS: calcd. for C19H15NO+ [M]+ = 273.1154; found = 273.1162.  
1-{2-[(4-Methoxyphenyl)ethynyl]phenyl}naphthalene (135y) 
Following GP4, 135y (215 mg, 643 μmol, 85%) was 
prepared from 4-iodoanisole (178 mg, 761 μmol), 
Pd(PPh3)4 (22 mg, 19 μmol, 2.5 mol%), CuI (7 mg, 37 
μmol, 4.9 mol%) and 182y (173 mg, 758 μmol) [rt, 3 h] 
as a pale yellow oil after flash chromatography (n-
hexanes/EtOAc 9:1). 1H NMR (600 MHz, CDCl3, ppm) δ = 3.72 (3H, s), 6.59 – 6.67 (2H, 
m), 6.67 – 6.74 (2H, m), 7.37 – 7.52 (6H, m), 7.55 (1H, dd, J = 8.2, 7.0 Hz), 7.63 – 7.69 
(1H, m), 7.71 (1H, dd, J=8.5, 1.0 Hz), 7.88 – 7.96 (2H, m). 13C NMR (126 MHz, CDCl3, 
ppm) δ = 55.4, 87.9, 93.2, 113.7, 115.4, 124.1, 125.2, 125.7, 125.9, 126.6, 127.4, 127.5, 
127.8, 127.9, 128.1, 130.6, 131.7, 132.0, 132.7, 133.6, 139.1, 143.0, 159.4. IR (neat, cm–
1): 524, 756, 776, 801, 830, 1027, 1173, 1243, 1286, 1508, 1604, 1733, 2213, 2834, 3054. 
HRMS: calcd. for C25H18O+ [M]+ = 334.1358; found = 334.1351. 
2-[(4-Methoxyphenyl)ethynyl]-1,1'-binaphthalene (135z) 
Following GP4, 135z (165 mg, 429 μmol, 96%) was 
prepared from 4-iodoanisole (126 mg, 538 μmol, 1.2 
equiv.), Pd(PPh3)4 (13 mg, 11 μmol, 2.4 mol%), CuI (4 
mg, 21 μmol, 4.7 mol%) and 182z (125 mg, 449 μmol) 
[rt, 12 h] as a white solid after flash chromatography (n-
hexane/EtOAc 25:1). 1H NMR (400 MHz, CDCl3, ppm) δ = 3.73 (3H, s), 6.64 – 6.70 (2H, 
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m), 6.74 – 6.79 (2H, m), 7.32 (2H, ddd, J = 8.4, 6.7, 1.3 Hz), 7.41 (2H, dddt, J = 8.5, 2.9, 
1.4, 0.8 Hz), 7.50 (2H, dddd, J = 8.1, 6.7, 3.8, 1.3 Hz), 7.57 (1H, dd, J = 7.0, 1.3 Hz), 7.67 
(1H, dd, J = 8.2, 7.0 Hz), 7.77 (1H, d, J = 8.5 Hz), 7.92 – 7.96 (2H, m), 7.99 – 8.06 (2H, 
m). 13C NMR (101 MHz, CDCl3, ppm) δ = 55.3, 88.6, 94.0, 113.8, 115.4, 121.9, 125.5, 
125.9, 126.1, 126.4, 126.5, 126.7, 126.9, 127.9, 128.1, 128.1, 128.2, 128.3, 128.5, 132.8, 
132.8, 133.0, 133.1, 133.7, 137.2, 141.1, 159.5. IR (neat, cm–1): 627, 746, 779, 817, 1028, 
1174, 1243, 1284, 1508, 1590, 1603, 2205, 2535, 2833, 3052. HRMS: calcd. for C29H20O+ 
[M]+ = 384.1514; found = 384.1523. 
1-Methoxy-4-(5-phenylpent-1-yn-1-yl)benzene (102au) 
Following GP4, compound 102au (289 mg, 1.15 mmol, 
58%) was prepared from 4-iodoanisole (509 mg, 2.17 
mmol, 1.1 equiv.), PdCl2(PPh3)2 (69 mg, 98 μmol, 4.9 
mmol), CuI (190 mg, 100 μmol, 5.0 mol%) and 4-
pentynylbenzene (285 mg, 1.98 mmol) [rt, 50 min] as a yellow oil after flash 
chromatography (n-hexane/EtOAc 9:1). 1H NMR (400 MHz, CDCl3, ppm) δ = 1.93 (2H, dt, 
J = 14.6, 7.1 Hz), 2.42 (2H, t, J = 7.0 Hz), 2.77 – 2.84 (2H, m), 3.81 (3H, s), 6.80 – 6.87 
(2H, m), 7.20 – 7.26 (3H, m), 7.28 – 7.34 (2H, m), 7.34 – 7.39 (2H, m). 13C NMR (101 
MHz, CDCl3, ppm) δ = 19.0, 30.6, 35.0, 55.4, 81.0, 88.3, 114.0, 116.3, 126.0, 128.5, 
128.7, 133.0, 141.9, 159.2. IR (neat, cm–1): 535, 698, 743, 830, 1030, 1105, 1170, 1242, 
1287, 1454, 1507, 1604, 1737, 2834, 2933. HRMS: calcd. for C18H18O+ [M]+ = 250.1358; 
found = 250.1357.  
1-Benzyl-2-[(4-methoxyphenyl)ethynyl]benzene (102av) 
Following GP4, 102av (104 mg, 349 μmol, 72%) was 
prepared from 1-benzyl-2-iodobenzene (142 mg, 483 
μmol), Pd(PPh3)4 (14 mg, 12 μmol, 2.5 mol%), CuI (4 
mg, 21 μmol, 4.3 mol%) and 4-ethynylanisol (77 mg, 583 
μmol, 1.21 equiv.) [rt, 3 h] as a white solid after flash 
chromatography (n-hexane). 1H NMR (400 MHz, CDCl3, ppm) δ = 3.80 (3H, s), 4.23 (2H, 
s), 6.81 – 6.89 (2H, m), 7.12 – 7.29 (8H, m), 7.35 – 7.44 (2H, m), 7.51 (1H, ddd, J = 7.0, 
1.9, 0.7 Hz). 13C NMR (75 MHz, CDCl3, ppm) δ = 40.5, 55.4, 87.2, 93.5, 114.1, 115.7, 
123.4, 126.2, 126.3, 128.3, 128.5, 129.1, 129.5, 132.2, 133.1, 140.8, 143.0, 159.7. IR 
(neat, cm–1): 529, 696, 728, 756, 829, 906, 1028, 1173, 1245, 1285, 1451, 1509, 1604, 
2358, 2835. HRMS: calcd. for C22H18O+ [M]+ = 298.1358; found = 298.1357. 
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1-Bromo-2-[(4-methoxyphenyl)ethynyl]benzene (102aw)  
Following GP4, 102aw (503 mg, 1.75 mmol, 99%) was 
prepared from 1,2-bromoiodobenzene (500 mg, 1.77 mmol), 
Pd(PPh3)4 (51 mg, 44 μmol, 3.7 mol%), CuI (15 mg, 79 μmol, 
6.7 mol%) and 4-ethynylanisol (233 mg, 1.76 mmol) [rt, 3 h]. A 
white solid was obtained after flash chromatography (n-hexane/EtOAc 9:1). 1H NMR (400 
MHz, CDCl3, ppm) δ = 3.84 (3H, s), 6.85 – 6.93 (2H, m), 7.16 (1H, ddd, J = 8.1, 7.5, 1.7 
Hz), 7.24 – 7.31 (1H, m), 7.48 – 7.56 (3H, m), 7.61 (1H, dd, J = 8.1, 1.2 Hz). 13C NMR 
(101 MHz, CDCl3, ppm) δ = 55.5, 87.0, 94.2, 114.2, 115.2, 125.6, 125.9, 127.1, 129.1, 
132.5, 133.2, 133.3, 160.1. IR (neat, cm–1): 520, 533, 673, 756, 836, 1022, 1107, 1174, 
1247, 1290, 1435, 1508, 1602, 2360, 2963. HRMS: calcd. for C15H11BrO+ [M]+ = 285.9993; 
found = 285.9992.  
 
N-(Cyclohex-2-en-1-yl)-N-(3-(4-methoxyphenyl)prop-2-yn-1-yl)-4-methylbenzenesul-
fonamide (170a) 
Following GP4, 170a (166 mg, 420 μmol, 81%) was 
prepared from 4-iodoanisole (146 mg, 624 μmol, 1.2 equiv.), 
Pd(PPh3)4 (15 mg, 13 μmol, 2.5 mol%), CuI (4 mg, 21 μmol, 
4.1 mol%) and N-(2-cyclohexen-1-yl)-4-methyl-N-(2-propyn-
1-yl)benzenesulfonamide (150 mg, 518 μmol) [rt, 90 min]. A white solid was obtained after 
flash chromatography (n-hexane/EtOAc 5:1). 1H NMR (400 MHz, CDCl3, ppm) δ =  1.74 – 
1.87 (3H, m), 1.93 – 2.07 (2H, m), 2.36 (3H, s), 3.80 (3H, d, J = 0.7 Hz), 4.08 – 4.40 (2H, 
m), 4.57 (1H, td, J = 5.5, 2.7 Hz), 5.42 (1H, dd,  J = 10.2, 2.3 Hz), 5.77 – 5.99 (1H, m), 
6.73 – 6.85 (2H, m), 7.09 – 7.24 (4H, m), 7.78 – 7.90 (2H, m). 13C NMR (101 MHz, CDCl3, 
ppm) δ = 21.6, 21.6, 24.6, 28.1, 33.8, 55.2, 55.4, 84.0, 84.6, 113.9, 115.0, 127.6, 127.6, 
129.5, 132.9, 133.0, 138.5, 143.1, 159.7. IR (neat, cm–1): 542, 582, 647, 665, 726, 907, 
1031, 1094, 1157, 1246, 1333, 1508, 1605, 2359, 2933. HRMS: calcd. for C23H25NO3S+ 
[M]+ = 395.1555; found = 395.1560.  
1-Methoxy-4-(4-phenylbut-1-yn-1-yl)benzene (170b) 
Following GP4, 170b (349 mg, 1.48 mmol, 96%) was 
prepared from 4-iodoanisole (360 mg, 1.54 mmol), 
PdCl2(PPh3)2 (49 mg, 70 μmol, 6.1 mol%), CuI (13 mg, 68 
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μmol, 5.9 mol%) and 3-butynylbenzene (200 mg, 1.54 mmol) [rt, 24 h] as a white solid 
after flash chromatography (n-hexane/EtOAc 9:1). 1H NMR (400 MHz, CDCl3, ppm) δ = 
2.66 (2H, t, J = 7.5 Hz), 2.90 (2H, t, J = 7.6 Hz), 3.78 (3H, s), 6.77 – 6.82 (2H, m), 7.23 – 
7.32 (7H, m). 13C NMR (101 MHz, CDCl3, ppm) δ = 21.8, 35.5, 55.4, 81.2, 88.0, 114.0, 
116.2, 126.4, 128.5, 128.7, 133.0, 141.0, 159.2. IR (neat, cm–1): 506, 697, 746, 830, 1030, 
1172, 1241, 1287, 1453, 1485, 1508, 1605, 2833, 2930, 3025. HRMS: calcd. for C17H16O+ 
[M]+ = 236.1201; found = 236.1202.  
1-Methoxy-4-(3-phenoxyprop-1-yn-1-yl)benzene (170c) 
Following GP4, 170c (475 mg, 1.99 mmol, 85%) was prepared 
from 4-iodoanisole (602 mg, 2.57 mmol, 1.1 equiv.), 
PdCl2(PPh3)2 (82 mg, 117 μmol, 5.0 mol%), CuI (22 mg, 116 
μmol, 5.0 mol%) and (2-propynyloxy)benzene (309 mg, 2.34 
mmol) [rt, 1 h] as white crystals after flash chromatography (n-hexane/EtOAc 9:1). 1H 
NMR (400 MHz, CDCl3, ppm) δ = 3.80 (3H, s), 4.96 (2H, s), 6.83 – 6.94 (2H, m), 7.03 – 
7.18 (3H, m), 7.35 – 7.44 (2H, m), 7.44 – 7.51 (2H, m). 13C NMR (101 MHz, CDCl3, ppm) 
δ = 55.1, 56.6, 82.7, 87.1, 113.9, 114.3, 114.9, 121.3, 129.4, 133.3, 157.9, 159.9. IR 
(neat, cm–1): 533, 756, 837, 1023, 1107, 1176, 1247, 1290, 1440, 1462, 1507, 1602, 2217, 
2837, 2965. HRMS: calcd. for C16H14O2+ [M]+ = 238.0994; found = 238.0999. 
 
2,2'-Bis[(4-methoxyphenyl)ethynyl]-1,1'-biphenyl (190) 
Following GP4, 190 (130 mg, 314 μmol, 
65%) was prepared from 4-iodoanisole 
(454 mg, 1.94 mmol, 4.0 equiv.), 
Pd(PPh3)4 (28 mg, 24 μmol, 2.5 mol%), 
CuI (8 mg, 42 μmol, 4.3 mol%) and 2,2'-
diethynyl-1,1'-biphenyl (98 mg, 485 μmol) [rt, 12 h] as a yellow solid (130 mg, 0.31 mmol, 
65%) after flash chromatography (n-hexane/toluene 1/1). 1H NMR (400 MHz, CDCl3, ppm) 
δ = 3.77 (3H, s), 6.72 – 6.83 (2H, m), 7.11 – 7.21 (2H, m), 7.31 – 7.44 (2H, m), 7.51 – 7.60 
(1H, m), 7.60 – 7.68 (1H, m). 13C NMR (101 MHz, CDCl3, ppm) δ = 55.4, 88.0, 92.6, 
114.0, 115.8, 123.3, 127.4, 127.4, 130.5, 131.9, 132.9, 143.1, 159.5. IR (neat, cm–1): 756, 
831, 1028, 1106, 1173, 1247, 1287, 1439, 1463, 1510, 1604, 1656, 2213, 2361, 2835. 
HRMS: calcd. for C30H22O2+ [M]+ = 414.1620; found = 414.1619. 
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1,7-bis(4-methoxyphenyl)hepta-1,6-diyne (193) 
Following GP4, 193 (912 mg, 3.00 mmol, 92%) was prepared 
from 4-iodoanisole (1.679 g, 7.17 mmol, 2.2 equiv.), Pd(PPh3)4 
(188 mg, 163 μmol, 2.5 mol%), CuI (56 mg, 294 μmol, 4.5 mol%) 
and hepta-1,6-diyne (300 mg, 3.26 mmol, 1.0 equiv.) [rt for 3 h] 
as a white solid after flash chromatography (n-hexane/EtOAc 
9:1). 1H NMR (400 MHz, CDCl3, ppm) δ = 1.90 (2H, d, J = 7.1 Hz), 2.58 (4H, t, J = 7.0 Hz), 
3.80 (6H, s), 6.75 – 6.91 (4H, m), 7.30 – 7.40 (4H, m). 13C NMR (101 MHz, CDCl3, ppm) δ 
= 18.8, 28.3, 55.3, 81.0, 87.7, 113.9, 116.1, 133.0, 159.2. IR (neat, cm–1): 538, 823, 836, 
1030, 1107, 1172, 1216, 1231, 1286, 1366, 1439, 1508, 1604, 1738, 2362.  
 
6.3.1.3. Alkynes 135 by Suzuki-Miyaura coupling. 
 
 
Scheme 125. Suzuki-Miyaura cross-coupling with bromotolanes 102aw. 
 
 
General procedure GP5: Following the reported procedure,[135] a round-bottomed flask 
was charged with PdCl2(PPh3)2 (5 mol%), arylboronic acid (1.3 equiv.), arylbomide 
102aw (1.0 equiv.), Na2CO3 (2.0 equiv.) and previously degassed mixture of 
toluene/EtOH/H2O (2:1:1) of (ĉ ~ 0.005 M with respect to 102aw). The reaction mixture 
was placed into an oil bath preheated to 70 °C and stirred at this temperature for 3 h. 
The mixture was cooled down to room temperature, diluted with EtOAC and H2O (10 ml 
each). The organic layer was dried (Na2CO3), the solvent evaporated and the residue 
purified by column chromatography. 
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{2'-[(4-Methoxyphenyl)ethynyl]-[1,1'-biphenyl]-4-yl}trimethylsilane (135l) 
Following GP5, 135l (58 mg, 163 μmol, 62%) was prepared 
from 102aw (76 mg, 265 μmol), 4-trimethylsilylphenylboronic 
acid (66 mg, 340 μmol), PdCl2(PPh3)2 (9 mg, 12.8 μmol, 4.8 
mol%) and Na2CO3 (56 mg, 528 μmol) as a colorless oil after 
flash chromatography (n-hexane/EtOAc 9:1). 1H NMR (400 
MHz, CDCl3, ppm) δ = 0.35 (9H, s), 3.82 (3H, s), 6.80 – 6.86 
(2H, m), 7.24 – 7.30 (2H, m), 7.33 (1H, td, J = 7.4, 1.6 Hz), 7.39 (1H, td, J = 7.5, 1.6 Hz), 
7.45 (1H, ddd, J = 7.7, 1.6, 0.6 Hz), 7.61 – 7.66 (3H, m), 7.66 – 7.73 (2H, m). 13C NMR 
(101 MHz, CDCl3, ppm) δ = 55.4, 88.3, 92.5, 114.0, 115.8, 122.1, 127.2, 128.3, 128.8, 
129.5, 132.7, 132.9, 133.0, 139.5, 141.2, 143.7, 159.6. IR (neat, cm–1): 534, 752, 822, 
1028, 1116, 1173, 1244, 1286, 1439, 1463, 1509, 1604, 1738, 2213, 2952. HRMS: calcd. 
for C24H24OSi+ [M]+ = 356.1596; found = 356.1597. 
4'-(Bromomethyl)-2-[(4-methoxyphenyl)ethynyl]-1,1'-biphenyl (135m) 
Following GP5, 135m (29 mg, 77 μmol, 22%) was prepared 
from 102aw (100 mg, 348 μmol), 4-
(bromomethyl)phenylboronic acid (97 mg, 451 μmol), 
PdCl2(PPh3)2 (12 mg, 17 μmol, 4.9 mol%) and Na2CO3 (74 
mg, 698 μmol) as a yellow oil after flash chromatography (n-
hexane/EtOAc 9:1). 1H NMR (400 MHz, CDCl3, ppm) δ = 
3.77 (3H, s), 4.56 (2H, s), 6.74 – 6.83 (2H, m), 7.16 – 7.47 (8H, m), 7.60 – 7.66 (2H, m). 
13C NMR (101 MHz, CDCl3, ppm) δ = 65.9, 72.7, 88.2, 92.4, 114.1, 115.8, 122.0, 127.1, 
127.3, 128.3, 129.5, 129.6, 132.8, 132.9, 137.9, 140.1, 143.5, 159.7. IR (neat, cm–1): 534, 
731, 756, 829, 1027, 1094, 1173, 1245, 1285, 1508, 1604, 2212, 2853, 2927, 2970.  
6.3.1.4. Bromination of terminal alkynes. 
2-(Bromoethynyl)-1,1'-biphenyl (135t) 
Following the published procedure,[144] to a solution of 135f (100 mg, 
561 μmol, 1.0 equiv.) in acetone (30 ml) were added NBS (120 mg, 674 
μmol, 1.2 equiv.) and AgNO3 (10 mg, 59 μmol, 0.11 equiv.) and the 
resulting mixture was stirred at room temperature for 1 h. After 
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completion of the reaction, the reaction mixture was filtered and the filtrate was 
concentrated in vacuum. The crude product was purified by column chromatography (n-
hexane) affording 135t as a colorless oil (79 mg, 307 μmol, 55%). 1H NMR (400 MHz, 
CDCl3, ppm) δ = 7.28 – 7.34 (1H, m), 7.37 – 7.43 (3H, m), 7.44 – 7.49 (2H, m), 7.57 – 
7.62 (3H, m). 13C NMR (101 MHz, CDCl3, ppm) δ = 52.3, 79.7, 121.0, 127.0, 127.6, 128.1, 
128.9, 129.1, 129.6, 133.7, 140.1, 144.4. IR (neat, cm–1): 696, 734, 914, 1007, 1073, 
1159, 1430, 1448, 1472, 1592, 1762, 2193, 2363, 3020, 3055. HRMS: calcd. for C14H9Br+ 
[M]+ = 255.9888; found = 255.9889.  
6.3.1.5. Thioalkynes. 
([1,1'-Biphenyl]-2-ylethynyl)(4-bromobutyl)sulfane (135u) 
Following the literature procedure,[145] 135t (58 mg, 226 
µmol) was solved in tetrahydrothiophene (1 mL) and 
heated at 120 °C under microwave irradiation for 3 h. The 
reaction mixture was concentrated and purified by column 
chromatography (n-hexane/EtOAc 9:1) affording 135u as a 
yellow oil (44 mg, 127 µmol, 56%). 1H NMR (400 MHz, CDCl3, ppm) δ = 1.62 – 1.74 (2H, 
m), 1.87 (2H, tt, J = 8.5, 6.5 Hz), 2.62 (2H, t, J = 7.0 Hz), 3.30 (2H, t, J = 6.7 Hz), 7.32 – 
7.45 (6H, m), 7.47 – 7.51 (1H, m), 7.53 – 7.57 (2H, m). 13C NMR (101 MHz, CDCl3, ppm) 
δ = 27.7, 31.0, 32.9, 34.5, 81.7, 93.2, 121.9, 127.1, 127.4, 127.9, 128.1, 129.2, 129.5, 
132.3, 140.7, 143.5. IR (neat, cm–1): 562, 697, 731, 753, 908, 1007, 1073, 1236, 1270, 
1305, 1430, 1471, 2163, 2934, 3057. HRMS: calcd. for C18H17BrS+ [M]+ = 344.0234; found 
= 344.0227. 
 
6.3.2. Synthesis of new products. 
6.3.2.1. Cyanative cyclizations. 
 
Scheme 126. Cyanative cyclization procedure. 
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Method A: A dry Schlenk flask was charged with the corresponding alkyne (1.0 equiv.) 
and reagent 122b (1.2 equiv.). The mixture was suspended in DCM (ĉ ~ 0.05 M with 
respect to alkyne) and a cooled down to 0 °C. Under stirring, 2,6-di-tert-butylpyridine 
(178) (1.0 equiv.) and a DCM solution of BCl3 (1.0 M, 1.2 equiv.) were successively 
added to the suspension in one portion. The reaction mixture was stirred at 0 °C for 1 h. 
All volatiles were removed under reduced pressure and then in high vacuum, and the 
remaning solid was washed with ethylacetate, filtered through a Silica pad and 
concentrated in vacuo. The mixture was further purified by column chromatography (n-
hexane/ethylacetate) affording the corresponding product. 
10-(p-Tolyl)phenanthrene-9-carbonitrile (136b) 
Following Method A, 136b (43 mg, 147 µmmol, 51%) was 
prepared from 135b (77 mg, 287 µmol), 122b (162 mg, 342 
µmol), 2,6-di-tert-butylpyridine 178 (55 mg, 287 µmol) and 
trichloroborane (0.34 ml, 1 M in DCM, 340 µmol) in DCM (5.7 
ml) as a a white solid after flash chromatography (n-
hexane/EtOAc 9:1). 1H NMR (300 MHz, CDCl3, ppm) δ = 2.51 (3H, s), 7.40 (4H, s), 
7.57 (1H, ddd, J = 8.2, 6.9, 1.2 Hz), 7.72 – 7.83 (4H, m), 8.38 (1H, dt, J = 8.0, 2.9 Hz), 
8.77 (2H, dd, J = 8.7, 3.9 Hz). 13C NMR (126 MHz, CDCl3, ppm) δ = 21.7, 109.7, 117.5, 
123.0, 126.5, 127.4, 128.0, 128.3, 128.9, 129.0, 129.4, 129.7, 129.9, 130.4, 131.8, 
134.1, 138.9, 147.6. IR (neat, cm–1): 419, 525, 724, 757, 814, 856, 1018, 1372, 1446, 
1948, 2054, 2148, 2217, 2381, 3789. HRMS: calcd. for C22H15N+ [M]+ = 293.1204; 
found = 293.1202. 
10-(p-Tolyl)-4-(trifluoromethyl)phenanthrene-9-carbonitrile (136g) 
Following Method A, 136g (29 mg, 80 µmol, 52%) was 
prepared from 135g (52 mg, 155 µmol), 122b (88 mg, 0.19 
mmol), 2,6-di-tert-butylpyridine 178 (30 mg, 157 µmol) and 
trichloroborane (0.19 ml, 1 M in DCM, 190 µmol) in DCM (3 
ml) as a a pale yellow solid after flash chromatography (n-
hexane/EtOAc 9:1). 1H NMR (400 MHz, CDCl3, ppm) δ = 2.51 (3H, s), 7.31 – 7.44 (4H, 
m), 7.62 (1H, t, J = 7.9 Hz), 7.71 – 7.79 (1H, m), 7.83 (1H, t, J = 7.5 Hz), 7.93 (1H, d, J = 
8.2 Hz), 8.21 (1H, d, J = 7.5 Hz), 8.42 (1H, d, J = 7.9 Hz), 8.80 (1H, d, J = 8.6 Hz). 13C 
NMR (126 MHz, CDCl3, ppm) δ = 21.6, 111.4, 117.0, 125.4 (q, J = 289.8 Hz), 126.0, 
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126.1, 127.4, 128.0, 128.85 (q, J = 8.1 Hz), 129.3, 129.7, 130.0, 130.0, 130.27 (q, J = 6.9 
Hz), 130.7, 132.4, 133.0, 133.9, 139.3, 147.0.19F NMR (376 MHz, CDCl3, ppm) δ = –54.0. 
IR (neat, cm–1): 508, 723, 756, 815, 1033, 1104, 1120, 1165, 1284, 1314, 1438, 1511, 
2221, 2920, 3060. HRMS: calcd. for C23H14F3N+ [M]+ = 361.1078; found = 361.1088. 
10-(4-Methoxyphenyl)-4-(trifluoromethyl)phenanthrene-9-carbonitrile (136h) 
Following Method A, 136h (58 mg, 154 µmol, 67%) was 
prepared from 135h (81 mg, 230 µmol), 122b (131 mg, 276 
µmol), 2,6-di-tert-butylpyridine (178) (44 mg, 230 µmol) and 
trichloroborane (0.28 ml, 1 M in DCM, 280 µmol) in DCM (3 
ml) as a white solid after flash chromatography (n-
hexane/EtOAc 9:1). 1H NMR (400 MHz, CDCl3, ppm) δ = 3.93 (3H, s), 7.07 – 7.18 (2H, 
m), 7.31 – 7.44 (2H, m), 7.63 (1H, t, J = 7.9 Hz), 7.74 (1H, ddd, J = 8.5, 7.0, 1.5 Hz), 7.78 
– 7.90 (1H, m), 7.96 (1H, d, J = 8.1 Hz), 8.21 (1H, d, J = 7.4 Hz), 8.42 (1H, dd, J = 8.1, 1.4 
Hz), 8.79 (1H, d, J = 8.5 Hz). 13C NMR (101 MHz, CDCl3, ppm) δ = 55.5, 111.6, 114.5, 
117.0, 125.3 (q, J = 315.0 Hz), 126.1, 126.5, 126.8, 126.9, 127.3, 128.0, 128.74 – 128.96 
(m), 129.3, 130.03 – 130.37 (m), 130.7, 131.5, 132.6, 132.9, 146.7, 160.4. 19F NMR (376 
MHz, CDCl3, ppm) δ = –53.9. IR (neat, cm–1): 562, 697, 731, 753, 908, 1007, 1236, 1270, 
1430, 1471, 1591, 2163, 2933, 2959, 3057. HRMS: calcd. for C23H14F3NO+ [M]+ = 
377.1027; found = 377.1026. 
4-Chloro-10-(4-methoxyphenyl)phenanthrene-9-carbonitrile (136i) 
Following Method A, 136i (75 mg, 218 µmol, 86%) was 
prepared from 135i (81 mg, 254 µmol), 122b (145 mg, 305 
µmol), 2,6-di-tert-butylpyridine (178) (49 mg, 256 µmol) and 
trichloroborane (0.31 ml, 1 M in DCM, 310 µmol) in DCM (5 
ml) as white crystals after flash chromatography (n-
hexane/EtOAc 9:1). 1H NMR (400 MHz, CDCl3, ppm) δ = 3.93 (3H, s), 7.11 (2H, d, J = 8.2 
Hz), 7.41 (3H, dd, J = 23.2, 8.1 Hz), 7.65 – 7.89 (4H, m), 8.42 (1H, d, J = 8.5 Hz), 9.90 
(1H, d, J = 8.3 Hz). 13C NMR (101 MHz, CDCl3, ppm) δ = 55.5, 111.6, 114.4, 117.2, 126.3, 
126.9, 127.2, 127.7, 128.5, 128.7, 129.0, 129.3, 129.3, 129.9, 131.3, 131.9, 133.5, 133.7, 
147.0, 160.3. IR (neat, cm–1): 545, 583, 717, 753, 767, 791, 810, 863, 1020, 1176, 1259, 
1291, 1510, 1609, 2218. HRMS: calcd. for C22H14ClNO+ [M]+ = 343.0764; found = 
343.0760. 
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10-(4-Methoxyphenyl)-2-(trimethylsilyl)phenanthrene-9-carbonitrile (136l) 
Following Method A, 136l (17 mg, 45 µmol, 56%) was prepared 
from 135l (29 mg, 81 µmol), 122b (46 mg, 97 µmol), 2,6-di-tert-
butylpyridine (178) (16 mg, 84 µmol) and trichloroborane (0.10 
ml, 1 M in DCM,100 µmol) in DCM (2 ml) as a white solid after 
flash chromatography (n-hexane/toluene 5:1). 1H NMR (300 
MHz, CDCl3, ppm) δ = 0.26 (9H, s), 3.95 (3H, s), 7.09 – 7.16 
(2H, m), 7.42 – 7.49 (2H, m), 7.73 – 7.80 (2H, m), 7.89 – 7.96 (2H, m), 8.35 – 8.41 (1H, 
m), 8.71 – 8.79 (2H, m). 13C NMR (101 MHz, CDCl3, ppm) δ = -1.0, 55.5, 109.6, 114.1, 
117.7, 122.0, 123.0, 126.5, 127.9, 128.4, 129.1, 129.2, 129.6, 129.7, 131.4, 132.1, 133.8, 
134.2, 140.1, 147.5, 160.1. IR (neat, cm–1): 722, 754, 791, 1020, 1088, 1172, 1247, 1288, 
1369, 1448, 1511, 1606, 2217, 2922, 2960. HRMS: calcd. for C25H23NOSi+ [M]+ = 
381.1549; found = 381.1553. 
10-(Thiophen-2-yl)phenanthrene-9-carbonitrile (136o) 
Following Method A, 136o (16 mg, 56 µmol, 22%) was prepared from 
135o (66 mg, 254 µmol), 122b (145 mg, 306 µmol), 2,6-di-tert-
butylpyridine (178) (49 mg, 256 µmol) and trichloroborane (0.30 ml, 1 M 
in DCM, 300 µmol) in DCM (5 ml) as a white solid after flash 
chromatography (n-hexane/EtOAc 9:1). 1H NMR (400 MHz, CDCl3, 
ppm) δ = 7.29 (1H, dd, J = 5.1, 3.5 Hz), 7.34 (1H, dd, J = 3.5, 1.2 Hz), 7.57 – 7.67 (2H, m), 
7.72 – 7.85 (3H, m), 7.95 (1H, ddd, J = 8.3, 1.4, 0.6 Hz), 8.32 – 8.44 (1H, m), 8.68 – 8.78 
(2H, m). 13C NMR (101 MHz, CDCl3, ppm) δ = 111.9, 117.0, 122.9, 123.1, 126.8, 127.5, 
127.8, 128.1, 128.5, 128.6, 128.6, 128.9, 129.8, 130.1, 130.1, 130.9, 131.7, 136.7, 140.0. 
IR (neat, cm–1): 512, 615, 712, 753, 854, 1042, 1160, 1233, 1369, 1443, 2165, 2212, 
2342, 2360, 2919. HRMS: calcd. for C19H11NS+ [M]+ = 285.0612; found = 258.0619. 
10-(Benzo[b]thiophen-2-yl)phenanthrene-9-carbonitrile (136p) 
Following Method A, 136p (16 mg, 48 µmol, 15%) was prepared 
from 135p (97 mg, 312 µmol), 122b (178 mg, 375 µmol), 2,6-di-
tert-butylpyridine (178) (60 mg, 314 µmol) and trichloroborane 
(0.38 ml, 1 M in DCM, 380 µmol) in DCM (6 ml) as a white solid 
after flash chromatography (n-hexane/EtOAc 9:1). 1H NMR (300 
MHz, CDCl3, ppm) δ = 7.41 – 7.51 (2H, m), 7.57 (1H, d, J = 0.7 Hz), 7.62 (1H, ddd, J = 
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8.3, 7.0, 1.2 Hz), 7.76 – 7.87 (3H, m), 7.88 – 7.98 (2H, m), 8.02 (1H, ddd, J = 8.3, 1.4, 0.6 
Hz), 8.37 – 8.46 (1H, m), 8.74 – 8.84 (2H, m). 13C NMR (126 MHz, CDCl3, ppm) δ = 111.9, 
116.9, 122.4, 123.0, 123.1, 124.4, 124.9, 125.3, 126.9, 127.0, 127.9, 128.7, 128.7, 128.8, 
128.9, 129.9, 130.3, 130.6, 131.7, 137.3, 139.7, 139.9, 141.3. IR (neat, cm–1): 698, 722, 
756, 794, 864, 1012, 1076, 1258, 1446, 1509, 1603, 1729, 2220, 2922, 2961. HRMS: 
calcd. for C23H13NS+ [M]+ = 335.0769; found = 335.0768. 
1,3-Dimethoxy-10-phenylphenanthrene-9-carbonitrile (136s) 
Following Method A, 136s (16 mg, 47 µol, 42%) was prepared 
from 135s (35 mg, 111 µmol), 122b (63 mg, 139 µmol), 2,6-di-
tert-butylpyridine (178) (21 mg, 110 µmol) and trichloroborane 
(0.13 ml, 1 M in DCM, 130 µmol) in DCM (2 ml) as a white solid 
after flash chromatography (n-hexane/EtOAc 9:1). 1H NMR (400 
MHz, CDCl3, ppm) δ = 3.82 (3H, s), 3.93 (3H, s), 6.49 (1H, d, J = 2.2 Hz), 6.70 (1H, d, J = 
2.3 Hz), 7.26 (5H, s), 7.36 – 7.45 (3H, m), 7.62 – 7.67 (1H, m). 13C NMR (101 MHz, 
CDCl3, ppm) δ = 55.9, 56.3, 88.3, 93.4, 95.2, 97.9, 107.9, 116.2, 122.5, 123.3, 128.4, 
128.4, 128.5, 128.7, 129.6, 131.5, 132.8, 140.5, 147.6, 163.3, 163.4. IR (neat, cm–1): 609, 
796, 831, 1027, 1105, 1174, 1247, 1512, 1604, 2218, 2342, 2361, 2849, 2917, 2961. 
HRMS: calcd. for C23H17NO2+ [M]+ = 339.1259; found = 339.1263. 
10-[(4-Bromobutyl)thio]phenanthrene-9-carbonitrile (136u) 
Following Method A, 136u (40 mg, 108 µmol, 86%) was 
prepared from 135u (43 mg, 125 µmol), 122b (71 mg, 150 
µmol), 2,6-di-tert-butylpyridine (178) (24 mg, 125 µmol) and 
trichloroborane (0.15 ml, 1 M in DCM, 150 µmol) in DCM (2.5 
ml) as a white solid after flash chromatography (n-
hexane/EtOAc 9:1). 1H NMR (400 MHz, CDCl3, ppm) δ = 1.76 (2H, tt, J = 9.7, 6.2 Hz), 
1.95 – 2.11 (2H, m), 3.08 (2H, t, J = 7.1 Hz), 3.38 (2H, t, J = 6.6 Hz), 7.66 – 7.90 (4H, m), 
8.27 – 8.39 (1H, m), 8.63 – 8.74 (2H, m), 8.74 – 8.84 (1H, m). 13C NMR (101 MHz, CDCl3, 
ppm) δ = 28.4, 31.5, 33.0, 36.6, 117.0, 118.1, 123.1, 123.4, 126.7, 128.2, 128.6, 128.9, 
129.4, 130.0, 130.3, 131.4, 132.0, 140.6. IR (neat, cm–1): 554, 721, 752, 801, 919, 974, 
1021, 1095, 1233, 1276, 1443, 1484, 2220, 2927, 3074. HRMS: calcd. for C19H16BrNS+ 
[M]+ = 369.0187; found = 369.0187. 
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6-(4-Methoxyphenyl)benzo[c]phenanthrene-5-carbonitrile (136y) 
Following Method A, 136y (61 mg, 170 µmol, 97%) was 
prepared from 135y (59 mg, 176 µmol), 122b (101 mg, 213 
µmol), 2,6-di-tert-butylpyridine (178) (33 mg, 172 µmol) and 
trichloroborane (0.21 ml, 1 M in DCM, 210 µmol) in DCM (3.5 
ml) as white crystals after flash chromatography (n-
hexane/EtOAc 9:1). 1H NMR (400 MHz, CDCl3, ppm) δ = 3.94 (3H, s), 7.08 – 7.19 (2H, 
m), 7.38 – 7.50 (2H, m), 7.66 (1H, d, J = 8.8 Hz), 7.69 – 7.89 (5H, m), 7.97 – 8.08 (1H, m), 
8.44 – 8.55 (1H, m), 9.00 – 9.13 (2H, m). 13C NMR (101 MHz, CDCl3, ppm) δ = 55.5, 
109.7, 114.3, 117.8, 124.9, 126.2, 126.8, 127.3, 127.8, 128.0, 128.0, 128.5, 128.7, 129.1, 
129.2, 129.4, 129.5, 129.6, 130.8, 130.9, 131.7, 134.4, 146.4, 160.2. IR (neat, cm–1): 666, 
754, 767, 798, 839, 1025, 1065, 1244, 1382, 1510, 1738, 2215, 2361, 2969, 3674. HRMS: 
calcd. for C26H17NO+ [M]+ = 359.1310; found = 359.1307. 
4-(4-Methoxyphenyl)dibenzo[c,g]phenanthrene-3-carbonitrile (136z) 
Following Method A, 136z (42 mg, 103 µmol, 71%) was 
prepared from 135z (56 mg, 146 µmol), 122b (83 mg, 175 
µmol), 2,6-di-tert-butylpyridine (178) (28 mg, 146 µmol) and 
trichloroborane (0.18 ml, 1 M in DCM, 180 µmol) in DCM (3 
ml) as a yellow solid after flash chromatography (n-
hexane/EtOAc 9:1). 1H NMR (400 MHz, CDCl3, ppm) δ = 
3.93 (3H, s), 7.12 (2H, td, J = 6.5, 3.3 Hz), 7.21 – 7.32 (2H, 
m), 7.38 – 7.49 (2H, m), 7.56 (2H, dddd, J = 8.0, 7.0, 6.0, 1.1 Hz), 7.71 (1H, d, J = 8.9 Hz), 
7.85 (1H, d, J = 8.9 Hz), 7.89 – 7.95 (1H, m), 7.95 – 8.04 (1H, m), 8.09 (1H, d, J = 8.8 Hz), 
8.29 – 8.42 (3H, m). 13C NMR (101 MHz, CDCl3, ppm) δ = 55.5, 109.9, 114.3, 114.3, 
117.8, 123.1, 124.3, 125.2, 125.4, 126.7, 127.3, 127.8, 128.1, 128.2, 129.1, 129.1, 129.8, 
130.0, 130.2, 130.2, 130.3, 130.4, 130.5, 131.4, 132.0, 132.7, 133.3, 145.8, 160.2. IR 
(neat, cm–1): 740, 800, 940, 1006, 1123, 1173, 1241, 1289, 1329, 1416, 1509, 1548, 2219, 
2359, 3047. HRMS: calcd. for C30H19NO+ [M]+ = 409.1467; found = 409.1459. 
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(Z)-2-([1,1'-Biphenyl]-2-ylchloromethylene)capronitrile (130as) 
Following Method A, 130as (119 mg, 402 µmol, 79%) was prepared 
from 135e (120 mg, 512 µmol), 122b (292 mg, 616 µmol), 2,6-di-tert-
butylpyridine (178) (98 mg, 512 µmol) and trichloroborane (0.62 ml, 1 
M in DCM, 620 µmol) in DCM (10 ml) as a yellow solid after flash 
chromatography (n-hexane). 1H NMR (400 MHz, CDCl3, ppm) δ = 0.75 
(3H, t, J = 7.3 Hz), 0.86 – 0.98 (1H, m), 1.00 – 1.21 (2H, m), 1.25 – 
1.38 (1H, m), 1.66 (1H, td, J = 9.7, 5.0 Hz), 1.88 (1H, ddd, J = 14.3, 9.9, 6.6 Hz), 7.32 – 
7.46 (8H, m), 7.47 – 7.53 (1H, m). 13C NMR (101 MHz, CDCl3, ppm) δ = 13.7, 22.1, 29.3, 
31.3, 116.1, 116.7, 127.7, 128.0, 128.7, 129.3, 130.4, 130.4, 134.0, 139.6, 140.9, 144.3. 
IR (neat, cm–1): 510, 555, 647, 700, 740, 755, 906, 1431, 1449, 1474, 2213, 2339, 2360, 
2928, 2958. HRMS: calcd. for C19H19ClN+ [M+H]+ = 296.1201; found = 296.1202. 
(Z)-2-[Chloro(4-methoxyphenyl)methylene]-5-phenylvaleronitrile130au 
Following slightly modified Method A, 130au (115 mg, 369 µmol, 
97%) was prepared from 102au (95 mg, 379 µmol), 122b (216 mg, 
456 µmol), 2,6-di-tert-butylpyridine (178) (73 mg, 382 µmol) and 
trichloroborane (0.76 ml, 1 M in DCM, 760 µmol, 2.0 equiv.) in 
DCM (7.5 ml) as a yellow oil after flash chromatography (n-
hexane/EtOAc 9:1). 1H NMR (400 MHz, CDCl3, ppm) δ = 1.88 – 
2.02 (2H, m), 2.28 – 2.38 (2H, m), 2.59 (2H, t, J = 7.5 Hz), 3.85 
(3H, s), 6.85 – 6.90 (2H, m), 7.07 – 7.11 (2H, m), 7.14 – 7.20 (1H, m), 7.21 – 7.27 (4H, m). 
13C NMR (101 MHz, CDCl3, ppm) δ = 30.1, 31.2, 34.9, 55.6, 113.2, 114.1, 117.5, 126.2, 
127.5, 128.5, 128.6, 130.2, 141.0, 145.5, 161.1. IR (neat, cm–1): 587, 698, 748, 830, 906, 
1027, 1174, 1253, 1299, 1454, 1507, 1603, 1738, 2213, 2932. HRMS: calcd. for 
C19H17ClNO+ [M–H]+ = 310.0999; found = 311.1073. 
4'-(Chloromethyl)-2-[(4-methoxyphenyl)ethynyl]-1,1'-biphenyl (135n) 
Compound 135n was obtained upon attempted cyanative 
cyclization of 135m (18 mg, 48 μmmol) by treatment with 
122b (27 mg, 57 μmol), 2,6-di-tert-butylpyridine (178) (9 mg, 
47 μmol) and trichloroborane (0.06 ml, 1 M in DCM, 60 
µmol) in DCM (1 ml) following Method A. 135n was isolated 
as a white solid (12 mg, 37 μmol, 77%) after flash 
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chromatography (n-hexane). 1H NMR (400 MHz, CDCl3, ppm) δ = 3.80 (3H, s), 4.67 (2H, 
s), 6.79 – 6.85 (2H, m), 7.23 – 7.28 (2H, m), 7.29 – 7.43 (3H, m), 7.47 (2H, d, J = 8.0 Hz), 
7.62 (1H, dd, J = 7.3, 1.5 Hz), 7.64 – 7.69 (2H, m). 13C NMR (101 MHz, CDCl3, ppm) δ = 
46.4, 55.4, 88.0, 92.7, 114.1, 115.6, 122.1, 127.4, 128.3, 128.3, 129.5, 129.9, 132.8, 
132.9, 136.7, 141.0, 143.0, 159.7. IR (neat, cm–1): 533, 675, 732, 753, 829, 1027, 1173, 
1244, 1509, 1604, 2212, 2341, 2360, 2923, 2957. HRMS: calcd. for C22H17ClO+ [M]+ = 
332.0968; found = 332.0958. 
1-{2-[(4-Methoxyphenyl)ethynyl]phenyl}-1H-pyrrole-2-carbonitrile (135x) 
Upon attempted cyanative cyclization following Method A, 
135x (22 mg, 74 µmol, 43%) was prepared from 135w (47 
mg, 172 µmol), 122b (98 mg, 207 µmol), 2,6-di-tert-
butylpyridine (178) (33 mg, 172 µmol) and trichloroborane 
(0.21 ml, 1 M in DCM, 210 µmol) in DCM (3.5 ml) as a white 
solid after flash chromatography (n-hexane/EtOAc 9:1). 1H NMR (300 MHz, CDCl3, ppm) δ 
= 3.81 (3H, s), 6.38 (1H, dd, J = 3.9, 2.8 Hz), 6.79 – 6.88 (2H, m), 7.02 (1H, dd, J = 3.9, 
1.6 Hz), 7.18 (1H, dd, J = 2.8, 1.6 Hz), 7.24 – 7.31 (2H, m), 7.39 – 7.49 (3H, m), 7.65 (1H, 
ddd, J = 7.3, 3.6, 2.3 Hz). 13C NMR (75 MHz, CDCl3, ppm) δ = 55.4, 83.7, 95.0, 105.5, 
109.8, 113.8, 114.1, 114.7, 121.3, 121.7, 127.0, 128.6, 128.9, 129.0, 133.0, 133.2, 139.0, 
160.1. IR (neat, cm–1): 528, 746, 758, 800, 823, 1020, 1104, 1174, 1251, 1456, 1509, 
1607, 2180, 2210, 2965. HRMS: calcd. for C20H14N2O+ [M]+ = 298.1106; found = 
298.1109. 
1-(4-Methoxyphenyl)-3,4-dihydronaphthalene-2-carbonitrile (195) 
Following a slightly modified Method A, 195 (12 mg, 46 µmol, 
90%) was prepared from 170b (12 mg, 51 µmol), 122b (28 mg, 
59 µmol), 2,6-di-tert-butylpyridine (178) (10 mg, 52 µmol) and 
trichloroborane (0.10 ml, 1 M in DCM, 100 µmol, 2.0 equiv.) in 
DCM (1 ml), obtaining a white solid after flash chromatography (n-hexane/EtOAc 9:1). 1H 
NMR (400 MHz, CDCl3, ppm) δ = 2.60 – 2.67 (2H, m), 2.93 (2H, dd, J = 9.1, 6.7 Hz), 3.85 
(3H, s), 6.89 – 6.94 (1H, m), 6.95 – 7.00 (2H, m), 7.13 (1H, td, J = 7.6, 1.6 Hz), 7.18 – 
7.23 (1H, m), 7.23 – 7.27 (1H, m), 7.27 – 7.32 (2H, m). 13C NMR (101 MHz, CDCl3, ppm) 
δ = 26.1, 27.6, 55.4, 106.7, 114.1, 120.1, 126.9, 127.9, 128.2, 128.8, 129.9, 130.9, 133.9, 
137.0, 152.8, 160.3. IR (neat, cm–1): 535, 735, 771, 817, 845, 1030, 1178, 1244, 1287, 
CN
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1511, 1603, 2200, 2832, 2905, 2958. HRMS: calcd. for C18H15NO+ [M]+ = 261.1154; found 
= 261.1554. 
11-(4-Methoxyphenyl)-5H-dibenzo[a,d][7]annulene-10-carbonitrile (197b) 
Following slightly modified Method A, 197b (68 mg, 210 µmol, 
82%) was prepared from 102av (76 mg, 255 µmol), 122b 
(145 mg, 306 µmol), 2,6-di-tert-butylpyridine (178) (49 mg, 
256 µmol) and trichloroborane (0.51 ml, 1 M in DCM, 510 
µmol, 2.0 equiv.) in DCM (5 ml) as white crystals after flash 
chromatography (n-hexane/EtOAc 20:1). 1H NMR (400 MHz, CDCl3, ppm) δ = 3.80 (1H, 
s), 3.87 (1H, s), 3.89 (3H, s), 6.86 – 6.93 (1H, m), 6.96 – 7.05 (2H, m), 7.09 (1H, ddd, J = 
8.4, 5.2, 3.6 Hz), 7.28 – 7.42 (5H, m), 7.42 – 7.49 (2H, m), 7.78 (1H, dd, J = 7.6, 1.3 Hz). 
13C NMR (101 MHz, CDCl3, ppm) δ = 41.0, 55.5, 111.7, 113.9, 120.2, 126.2, 126.7, 127.2, 
127.2, 128.5, 129.8, 130.9, 131.3, 132.0, 133.1, 136.0, 140.9, 141.7, 156.1, 160.6. IR 
(neat, cm–1): 539, 570, 614, 739, 758, 1029, 1174, 1251, 1439, 1508, 1603, 2202, 2852, 
2921, 2959. HRMS: calcd. for C23H17NO+ [M]+ = 323.1310; found = 323.1303. 
 
Method B: A dry Schlenk flask was charged with the corresponding alkyne (1.0 equiv.), 
reagent 122b (2.5 equiv.), DCM (C ~ 0.05 M with respect to alkyne) and cooled down to 
0 °C. Under stirring, 2,6-di-tert-butylpyridine (178) (2.0 equiv.) and a DCM solution of 
BCl3 (1.0 M, 2.5 equiv.) were successively added to the suspension in one portion. The 
reaction mixture was stirred at 0 °C for 1 h. All volatiles were removed under reduced 
pressure and then by high vacuum, the remaning solid was washed with ethylacetate, 
filtered through a Silica pad and concentrated in vacuo. The mixture was further purified 
by column chromatography (n-hexane/toluene) affording the corresponding product. 
5-(4-Methoxyphenyl)-11-[(4-methoxyphenyl)ethynyl]-12-phenylbenzo[c]phenanthre-
ne-6-carbonitrile (187a) 
Following Method B, 187a (100 mg, 177 
µmol, 93%) was prepared from 183a (103 
mg, 191 µmol), 122b (226 mg, 477 µmol), 
2,6-di-tert-butylpyridine (178) (76 mg, 397 
µmol) and trichloroborane (0.48 ml, 1 M in 
DCM, 480 µmol) in DCM (3.8 ml) as 
orange crystals after flash chromatography (n-hexane/toluene 1:1). 1H NMR (300 MHz, 
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CDCl3, ppm) δ = 3.82 (3H, s), 3.93 (3H, s), 6.05 (1H, s), 6.61 (1H, s), 6.81 – 6.89 (2H, m), 
6.96 (1H, tt, J = 7.4, 1.2 Hz), 7.06 – 7.24 (4H, m), 7.28 – 7.64 (6H, m), 7.91 – 8.08 (4H, 
m), 8.29 (1H, d, J = 8.6 Hz), 8.46 (1H, s). 13C NMR (101 MHz, CD2Cl2, ppm) δ = 53.5, 
53.7, 54.0, 54.3, 54.5, 55.9, 55.9, 89.7, 94.7, 114.5, 114.6, 115.9, 118.3, 123.9, 124.4, 
126.5, 126.5, 127.4, 127.7, 127.9, 128.0, 128.1, 128.8, 129.2, 129.5, 130.2, 130.4, 131.1, 
131.4, 131.5, 132.0, 133.3, 135.0, 141.6, 142.9, 147.6, 160.5, 160.8. IR (neat, cm–1): 538, 
571, 605, 702, 744, 758, 829, 1026, 1175, 1248, 1288, 1511, 1604, 2362, 2923. HRMS: 
calcd. for C41H27NNaO2+ [M+Na]+ = 588.1934; found = 588.1913. 
12-(3,5-Dimethylphenyl)-5-(4-methoxyphenyl)-11-[(4-methoxyphenyl)ethynyl]-2,4-
dimethylbenzo[c]phenanthrene-6-carbonitrile (187b) 
Following Method B, 187b (19 mg, 31 
µmol, 52%) was prepared from 183b (36 
mg, 60 µmol), 122b (71 mg, 150 µmol), 
2,6-di-tert-butylpyridine (178) (23 mg, 120 
µmol) and trichloroborane (0.15 ml, 1 M in 
DCM, 150 µmol) in DCM (1 ml) as a 
yellow solid after flash chromatography (n-hexane/toluene 1:1). 1H NMR (400 MHz, 
CDCl3, ppm) δ = 1.73 (3H, s), 1.89 (3H, s), 2.23 (3H, s), 2.45 (3H, s), 3.82 (3H, s), 3.91 
(3H, s), 5.62 (1H, s), 6.59 (1H, s), 6.80 (1H, s), 6.82 – 6.89 (2H, m), 7.01 (1H, dd, J = 8.4, 
2.7 Hz), 7.05 – 7.14 (2H, m), 7.30 – 7.35 (2H, m), 7.53 (1H, dd, J = 8.4, 2.3 Hz), 7.58 (1H, 
d, J = 1.7 Hz), 7.90 – 7.99 (3H, m), 8.01 (1H, s), 8.19 (1H, d, J = 8.5 Hz). 13C NMR (101 
MHz, CDCl3, ppm) δ = 21.6, 22.8, 24.9, 31.7, 55.5, 55.5, 89.6, 94.3, 113.8, 114.0, 114.1, 
115.8, 118.3, 122.8, 123.5, 126.6, 127.3, 128.1, 128.4, 128.5, 128.6, 128.8, 129.2, 129.2, 
130.0, 130.7, 130.8, 131.1, 132.3, 132.9, 133.0, 133.3, 134.4, 134.8, 136.7, 140.7, 142.6, 
146.5, 159.8, 159.9. IR (neat, cm–1): 803, 834, 1027, 1174, 1244 , 1439, 1511, 1604, 
2182, 2211, 2326, 2342, 2357, 2918, 2958. HRMS: calcd. for C45H35NO2+ [M]+ = 
621.2668; found = 621.2666. 
3-Chloro-12-(4-chlorophenyl)-5-(p-tolyl)-11-(p-tolylethynyl)benzo[c]phenanthrene-6-
carbonitrile (187c) 
Following Method B, 187c (15 mg, 25 µmol, 
18%) was prepared from 183c (82 mg, 142 
µmol), 122b (168 mg, 354 µmol), 2,6-di-tert-
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butylpyridine (178) (54 mg, 282 µmol) and trichloroborane (0.36 ml, 1 1 M in DCM, 360 
µmol) in DCM (3 ml) as a yellow solid after flash chromatography (n-hexane/toluene 1:1). 
1H NMR (400 MHz, CDCl3, ppm) δ = 2.38 (3H, s), 2.52 (3H, s), 5.99 (1H, s), 6.63 (1H, s), 
7.06 (1H, dd, J = 8.9, 2.2 Hz), 7.12 – 7.21 (2H, m), 7.27 – 7.32 (2H, m), 7.35 (1H, s), 7.39 
– 7.54 (5H, m), 7.89 (1H, d, J = 8.9 Hz), 7.98 (1H, d, J = 8.3 Hz), 8.00 – 8.11 (2H, m), 8.30 
(1H, d, J = 8.6 Hz), 8.38 (1H, s). 13C NMR (101 MHz, CDCl3, ppm) δ = 21.6, 21.7, 89.3, 
95.3, 109.7, 117.5, 120.1, 123.7, 124.2, 125.4, 127.1, 127.7, 127.7, 128.0, 128.1, 129.2, 
129.2, 129.4, 129.6, 129.8, 130.1, 130.2, 130.6, 131.4, 131.7, 132.0, 132.5, 133.0, 133.3, 
134.7, 139.1, 139.2, 139.4, 141.0, 146.7. IR (neat, cm–1): 537, 605, 728, 826, 1028, 1172, 
1245, 1511, 1591, 1604, 2210, 2326, 2362, 2835, 2932. HRMS: calcd. for C41H25Cl2N+ 
[M]+= 601.1364; found = 601.1340. 
3-Chloro-12-(4-chlorophenyl)-5-(4-methoxyphenyl)-11-[(4-methoxyphenyl)ethynyl]-
benzo[c]phenanthrene-6-carbonitrile (187d) 
Following Method B, 187d (29 mg, 46 
µmol, 47%) was prepared from 183d (60 
mg, 98 µmol), 122b (117 mg, 247 µmol), 
2,6-di-tert-butylpyridine (178) (38 mg, 199 
µmol) and trichloroborane (0.25 ml, 1 M in 
DCM, 250 µmol) in DCM (2 ml) as a yellow 
solid after flash chromatography (n-hexane/toluene 1/1). 1H NMR (400 MHz, CDCl3, ppm) 
δ = 3.81 (3H, s), 3.93 (3H, s), 5.98 (1H, d, J = 15.2 Hz), 6.61 (1H, s), 6.81 – 6.92 (2H, m), 
7.04 (1H, dd, J = 8.9, 2.2 Hz), 7.12 (2H, dt, J = 8.5, 1.2 Hz), 7.26 – 7.34 (2H, m), 7.34 – 
7.56 (4H, m), 7.85 (1H, d, J = 8.9 Hz), 7.94 (1H, d, J = 8.3 Hz), 7.96 – 8.03 (2H, m), 8.26 
(1H, d, J = 8.5 Hz), 8.35 (1H, s). 13C NMR (101 MHz, CDCl3, ppm) δ = 55.5, 55.6, 88.7, 
95.2, 109.7, 114.3, 114.5, 115.2, 117.5, 123.8, 124.1, 125.4, 126.9, 127.7, 127.7, 128.0, 
128.0, 128.1, 129.2, 129.3, 130.1, 130.7, 131.5, 131.8, 132.0, 132.5, 133.0, 133.3, 134.5, 
139.3, 140.7, 146.3, 160.1, 160.5. IR (neat, cm–1): 537, 605, 728, 826, 1028, 1172, 1245, 
1511, 1591, 1604, 2045, 2210, 2326, 2362, 2835, 2932. HRMS: calcd. for C41H26Cl2NO2+ 
[M+H]+ = 634.1335; found = 634.1335. 
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6.3.2.2. Cycloisomerizations. 
 
Scheme 127. Cycloisomerization of [4]helicenes 187 to [6]helicenes 188. 
General procedure GP6: A dry Schlenk flask was charged with the corresponding 
alkyne (1.0 equiv.) and solved in DCM (1 ml) before BF3·Et2O (1.0 equiv.) was added. 
The mixture was stirred at rt for 5 min. All volatiles were removed under reduced 
pressure and then by high vacuum, the remaining solid was solved in ethylacetate, 
filtered through a Silica pad and concentrated in vacuo affording the corresponding 
product. 
 
1,8-bis(4-Methoxyphenyl)hexahelicene-2-carbonitrile (188a) 
Following GP6, 188a (12 mg, 21 µmol, 
99%) was prepared from 187a (12 mg, 21.2 
µmol) and BF3·Et2O (3 mg, 21 µmol) as a 
yellow solid. 1H NMR (400 MHz, CD2Cl2, 
ppm) δ = 3.94 (3H, s), 3.97 (3H, s), 6.74 
(1H, t, J = 7.9 Hz), 6.83 (1H, t, J = 7.8 Hz), 
7.06 – 7.30 (6H, m), 7.52 – 7.74 (6H, m), 7.77 (1H, d, J = 8.5 Hz), 7.85 – 7.99 (2H, m), 
8.03 – 8.17 (2H, m), 8.24 (1H, d, J = 8.4 Hz), 8.46 (1H, d, J = 8.3 Hz). 13C NMR (101 MHz, 
CD2Cl2, ppm) δ = 56.0, 106.8, 109.5, 114.4, 114.6, 118.4, 123.1, 124.1, 124.5, 125.2, 
126.3, 126.6, 126.8, 126.9, 127.7, 127.7, 128.0, 128.2, 128.3, 128.6, 128.8, 129.2, 129.4, 
129.7, 130.6, 130.7, 131.4, 131.7, 131.8, 132.0, 132.2, 133.0, 134.0, 140.4, 147.7, 159.9, 
160.8. IR (neat, cm–1): 610, 702, 765, 793, 864, 1013, 1084, 1175, 1257, 1444, 1511, 
1606, 2853, 2923, 2961. HRMS: calcd. for C41H27NO2+ [M]+= 565.2042; found = 565.2045. 
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10,15-Dichloro-1,8-bis(4-methoxyphenyl)hexahelicene-2-carbonitrile (188d) 
Following GP6, 188d (10 mg, 15.7 µmol, 
99%) was prepared from 187d (10 mg, 15.7 
µmol) and BF3·Et2O (2.2 mg, 15.7 µmol) as a 
yellow solid. 1H NMR (400 MHz, CDCl3, ppm) 
δ = 3.96 (3H, s), 3.98 (3H, s), 6.75 (1H, dd, J 
= 9.0, 2.2 Hz), 6.83 (1H, dd, J = 9.0, 2.3 Hz), 
7.12 – 7.17 (2H, m), 7.19 (2H, d, J = 8.2 Hz), 7.57 (1H, s), 7.58 – 7.63 (3H, m), 7.66 – 
7.71 (2H, m), 7.87 (1H, d, J = 2.2 Hz), 7.93 (1H, s), 7.99 – 8.13 (2H, m), 8.20 (1H, d, J = 
8.5 Hz), 8.48 (1H, d, J = 8.4 Hz). 13C NMR (101 MHz, CDCl3, ppm) δ = 55.6, 55.6, 105.1, 
110.4, 114.4, 114.7, 117.6, 123.3, 124.5, 125.5, 125.6, 126.7, 126.9, 127.4, 127.6, 127.7, 
128.0, 128.3, 128.6, 128.9, 129.3, 129.4, 129.7, 129.9, 131.3, 131.3, 131.4, 131.7, 131.9, 
132.2, 132.2, 132.2, 132.9, 133.9, 139.4, 146.4, 159.7, 160.6. IR (neat, cm–1): 609, 796, 
831, 1027, 1105, 1174, 1247, 1512, 1604, 2218, 2342, 2361, 2849, 2917, 2961. HRMS: 
calcd. for C41H26Cl2NO2+ [M+H]+ = 634.1335; found = 634.1344. 
6.4. X-Ray structures. 
Crystal Structure Analysis: Suitable for X-ray diffractometry crystals of compounds were 
obtained by recrystallization from n-heptane [(Z)-130l, (Z)-130u and (Z)-130ao], from a 1/1 
mixture of DCM/n-pentane [(136a, 136y, (Z)-141b, 187a, 195 and 197b] and from a 1/1 
mixture of Acetonitrile/Diethylether [140a]. 
Data collections were done on a Bruker D8 Venture four-circle-diffractometer from Bruker 
AXS GmbH; used detector: Photon II from Bruker AXS GmbH; used X-ray sources: 
microfocus IµS Cu/Mo from Incoatec GmbH with mirror optics HELIOS and single-hole 
collimator from Bruker AXS GmbH. Radiation: MoKα (λ = 0.71073). 
Used programs: APEX3 Suite (v2017.3-0) and therein integrated programs SAINT 
(Integration) und SADABS (Absorption correction) from Bruker AXS GmbH; structure 
solution was done with SHELXT, refinement with SHELXS;[149] OLEX2 was used for data 
finalization.[150] 
Special Utilities: SMZ1270 stereomicroscope from Nikon Metrology GmbH was used for 
sample preparation; crystals were mounted on MicroMounts or MicroLoops from 
MiTeGen; for sensitive samples the X-TEMP 2 System was used for picking of crystals;[151] 
crystals were cooled to given temperature with Cryostream 800 from Oxford Cryosystems. 
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Table 17 Crystal and data collection parameters for compounds (Z)-130l, (Z)-130u, (Z)-
130ao, 136a, 140a, (Z)-141b, 136y, 187a, 195 and 197b. The numbering does not 
correspond to the IUPAC rules. 
Compound (Z)-130l (Z)-130u (Z)-130ao 136a 140a 
Formula C16H11NOClBr 
C13H8ClNS 
 C22H15NO C22H40Cl4F6N
4S2Sb2 
Molecular mass 348.62 245.71  309.35 924.00 
Temperature/K 100(2) 296.15  100(2) 100(2) 
Crystal system orthorhombic monoclinic  triclinic triclinic 
Space group P212121 P21/c  P-1 P-1 
Crystal size [mm]  0.2 × 0.169 × 
0.12 
 0.10 x 0.10 x 
0.03 
0.07 × 0.067 
× 0.029 
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a [Å] 7.4816(3) 14.7305(17)  9.5671(14) 8.2494(11) 
b [Å] 9.8397(6) 5.7754(7)  9.8579(15) 13.1492(18) 
c [Å] 18.8362(7) 13.4004(16)  10.1130(15) 16.459(2) 
α [°] 90 90  117.760(3) 96.967(2) 
β [°] 90 94.853(2)  107.436(3) 101.713(3) 
γ [°] 90 90  96.488(3) 102.793(3) 
V [Å3] 1386.66(11) 1135.9(2)  768.3(2) 1678.7(4) 
Z 4 4  2 2 
D [g cm–3] 1.670 1.437  1.337 1.828 
µ [mm–1] 3.150 0.487  0.082 2.107 
F(000) 696.0 504.0  324 912.0 
2Θmax [°] 66.322 72.632  61.990 72.784 
Refl. collected 28409 42929  14058 66099 
Refl. independent 5277 5513  4834 16073 
Rint 0.0300 0.0227  0.0290 0.0497 
Rsigma 0.0202 0.0120   0.0505 
R1 [I ≥ 2σ(I)] 0.0189 0.0291  0.0459 0.0337 
wR2(all data) 0.0453 0.0930  0.1355 0.0703 
No. of parameters 
refined 
182 182  218 376 
GOOF 1.074 1.023  1.074 1.026 
Largest diff. peak 
and hole, e·Å–3 
0.40/–0.29 0.55/–0.35  0.446/–0.249 1.77/–1.09 
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Table 17 (Continued) 
Compound (Z)-141b 136y 187a 195 197b 
Formula C22H16FNO C26H17NO C48H35NO2 C18H15NO C23H17NO 
Molecular mass 329.36 359.40 657.77 261.31 323.38 
Temperature/K 100.(2) 101.93 100.0 100.01 100.01 
Crystal system triclinic triclinic monoclinic monoclinic triclinic 
Space group P-1 P-1 P21/c P21/c P1 
Crystal size [mm] 0.340 × 0.172 0.563 × 0.383 0.216 × 0.134 0.335 × 0.117 0.448 × 0.202 
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× 0.169 × 0.314 × 0.066 × 0.105 × 0.038 
a [Å] 8.9882(3) 9.0102(6) 9.4796(14) 5.6886(8) 8.7262(7) 
b [Å] 10.1746(4) 10.1932(7) 36.328(6) 21.347(3) 9.7738(8) 
c [Å] 10.7749(4) 11.6228(6) 10.6427(19) 11.2486(14) 9.8796(7) 
α [°] 109.464(2) 67.190(2) 90 90 90.947(2) 
β [°] 103.932(2) 76.502(2) 111.093(6) 96.637(5) 90.917(2) 
γ [°] 99.489(2) 67.338(2) 90 90 103.584(3) 
V [Å3] 868.79(6) 903.58(10) 3419.5(10) 1356.8(3) 818.76(11) 
Z 2 2 4 4 2 
D [g cm–3] 1.259 1.321 1.278 1.279 1.312 
µ [mm–1] 0.084 0.080 0.077 0.079 0.080 
F(000) 344.0 376.0 1384.0 552.0 340.0 
2Θmax [°] 61.30 61.03 59.206 63.066 59.238 
Refl. collected 54135 28914 64282 20204 8701 
Refl. independent 5360 5519 9612 4529 8701 
Rint 0.0801 0.0231 0.0229 0.0229  
Rsigma 0.0408 0.0169 0.0155 0.0192 0.0294 
R1 [I ≥ 2σ(I)] 0.0531 0.0420 0.0451 0.0389 0.0365 
wR2(all data) 0.1383 0.1226 0.1237 0.1114 0.0991 
No. of parameters 
refined 
227 254 463 182 454 
GOOF 1.020 1.040 1.043 1.023 1.030 
Largest diff. peak 
and hole, e·Å–3 
0.46/–0.38 0.46/–0.18 0.50/–0.23 0.43/–0.20 0.29/–0.20 
 
CCDC 1545693, 1545694, 1545695, 1545696, 1545697, 1567971, and 1567989 contain 
(in part) the supplementary crystallographic data published in our paper.[142] These data 
can be obtained free of charge from The Cambridge Crystallographic Data Cent 
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7. Appendix. 
7.1. NMR spectra. 
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1H NMR (400 MHz, CDCl3) Compound 122c 
 
13C NMR (101 MHz, CDCl3) Compound 122c 
 
 
 173 
 
11B NMR (128 MHz, CDCl3) Compound 122c 
 
19F NMR (376 MHz, CDCl3) Compound 122c 
 
 
 174 
 
1H NMR (500 MHz, CD3CN) Compound 122d 
 
 
13C NMR (126 MHz, CD3CN) Compound 122d 
 
 175 
 
19F NMR (470 MHz, CD3CN) Compound 122d 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 176 
 
1H NMR (300 MHz, CDCl3) Compound (Z)-130a 
 
 13C NMR (126 MHz, CDCl3) Compound (Z)-130a 
 
 
 177 
 
 
1H NMR (500 MHz, CDCl3) Compound (Z)-130e 
 
13C NMR (126 MHz, CDCl3) Compound (Z)-130e 
  
NC Cl
OMeMe
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1H NMR (300 MHz, CDCl3) Compound (Z)-130j 
13C NMR (126 MHz, CDCl3) Compound (Z)-130j 
 
 179 
 
19F NMR (282 MHz, CDCl3) Compound (Z)-130j 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 180 
 
1H NMR (300 MHz, CDCl3) Compound (Z)-130k 
 
 
13C NMR (75 MHz, CDCl3) Compound (Z)-130k 
 
 181 
 
1H NMR (500 MHz, CDCl3) Compound (Z)-130l 
 
 
13C NMR (126 MHz, CDCl3) Compound (Z)-130l 
 
 182 
 
1H NMR (400 MHz, CDCl3) Compound (Z)-130m 
 
 
13C NMR (100 MHz, CDCl3) Compound (Z)-130m 
 
 183 
 
1H NMR (300 MHz, CDCl3) Compound (Z)-130n 
  
 
13C NMR (126 MHz, CDCl3) Compound (Z)-130n 
  
 184 
 
1H NMR (300 MHz, CDCl3) Compound (Z)-130o 
 
 
13C NMR (126 MHz, CDCl3) Compound (Z)-130o 
 
 185 
 
1H NMR (500 MHz, CDCl3) Compound (Z)-130g 
 
 
13C NMR (126 MHz, CDCl3) Compound (Z)-130g 
 
 186 
 
1H NMR (500 MHz, CDCl3) Compound (Z)-130b 
 
 
13C NMR (126 MHz, CDCl3) Compound (Z)-130b 
 
 187 
 
1H NMR (300 MHz, CDCl3) Compounds (Z)-130d (left) and (Z)-130d’ (right) 
 
 
13C NMR (126 MHz, CDCl3) Compounds (Z)-130d and (Z)-130d’
 
 188 
 
1H NMR (300 MHz, CDCl3) Compound (Z)-130u 
 
 
13C NMR (126 MHz, CDCl3) Compound (Z)-130u 
 
 189 
 
1H NMR (400 MHz, C6D6) Compound (Z)-130w 
 
 
13C NMR (101 MHz, C6D6) Compound (Z)-130w 
 190 
 
1H NMR (500 MHz, C6D6) Compound (Z)-130x 
 
13C NMR (126 MHz, CDCl3) Compound (Z)-130x 
 
Cl
Et
NC
 191 
 
1H NMR (300 MHz, CDCl3) Compound (Z)-130y 
 
13C NMR (126 MHz, CDCl3) Compound (Z)-130y 
 
Cl
Pr
NC
 192 
 
1H NMR (500 MHz, C6D6) Compound (Z)-130z 
 
 
13C NMR (126 MHz, C6D6) Compound (Z)-130z 
Cl
Bn
NC
 193 
 
1H NMR (300 MHz, CDCl3) Compound (Z)-130ab 
 
 
13C NMR (126 MHz, CDCl3) Compound (Z)-130ab 
 
 194 
 
1H NMR (300 MHz, CDCl3) Compound (Z)-130aa 
 
 
13C NMR (126 MHz, CDCl3) Compound (Z)-130aa 
 195 
 
1H NMR (400 MHz, CDCl3) Compound (Z)-130ad 
 
 
13C NMR (100 MHz, CDCl3) Compound (Z)-130ad 
 196 
 
1H NMR (400 MHz, C6D6) Compound (Z)-130ac 
 
 
13C NMR (76 MHz, C6D6) Compound (Z)-130ac 
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1H NMR (400 MHz, C6D6) Compound (Z)-130ag 
 
 
13C NMR (100 MHz, C6D6) Compound (Z)-130ag 
 
Cl
H
NC
 198 
 
1H NMR (300 MHz, CDCl3) Compound (Z)-130ai
 
 
13C NMR (126 MHz, CDCl3) Compound (Z)-130ai
 
 199 
 
1H NMR (500 MHz, CDCl3) Compound (Z)-130al 
 
 
13C NMR (126 MHz, CDCl3) Compound (Z)-130al 
 
 200 
 
1H NMR (300 MHz, CDCl3) Compound (Z)-130ao 
 
13C NMR (126 MHz, CDCl3) Compound (Z)-130ao 
 
 
 201 
 
1H NMR (300 MHz, CDCl3) Compound (Z)-130ak 
 
 
13C NMR (126 MHz, CDCl3) Compound (Z)-130ak 
 
 202 
 
1H NMR (300 MHz, C6D6) Compound (Z)-130ah 
 
 
13C NMR (125 MHz, C6D6) Compound (Z)-130ah 
 
 203 
 
1H NMR (500 MHz, CDCl3) Compound (Z)-130c 
 
 
13C NMR (126 MHz, CDCl3) Compound (Z)-130c 
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1H NMR (300 MHz, CDCl3) Compound (Z)-130q 
 
 
13C NMR (126 MHz, CDCl3) Compound (Z)-130q 
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1H NMR (400 MHz, CD2Cl2) Compound 133 
 
13C NMR (126 MHz, CD2Cl2) Compound 133 
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11B NMR (128 MHz, CD2Cl2) Compound 133 
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1H NMR (400 MHz, CD3CN) Compound (Z)-129 
 
1H NMR (400 MHz, CD3CN) Compound (E)-129 
 
 208 
 
1H NMR (300 MHz, C6D6) Compound 128 
 
13C NMR (126 MHz, C6D6) Compound 128 
 209 
 
1H NMR (400 MHz, CDCl3) Compound 136a 
 
13C NMR (400 MHz, CDCl3) Compound 136a 
 
 
 210 
 
1H NMR (500 MHz, CD3CN) Compound 140a 
 
 
13C NMR (126 MHz, CD3CN) Compound 140a 
 211 
 
1H NMR (400 MHz, CDCl3) Compound (Z)-141b 
 
13C NMR (101 MHz, CDCl3) Compound (Z)-141b 
 
 
 212 
 
19F NMR (376 MHz, CDCl3) Compound (Z)-141b 
 
 
1H NMR (400 MHz, C6D6) Compound (E)-144 
 
 213 
 
1H NMR (400 MHz, C6D6) Compound (Z)-144 
 
13C NMR (126 MHz, C6D6) Compound 144  
 
 214 
 
1H NMR (400 MHz, CDCl3) Compound (E)-145 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 215 
 
1H NMR (400 MHz, CDCl3) Compound (Z)-145 
 
13C NMR (101 MHz, CDCl3) Compound 145 
 216 
 
1H NMR (400 MHz, C6D6) Compound (Z)-141c 
13C NMR (101 MHz, C6D6) Compound (Z)-141c 
 
 217 
 
1H NMR (300 MHz, CDCl3) Compound 141a 
 
13C NMR (126 MHz, CDCl3) Compound 141a 
 
 218 
 
1H NMR (500 MHz, C6D6) Compound 146a 
13C NMR (126 MHz, C6D6) Compound 146a 
 219 
 
1H NMR (600 MHz, C6D6) Compound 147 
13C NMR (126 MHz, C6D6) Compound 147 
NC
S
CN
OMe
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1H NMR (400 MHz, CDCl3) Compounds 149a and 149b 
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.5
f1 (ppm)
3
.0
0
3
.0
0
1
.9
6
4
.8
9
2
.3
4
3
.6
2
3
.8
1
6
.8
7
6
.8
7
6
.8
8
6
.8
9
6
.8
9
6
.9
0
7
.0
9
7
.1
0
7
.1
1
7
.1
1
7
.1
2
7
.1
3
7
.1
3
7
.1
4
7
.1
4
7
.1
5
7
.1
6
7
.1
6
7
.1
7
7
.2
0
7
.2
0
7
.2
0
7
.2
1
7
.2
2
7
.2
2
7
.2
3
7
.2
3
7
.2
4
7
.2
4
7
.2
5
7
.2
5
7
.2
6
7
.2
6
 C
D
C
l3
13C NMR (100 MHz, CDCl3) Compounds 149a and 149b 
0102030405060708090100110120130140150160170
f1 (ppm)
3
6
.4
7
5
5
.4
1
7
6
.9
1
 C
D
C
l3
7
7
.1
6
 C
D
C
l3
7
7
.4
1
 C
D
C
l3
1
0
7
.0
8
1
1
4
.2
4
1
2
2
.4
0
1
2
6
.0
4
1
2
8
.7
3
1
2
8
.9
8
1
2
9
.7
3
1
3
1
.3
7
1
4
1
.7
4
1
5
1
.1
7
1
5
9
.8
7
 
Regioisomer (15%) 
 
 221 
 
1H NMR (400 MHz, CDCl3) Compound 149c 
13C NMR (100 MHz, CDCl3) Compound 149c
 
 222 
 
1H NMR (400 MHz, CDCl3) Compound 150 
13C NMR (100 MHz, CDCl3) Compound 150 
 223 
 
1H NMR (400 MHz, CDCl3) Compound 152 
13C NMR (101 MHz, CDCl3) Compound 152 
 224 
 
1H NMR (400 MHz, CDCl3) Compound 153 
13C NMR (101 MHz, CDCl3) Compound 153 
 225 
 
1H NMR (400 MHz, CDCl3) Compound 135f 
 
13C NMR (126 MHz, CDCl3) Compound 135f 
 
 226 
 
1H NMR (400 MHz, CDCl3) Compound 182g 
13C NMR (101 MHz, CDCl3) Compound 182g 
 227 
 
19F NMR (376 MHz, CDCl3) Compound 182g 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 228 
 
1H NMR (400 MHz, CDCl3) Compound 182i 
 
13C NMR (101 MHz, CDCl3) Compound 182i 
 
 
Cl
 229 
 
 
1H NMR (400 MHz, CDCl3) Compound 182r 
 
13C NMR (101 MHz, CDCl3) Compound 182r 
 
 230 
 
 
1H NMR (400 MHz, CDCl3) Compound 182s 
 
13C NMR (101 MHz, CDCl3) Compound 182s 
 
 231 
 
 
1H NMR (400 MHz, CDCl3) Compound 182v 
 
13C NMR (126 MHz, CDCl3) Compound 182z 
 
 232 
 
19F NMR (376 MHz, CDCl3) Compound 182z 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 233 
 
1H NMR (400 MHz, CDCl3)  Compound 182z 
 
13C NMR (101 MHz, CDCl3) Compound 182z 
 
 
 234 
 
1H NMR (400 MHz, CDCl3) Compound 135d 
 
13C NMR (101 MHz, CDCl3) Compound 135d 
 
 
 235 
 
1H NMR (500 MHz, CDCl3) Compound 135g 
 
13C NMR (126 MHz, CDCl3) Compound 135g 
 
 
 236 
 
19F NMR (471 MHz, CDCl3) Compound 135g 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 237 
 
1H NMR (400 MHz, CDCl3) Compound 135h 
 
13C NMR (126 MHz, CDCl3) Compound 135h 
 
 
 238 
 
19F NMR (376 MHz, CDCl3) Compound 135h 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 239 
 
1H NMR (400 MHz, CDCl3) Compound 135i 
 
13C NMR (101 MHz, CDCl3) Compound 135i 
 
 
 240 
 
1H NMR (400 MHz, CDCl3) Compound 135j 
 
13C NMR (101 MHz, CDCl3) Compound 135j 
 
 
 241 
 
1H NMR (400 MHz, CDCl3) Compound 135o 
 
13C NMR (101 MHz, CDCl3) Compound 135o 
 
 
 242 
 
1H NMR (400 MHz, CDCl3) Compound 135p 
 
13C NMR (101 MHz, CDCl3) Compound 135p 
 
 
 243 
 
1H NMR (400 MHz, CDCl3) Compound 135q 
 
13C NMR (101 MHz, CDCl3) Compound 135q 
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 244 
 
1H NMR (400 MHz, CDCl3) Compound 135r
 
13C NMR (101 MHz, CDCl3) Compound 135r 
 
 
 245 
 
 
19F NMR (376 MHz, CDCl3) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 246 
 
 
1H NMR (400 MHz, CDCl3) Compound 135s 
 
13C NMR (101 MHz, CDCl3) Compound 135s 
 
 247 
 
 
1H NMR (400 MHz, CDCl3) Compound 135v 
 
13C NMR (101 MHz, CDCl3) Compound 135v 
 
 248 
 
1H NMR (300 MHz, CDCl3) Compound 135w 
 
13C NMR (126 MHz, CDCl3) Compound 135w 
 
 
 249 
 
1H NMR (600 MHz, CDCl3) Compound 135y 
 
13C NMR (126 MHz, CDCl3) Compound 135y 
 
 
 250 
 
1H NMR (400 MHz, CDCl3) Compound 135z 
 
13C NMR (101 MHz, CDCl3) Compound 135z 
 
 
 251 
 
 
1H NMR (400 MHz, CDCl3) Compound 102au 
 
13C NMR (101 MHz, CDCl3) Compound 102au 
 
 252 
 
1H NMR (400 MHz, CDCl3) Compound 102av 
 
13C NMR (75 MHz, CDCl3) Compound 102av 
 
 
 253 
 
1H NMR (400 MHz, CDCl3) Compound 102aw 
 
13C NMR (101 MHz, CDCl3) Compound 102aw 
 
 
 254 
 
1H NMR (400 MHz, CDCl3) Compound 170a 
 
13C NMR (101 MHz, CDCl3) Compound 170a 
 
 
 255 
 
1H NMR (400 MHz, CDCl3) Compound 170b 
 
13C NMR (101 MHz, CDCl3) Compound 170b 
 
 
 256 
 
1H NMR (400 MHz, CDCl3) Compound 170c 
 
13C NMR (101 MHz, CDCl3) Compound 170c 
 
 
 257 
 
1H NMR (400 MHz, CDCl3) Compound 190 
 
13C NMR (126 MHz, CDCl3) Compound 190 
 
 
 258 
 
1H NMR (400 MHz, CDCl3) Compound 193 
 
13C NMR (101 MHz, CDCl3) Compound 193 
 
 
 259 
 
1H NMR (400 MHz, CDCl3) Compound 135l 
 
13C NMR (101 MHz, CDCl3) Compound 135l 
 
 
 260 
 
1H NMR (400 MHz, CDCl3) Compound 135m 
 
13C NMR (101 MHz, CDCl3) Compound 135m 
 
 
 261 
 
1H NMR (300 MHz, CDCl3) Compound 198 
 
13C NMR (75 MHz, CDCl3) Compound 198 
 
 
 262 
 
1H NMR (400 MHz, CDCl3) Compound 135t 
 
13C NMR (101 MHz, CDCl3) Compound 135t 
 
 
 263 
 
1H NMR (400 MHz, CDCl3) Compound 135u 
 
13C NMR (101 MHz, CDCl3) Compound 135u 
 
 
 264 
 
1H NMR (300 MHz, CDCl3) Compound 136b 
 
13C NMR (126 MHz, CDCl3) Compound 136b 
 
 
 265 
 
1H NMR (400 MHz, CDCl3) Compound 136g 
 
13C NMR (126 MHz, CDCl3) Compound 136g 
 
 
 266 
 
19F NMR (376 MHz, CDCl3) Compound 136g 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 267 
 
1H NMR (400 MHz, CDCl3) Compound 136h 
 
13C NMR (101 MHz, CDCl3) Compound 136h 
 
 
 268 
 
19F NMR (376 MHz, CDCl3) Compound 136h 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 269 
 
1H NMR (400 MHz, CDCl3) Compound 136i 
 
13C NMR (101 MHz, CDCl3) Compound 136i 
 
 
 270 
 
1H NMR (300 MHz, CDCl3) Compound 136l 
 
13C NMR (101 MHz, CDCl3) Compound 136l 
 
 
 271 
 
1H NMR (400 MHz, CDCl3) Compound 136o 
 
13C NMR (101 MHz, CDCl3) Compound 136o 
 
 
 272 
 
1H NMR (300 MHz, CDCl3) Compound 136p 
 
13C NMR (126 MHz, CDCl3) Compound 136p 
 
 
 273 
 
1H NMR (400 MHz, CDCl3) Compound 136s 
 
13C NMR (101 MHz, CDCl3) Compound 136s 
 
. 
 274 
 
1H NMR (400 MHz, CDCl3) Compound 136u 
 
13C NMR (101 MHz, CDCl3) Compound 136u 
 
 
 275 
 
1H NMR (400 MHz, CDCl3) Compound 136y 
 
13C NMR (101 MHz, CDCl3) Compound 136y 
 
 
 276 
 
1H NMR (400 MHz, CDCl3) Compound 136z 
 
13C NMR (126 MHz, CDCl3) Compound 136z 
 
 
 277 
 
1H NMR (400 MHz, CDCl3) Compound 130as 
 
13C NMR (101 MHz, CDCl3) Compound 130as 
 
 
 278 
 
1H NMR (400 MHz, CDCl3) Compound 130au 
 
13C NMR (101 MHz, CDCl3) Compound 130au 
 
 
 279 
 
1H NMR (400 MHz, CDCl3) Compound 135n 
 
13C NMR (101 MHz, CDCl3) Compound 135n 
 
 
 280 
 
1H NMR (300 MHz, CDCl3) Compound 135x 
 
13C NMR (75 MHz, CDCl3) Compound 135x 
 
 
 281 
 
1H NMR (400 MHz, CDCl3) Compound 195 
 
13C NMR (101 MHz, CDCl3) Compound 195 
 
 
 282 
 
1H NMR (400 MHz, CDCl3) Compound 197b 
 
13C NMR (101 MHz, CDCl3) Compound 197b 
 
 
 283 
 
1H NMR (300 MHz, CDCl3) Compound 187a 
 
13C NMR (101 MHz, CD2Cl2) Compound 187a 
 
 
 284 
 
1H NMR (400 MHz, CDCl3) Compound 187b 
 
13C NMR (101 MHz, CDCl3) Compound 187b 
 
 
 285 
 
1H NMR (400 MHz, CDCl3) Compound 187c 
 
13C NMR (101 MHz, CDCl3) Compound 187c 
 
 
 286 
 
1H NMR (400 MHz, CDCl3) Compound 187d 
 
13C NMR (101 MHz, CDCl3) Compound 187d 
 
 
 287 
 
1H NMR (400 MHz, CD2Cl2) Compound 188a 
 
13C NMR (101 MHz, CD2Cl2) Compound 188a 
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1H NMR (400 MHz, CDCl3) Compound 188d 
 
13C NMR (101 MHz, CDCl3) Compound 188d 
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7.2. List of abbreviations.  
 
Ac   acetyl 
AIBN   2,2'-azobis(2-metilpropionitrilo) 
aq.   aqueous media 
Ar   aromatic substituent 
B   base 
bs   broad NMR singlet 
Bu   butyl 
Bn   benzyl 
Bz   benzoyl 
ºC   degree Celsius 
ĉ   concentration 
ca.    circa 
calcd.   calculated 
cat.   catalytic amount 
cf.   confer 
cm   centimetres 
Cy   cyclohexyl 
δ    chemical shift 
d   doublet (NMR) 
DABCO  1,4-diazabicyclo[2.2.2]octane 
dba   dibenzylideneacetone 
DBU   1,8-Diazabicyclo[5.4.0]undec-7-ene 
DCE   dichloroethane 
DCM   dichloromethane 
dd   doublet of doublets (NMR) 
ddd   doublet of doublets of doublets (NMR) 
DDQ   2,3-Dichloro-5,6-dicyano-pbenzoquinone 
decomp.  decomposition 
DG   directing group 
DIBAL-H  diisobutylaluminium hydride   
DIPEA   N,N-Diisopropylethylamine 
DMA   dimethylacetamide 
DMF   N,N-Dimethylformamide 
DMP   Dess-Martin Periodinane 
DMSO   dimethyl sulfoxide 
DPEPhos  bis[(2-diphenylphosphino)phenyl] ether 
DPPE   1,2-Bis(diphenylphosphino)ethane 
dt   doublet of triplets (NMR) 
e−   electron 
ee   enantiomeric excess 
EI   Electron Ionization   
equiv.   equivalents 
ESI   Electrospray Ionization 
Et   ethyl 
et al.   et alii 
eV   electronvolt 
EWG   electron-withdrawing group 
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g   gram 
GC   Gas Chromatography 
gas.    gaseous 
h   hour 
HMBC   Heteronuclear Multiple-Bond Correlation spectroscopy 
HOMO   Highest Occupied Molecular Orbital 
HRMS   High Resolution Mass Spectroscopy 
Hz   Herz 
i    iso- 
IR   infrarred spectroscopy 
IUPAC   International Union of Pure and Applied Chemistry 
J    coupling constant 
K   Kelvin 
kcal   kilocalorie 
kJ    kilojoule 
L    generic ligand 
L   litre 
LUMO   Lowest Unoccupied Molecular Orbital 
m   meta- 
m   multiplet (NMR) 
m/z   mass-to-charge ratio  
M   generic metal 
Μ   molar 
mCPBA  m-chloroperoxybenzoic acid 
Me   methyl 
min   minute 
MS   Mass Spectrometry 
µW   microwave 
n   linear 
n.a.   not applicable 
n.d.   not detected 
n.r.   no reaction 
NBS   N-bromosuccinimide 
NCTS   N-Cyano-N-phenyl-p-toluenesulfonamide 
NIS   N-iodosuccinimide 
NMP   N-Methyl-2-pyrrolidone 
NMR   Nuclear Magnetic Resonance 
NOE   Nuclear Overhauser Effect 
NOESY  Nuclear Overhauser Effect Spectroscopy 
Nu   generic nucleophile 
o   ortho-    
p    para- 
pent   pentet (NMR) 
Ph   phenyl 
PIFA   [Bis(trifluoroacetoxy)iodo]benzene 
pin   pinacol 
PMB   4-methoxybenzyl ether 
ppm   parts per million 
Pr   propyl 
q   quartet (NMR) 
R   generic substituent 
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rt   room temperature  
s   second 
s   singlet 
sept   septet (NMR) 
SET    Single Electron Transfer 
sext   sextuplet (NMR) 
SPhos   2-Dicyclohexylphosphino-2’,6’-dimethoxybiphenyl 
t   time 
t   triplet 
T   Temperature 
t   tert- 
TBAB   Tetra-n-butylammonium bromide 
TBAF   Tetra-n-butylammonium fluoride 
TBDPS  tert-butyldiphenylsilyl 
td   triplet of doublets (NMR) 
Tf   triflyl 
THF   tetrahydrofurane 
THP   tetrahydropyrane 
TLC   Thin Layer Chromatography 
TMS   trimethylsilyl 
Tol   tolyl 
Ts   tosyl  
tt   triplet of triplets (NMR) 
UV   Ultraviolet 
vs   versus 
X   generic halogen 
Y   generic heteroatom 
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